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Evolution of phages and their bacterial hosts are directed by interaction between phage and host-
encoded factors. These interactions have resulted in the development of several defense and 
counter-defense strategies such as DNA restriction and antirestriction systems. Type I restriction-
modification (R-M) systems present a barrier to foreign DNA, including phage, entering the 
bacterial cell, by cleaving inappropriately modified DNA in a sequence-specific manner. Phages 
have evolved diverse mechanisms to overcome restriction systems. The temperate coliphage P1 
encodes virion-associated proteins that protect its DNA from host type I R-M systems. By using 
genetic and biochemical analysis, it has been established that the P1 Dar (Dar for defense against 
restriction) system is comprised of at least six virion-associated proteins: DarB, Ulx, Hdf, DarA, 
DdrA and DdrB. DarB protects P1 DNA from EcoB and EcoK restriction in cis by an unknown 
mechanism and is incorporated into the virions only in the presence of Hdf, DarA and DdrA. Hdf 
and DarA have also been found to affect capsid morphogenesis, as their absence results in phage 
progeny with predominantly aberrant small heads. Examination of purified P1 proheads shows 
that Dar system proteins are incorporated into the virion before DNA packaging, and an N-
terminal signal is required for DarB packaging. Twenty-four additional P1 genes of unknown 
function were disrupted and none were found to alter the antirestriction phenotype.  A 
purification protocol for the ~250 kDa antirestriction protein DarB has been optimized, which 
will facilitate biochemical approaches for determining its mechanism of action.   
 
While the phage-host interactions of classical phages such as P1 are better understood, relatively 




hosts.  A high throughput genetic screen of the T1-like coliphage LL5 and the rV5-like coliphage 
LL12 was conducted against the E. coli Keio collection. This screen revealed host receptors 
required for both phages to initiate infection and two chaperones, PpiB and SecB, required for 
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Bacteriophages (phages) are natural predators of bacteria. It has been estimated that 
~96% of phages existing in nature belong to order Caudovirales, characterized by the 
presence of double stranded DNA as genomic material in the capsids and tails as 
infection apparatus (Brussow & Hendrix, 2002; Hatfull & Hendrix, 2011). Tailed phages 
are the most abundant life forms as they have been estimated to be present in numbers 
>1030 and outnumber their bacterial hosts by five- to ten-fold in environment (Brussow 
& Hendrix, 2002; Hendrix, 2002). Phages are categorized into different taxonomic 
groups based upon a system proposed by the International Committee on Taxonomy of 
Viruses (ICTV) (Nelson, 2004). Phages of order Caudovirales are further classified, 
based on tail morphology into different families: Myoviridae (long, straight, contractile 
tail), Siphoviridae (long, flexible, non-contractile tail) and Podoviridae (short, stubby, 
noncontractile tail) (Fig. 1.1) (Maniloff & Ackermann, 1998). This system of 
classification, based on shared characteristics, however, has various limitations. This 
system does not consider the genomic and proteomic information, resulting in resulting 
in grouping of unrelated phages based on their morphology only (Botstein & 
Herskowitz, 1974; Nelson, 2004). Since phage replication involves genetic 
recombination, phage genomes are mosaic, which is not considered in this classification 




characteristics when the phage genomes are obtained from community sequencing 
project (Nelson, 2004). 
 
Advances in structural biology has made analysis of phage structure in atomic resolution 
possible. Based on the conserved folds of structural proteins, Caudovirales phages are 










Fig. 1.1. Morphotypes of Caudovirales phages. Phages belonging to order 
Caudovirales are divided into three families, based upon characteristics of their tails. 
Panel A: Phages of family Myoviridae have long contractile tail. Panel B: Phages of 
family Siphoviridae have long, noncontractile but flexible tails. Panel C: Phages of 
family Podoviridae have short tails. 




from conserved components in a similar pathway (Fig. 1.2) (Fokine & Rossmann, 2014). 
In general, the capsids are icosahedral and are composed of eleven pentameric, and 
twenty hexameric capsomers (Mateu, 2013). One pentameric vertex is occupied by a 
dodecameric ring of portal protein and is called the portal vertex (Aksyuk & Rossmann, 
2011). The assembly of capsids start at the portal vertex in presence of scaffolding 
proteins and major capsid proteins, forming proheads (Fig. 1.2). The scaffolding proteins 
facilitate the assembly of capsid proteins into a definite geometry (Dokland, 1999). DNA 
is packaged into procapsids through the ring of portal proteins by DNA packaging 
machine composed of small and large terminases (Casjens, 2011). Once the DNA is 
packaged, the terminase complex disassociates and the head completion proteins are 
attached to the portal vertex. The head completion proteins serve as the attachment site 
for tails of Myoviridae and Siphoviridae phages, which are assembled in an independent 
pathway. The assembly of tails in Myoviridae and Siphoviridae start at the base plate and 
the hexamers of tail tube and tail sheath are sequentially added to a certain length as 
determined by tape measure protein. However, in Podoviridae phages, tails are 
































Fig. 1.2. General assembly pathway of Caudovirales phages. Schematics represent 
assembly pathway of Myoviridae and Siphoviridae phages. Major capsid proteins, 
scaffolding core and portal proteins assemble into procapsids. DNA is packaged into 
procapsids by DNA packaging complex, followed by maturation of capsids into 
icosahedral geometry. Tails are assembled in an independent pathway and are attached 
to DNA-filled capsids to form complete virions. In Podoviridae phages, tails are 





Phage infection cycle starts with adsorption of phages to the specific receptors on cell 
surface of a host, mediated by the phage receptor-binding protein, also called tail fiber 
proteins (Dowah & Clokie, 2018). This adsorption event is followed by ejection of 
phage genetic material into host cytoplasm. Depending upon if the infecting phage is 
virulent or temperate, a specific life cycle is pursued (Fig. 1.3) (Gill & Hyman, 2010). 
Virulent phages always pursue lytic life cycle, which begins with sequential expression 
of phage proteins to take over host cell, which usually follows by DNA replication and 
synthesis of structural components. Complete virions are assembled and host cells are 
lysed to liberate progeny phages to surroundings (Echols, 1972). Contrary to the 
lifecycle of virulent phages, temperate phages can pursue lytic or lysogenic life cycle. 
The lytic cycle is pursued in a similar fashion as described for virulent phages, whereas 
in lysogenic cycle, phage genome is integrated into host chromosome, in most cases and 
phage-host genome replicate simultaneously. During lysogenic state, genes responsible 
for synthesis of structural proteins and host lysis are repressed. Under certain conditions, 
lysogenic state can be induced to lytic cycle and phage progeny are released into 





























Phage P1 was discovered as a resident prophage in E. coli strain “Li” , along with two 
other phages, P2 and P3, by G. Bertani in 1951 (Bertani, 1951). These three phages, P1, 
Fig. 1.3. Lytic vs lysogenic life cycle. Phage infection cycle starts with adsorption of a 
phage to its host receptors, followed by ejection of its DNA into host cytoplasm. 
Depending upon whether infecting phages are virulent or temperate, phages can pursue 
either lytic or lysogenic life cycle. Panel A: In lytic life cycle, phage DNA replicates 
and simultaneously various components necessary for virion morphogenesis are 
synthesized. Phage DNA is packaged into procapsids by DNA packaging complex. The 
phage capsids and tails are attached forming mature virions. At a genetically 
determined time, the host cell lyses releasing progeny virions into the surroundings. 
Panel B: In lysogenic life cycle, phage DNA is mostly integrated into host 
chromosome. Phage DNA and host DNA are replicated simultaneously. Virulent phages 
can pursue only lytic life cycle, whereas temperate phages can pursue either lytic or 






P2, and P3, could be differentiated by plaque morphology as well as serum inactivation 
assay. The plaques formed by P1 were small, with size of less than 1 mm in diameter 
(Bertani, 1951). Along with other E. coli phages such as , T4 and T7, P1 has played a 
crucial role in the development of molecular biology and the study of phage infection 
cycle. T4 and T7 have a virulent lifecycle whereas both  and P1 have temperate 
lifecycles (Lobocka et al., 2004). Unlike phage  that is integrated into host 
chromosome during lysogeny, P1 is maintained as an extra-chromosomal plasmid (Ikeda 
& Tomizawa, 1968). P1 has been used as a workhorse of gene transduction as it can 
non-specifically package host chromosome (Lennox, 1955; Lobocka et al., 2004). 
 
Virion morphology 
P1 virions have been analyzed extensively by negative-stained electron microscopy. P1 
is a member of Myoviridae family and has an icosahedral head, and a long contractile 
tail that terminates in six tail fibers (Walker & Anderson, 1970; Lobocka et al., 2004). It 
has been reported that the lysates of P1 consist of virions of three different head sizes: 
P1B with ~86 nm, P1S with ~65 nm, and P1M with ~45 nm side-to-side diameter. The 
ratio of sizes of P1B:P1M:P1S is 4:3:2, which corresponds to T values of 16, 9 and 4 for 
P1B, P1M and P1S respectively (Walker & Anderson, 1970). Only the virions of head-
size class P1B can package the full-length genome, hence are infectious. On the 
contrary, virions of both P1S and P1M cannot package full-length genome and thus, do 
not have a complete set of genetic elements required to establish a successful infection 





The host specificity of P1 is determined by a 4.2 kb invertible C segment which involves 
a similar mechanism as in phage Mu (Iida, 1984). The C segment consists of tail fiber 
genes Sv-U or Sv’-U’, encoding the variable region of tail fibers, which is fused to the 
constant region encoded by Sc (Guidolin et al., 1989a). Cin, a site-specific recombinase, 
is encoded by a gene adjacent to the C segment and mediates recombination between the 
0.6 kb inverted repeats flanking the C segment, which form the cix ( for C inversion 
cross-over) sites (Iida et al., 1982). P1 virions induced from lysogens have both C(+) 
and C(-) orientations, whereas P1 virions produced from lytic infection have only C(+) 
orientation (Iida et al., 1982). P1 with C(+) orientation can infect both E. coli K12 and E. 
coli C, whereas P1 with C(-) orientation only infects an E. coli mutant (Iida et al., 1982). 
 
DNA packaging  
The infective virions of P1 contain of ~94 kb cyclically permuted, linear, double-
stranded DNA with a terminal redundancy of 10-15 kb (Sternberg, 1990; Lobocka et al., 
2004). P1 genome consists of 117 predicted genes, organized into 45 operons, of which 
112 are translated into proteins and five code for untranslated RNA’s (Lobocka et al., 
2004). The genomic DNA is produced as linear concatemers and packaged into P1 
procapsids by a headful mechanism by the P1-encoded pacase proteins, PacA and PacB 
(Skorupski et al., 1994a). P1 DNA contains a consensus pac sequence, which is 
recognized and cleaved by P1 pacase proteins, followed by packaging of the cleaved 




DNA in a non-sequence-dependent manner and initiates packaging of the remaining 
linear concatemeric DNA substrate into a new procapsid. After DNA packaging, P1 tails 
and DNA-filled capsids are attached to form complete P1 virions (Sternberg, 1990; 
Skorupski et al., 1994b).  
 
Cyclization of P1 DNA following infection 
After recognizing a specific bacterial host, P1 ejects its DNA into host cytoplasm. Once 
in the cytoplasm, unlike other phage DNA, P1 DNA exists as a self-replicating, extra-
chromosomal, circular form. P1 encoded recombinase protein Cre (for causes 
recombination) and loxP [for locus of crossing over (x), P1] sites, at which 
recombination occurs, are necessary for circularization of P1 DNA following infection 
(Sternberg & Hamilton, 1981; Hochman et al., 1983). The conversion of the linear DNA 
in the P1 capsid to the covalently closed circular form in host cytoplasm, after infection, 
occurs by an intramolecular recombination event that leads to the removal of the 
redundant portion of the DNA (Segev et al., 1980). This recombination event results in 
the genetic map of P1 being linear, despite P1 DNA being cyclically permuted, in 
contrast to the circular genetic maps of other phages such as P22 or T4 (Sternberg & 
Hamilton, 1981). Because of the linearity of P1 genome, P1 genes on the ends of the 
genome are not linked together (Sternberg & Hamilton, 1981). The Cre-loxP system also 
mediates the segregation of P1 prophage into daughter host cells during lysogenic 
growth by resolving a P1 dimer composed of two P1 monomers (Sternberg et al., 1986). 




cerevisiae, it has been used extensively in other eukaryotes for genome editing (Sauer, 
1987; Lambert et al., 2007). P1 DNA is also circularized by the host RecBCD nuclease 
complex. There is a total of 50 recombinational host spot Chi sites in positive and 
negative strands of P1 DNA. RecBCD complex functions as a 3’-to-5’ nuclease, but 
when this complex encounters Chi sites in P1 genome, the enzymatic activity of the 
complex is switched to recombination-promoting form and thus helps in homologous 




After circularization of DNA, P1, being a temperate phage, can pursue either lytic or 
lysogenic infection cycle. This lytic-lysogenic decision is controlled by genes in P1 
immunity circuitry, which is distributed in three regions of P1 genome: ImmC, ImmI and 
ImmT (Fig. 1.4) (Yarmolinsky, 2004). Among the temperate phages studied, the 
immunity region of P1 and P7 is the most complex one (Heinrich et al., 1995). The 
ImmC region consists of the c1 (master repressor) and coi (C1 inhibitor). The ImmI 
region include genes that code for translational repressor RNA, C4, and antirepressor 
proteins, Ant1and Ant2. The ImmT region has a gene, lxc that codes for a corepressor 
(Fig. 1.4) (Yarmolinsky, 2004). C1 and Coi are antagonistic to each other (Yarmolinsky, 




























Fig. 1.4. Lysis-lysogeny decision in P1. Panel A: The decision to pursue lytic or 
lysogenic lifecycle in P1 is determined by the immunity circuitry, located in three 
regions of temperate phage P1 genome (represented by circle): ImmC, ImmT and ImmI. 
ImmC encodes C1 (master repressor) and Coi, ImmT encodes Lxc and ImmI encodes 
C4 (RNA), Ant1 and Ant2. Panel B: The lytic or lysogenic lifecycle is decided by the 
interplay between different factors. If C1 prevails, lysogeny is established, whereas if 
Coi prevails, lytic replication is established (Heinrich et al., 1995), (Yarmolinsky, 2004), 




regulates the expression of genes required for lytic pathway, including Coi, whereas Coi 
inactivates C1 by direct interaction. The RNA, C4 blocks the ribosome binding site in 
the transcript of the antirepressor proteins, thereby reducing the cellular concentration of 
the antirepressor proteins. These antirepressor proteins inactivate the C1 repressor 
(Heinrich et al., 1995; Yarmolinsky, 2004). Lxc forms a complex with C1, and enhances 
the binding affinity of C1 to its operators, consequently resulting in the lowered 
expression of C1 itself (Yarmolinsky, 2004). Moreover, the ability of Coi to inhibit C1 
repressor activity is inhibited in the presence of Lxc. The decision to pursue lytic or 
lysogenic lifecycle, upon infection of host by P1, is determined by the competition 
between C1 and Coi proteins (Heinrich et al., 1995). If C1 synthesis is maintained, 
lysogeny growth is established, whereas if Coi synthesis is maintained, lytic growth is 
established (Lobocka et al., 2004). In our study, we have used P1 with temperature 
sensitive C1 repressor. At non-permissive temperature, C1 is degraded and lytic 
infection cycle is induced (Lobocka et al., 2004). 
 
Host lysis 
Phages of Gram-negative bacterial hosts are released into the surroundings after the 
disruption of the cellular membrane and the peptidoglycan layer. Usually, host lysis is 
accomplished by actions of three proteins. The holins create “holes” in the inner 
membrane releasing endolysins to the periplasmic space where the peptidoglycan layer 
is degraded by enzymatic activity of the endolysins (Young, 2013). In the final step, 




(Rajaure et al., 2015). The host lysis steps mediated by P1 is unique in that the export of 
endolysins to the periplasmic space is not dependent on holins (Xu et al., 2004).  P1 
endolysin, Lyz, has a N-terminal SAR (for signal-anchor and release) sequence and is 
exported and tethered in an inactive form to the inner membrane by the sec translocon. 
The SAR sequence is also sufficient for the release of Lyz from the inner membrane into 
the periplasmic space, without any proteolytic cleavage of the sequence, and this release 
occurs because of the collapse of the membrane potential(Xu et al., 2004).  
 
Host defense against phages 
It has been estimated that ~1023 phage infections occur every second (Hatfull & Hendrix, 
2011), which provide enormous selection pressure on bacterial host. Since bacteria need 
to survive constant predation by phages, bacteria have evolved a wide arsenal of defense 
systems to thwart the phage infection cycle (Fig. 1.5). In turn, phages are constantly 
evolving with antidefense systems to overcome these bacterial defense systems. This 
constant co-evolution of phages and their bacterial hosts have led to an evolutionary 
arms race, resulting in significant diversity in defense systems of bacteria and phages 































Fig. 1.5. Host defense against different stages of phage infection cycle. Bacteria have 
defense mechanisms to thwart phage infection at various stages. Bacteria can prevent 
adsorption of phages to the receptors by masking receptors with extracellular materials 
or by modifying receptors themselves. Even after successful adsorption, bacteria can 
prevent the ejection of phage DNA into cytoplasm by obstructing the DNA entry point. 
In the cytoplasm, phage DNA can be cleaved by CRISPR-Cas systems or Restriction-
Modification systems. Moreover, bacteria possess abortive infection or assembly 
interference mechanisms that eventually prevent the formation of mature virions 




Changes in receptors 
The first step of phage infection cycle is the recognition and adsorption to the specific 
receptors on the surface of host cell by the receptor binding proteins of the phages. The 
receptors are present on the outer surface of the host cells and may be comprised of 
proteins, polysaccharides and lipopolysaccharides (Samson et al., 2013). Bacteria have 
different strategies to prevent the adsorption of phages. The common theme of these 
strategies is to mask the specific receptor component. In Staphylococcus aureus, 
increased secretion of protein A has been shown to mask specific phage receptors 
(Nordstrom & Forsgren, 1974). Similarly, the K1 polysaccharide capsule of E. coli has 
been shown to prevent T7 infection (Scholl et al., 2005). In another instance, in 
Bordetella spp., phase variation, under the control of the BvgAS two-component 
regulatory system, determines the expression of receptors and hence, phage infection 
(Liu et al., 2002). Similar phase variation has also been reported in Vibrio cholerae O1 
serogroup strains, in which the expression of O1 antigen determines if the cells are 
susceptible to phage infection or not (Seed et al., 2012). Likewise, in other cases, 
extracellular components such as alginates, hyaluronan and glycoconjugates act as a 
barrier to prevent phages from accessing their specific receptors (Labrie et al., 2010).  
 
Phages have evolved with strategies to overcome this barrier provided by bacterial cells 
which masks receptors. By generating mutations in the host specificity determining gene 
mtd, Bordetella phage BPP-1 can infect host expressing different receptors (Liu et al., 




exopolysaccharide matrix surrounding the host, which might be necessary to reach the 
cell surface and initiate infection (Hanlon et al., 2001; Cornelissen et al., 2012). 
Moreover, several instances have also been reported where phages have acquired the 
ability to recognize these extracellular barriers as host receptors (Gross et al., 1977; 
Steinbacher et al., 1997).  
 
Blocking DNA entry into cytoplasm 
Only after recognition of the cell surface receptors, phage genetic material is ejected into 
host. This stage of phage infection cycle can be prevented by superinfection exclusion 
(Sie) systems. The Sie systems are encoded by phage genomes; thus, these systems 
specifically define the phage defense systems to prevent infection by closely related 
phages. The Sie proteins are localized in the membranes and prevent the phage genetic 
material from being delivered to the cytoplasm (Labrie et al., 2010). The well-studied 
coliphage T4 has two Sie proteins, Imm and Sp. Imm prevents the transfer of T4 DNA 
into the cytoplasm by interfering with the injection site (Vallee & Cornett, 1972; Lu & 
Henning, 1989). T4 tail-associated protein gp5 assists in DNA ejection process with its 
lysozymic activity by degrading peptidoglycan layer. The other Sie protein, Sp inhibits 
the activity of T4 gp5, thereby blocking DNA ejection into cytoplasm (Kao & McClain, 
1980). Other Sie systems are also described in coliphage P1 (Kliem & Dreiseikelmann, 
1989), HK97 (Cumby et al., 2012) and Salmonella enterica phage P22 (Susskind et al., 





The Sie system of P1 is encoded by sim gene in immC region of P1 genome (Kliem & 
Dreiseikelmann, 1989). Sim is synthesized as a ~25 kDa protein, which is proteolytically 
processed at its N-terminus to yield a ~24 kDa protein in a SecA-dependent manner. Sim 
is predicted to localize either in the membrane or the periplasmic space and prevents P1 
superinfection (Maillou & Dreiseikelmann, 1990). 
 
Degradation of phage DNA 
Once successfully introduced to the host cytoplasm, the phage genetic material still must  
overcome host defenses such as CRISPR (for Clustered regularly interspaced short 
palindromic repeats)- Cas (for CRISPR-associated) and R-M (for Restriction-
Modification) systems mediated cleavage of the genetic material (Labrie et al., 2010).  
 
CRISPR-Cas 
CRISPR-Cas systems are the nucleic-acid based adaptive immunity systems that provide 
protection against foreign DNA including phage DNA, in which DNA fragments of an 
infecting phage are incorporated into CRISPR arrays and subsequent infection from the 
same phage is prevented (Barrangou et al., 2007). CRISPR arrays consist of several 
partially palindromic repeats (CRISPR repeats, 23-55 nt) separated by variable (CRISPR 
spacers, 21-72 nt). These CRISPR arrays are often adjacent to cas genes (Barrangou et 
al., 2007; Barrangou & Marraffini, 2014). In general, protection provided by CRISPR-
Cas systems involve three distinct steps. In the first step, the spacer sequences are 




CRISPR arrays are transcribed and processed into CRISPR RNAs, which form a 
complex with Cas proteins. Eventually, upon infection by the same phage, the 
complementary base-pairing of CRISPR RNAs and phage genome results in the 
degradation of the target (Stern & Sorek, 2011; Barrangou & Marraffini, 2014; Leon et 
al., 2018). CRISPR-Cas systems are categorized into two major classes based on the 
organization of effector proteins, that mediate CRISPR RNA processing, and target 
recognition and cleavage (Koonin et al., 2017).  
 
Phage have diverse mechanisms to prevent CRISPR-Cas mediated DNA degradation. 
Any mutations in the spacer targeted (protospacer) region or the PAM (for protospacer-
adjacent motif) will render CRISPR-Cas ineffective (Deveau et al., 2008; Pawluk et al., 
2018). Moreover, recent studies have discovered several anti-CRISPR proteins encoded 
in phage genomes, that inhibit CRISPR-Cas systems (Bondy-Denomy et al., 2013; 
Pawluk et al., 2016a; Pawluk et al., 2016b; Rauch et al., 2017). 
 
Restriction-Modification systems 
The R-M systems are the innate host defense systems which specialize in cleaving the 
foreign DNA based on its modification status. The effects of R-M systems were initially 
observed as the host specificity imparted to phages after they were propagated on 
different hosts (Bertani & Weigle, 1953). It was later demonstrated that the factors 
determining host specificity were physically linked to phage DNA (Arber & Dussoix, 




& Arber, 1962). The R-M systems are broadly categorized into three types, type I, II and 
III, based on subunit composition, cofactor requirements, recognition site and cleavage 
position (Murray, 2000; Tock & Dryden, 2005). This study focuses on the P1 
components that are required to protect phage DNA from the restriction function of type 
I R-M system. 
 
The genes encoding components of type I R-M system were first identified in 1970 
(Hubacek & Glover, 1970). The type I R-M systems are hetero-oligomeric complexes,  
encoded by three genes hsdS, hsdM and hsdR (hsd for host specificity determinant) (Fig. 
1.6) (Murray, 2000). Unlike type I R-M systems, type II and III are composed of two 
subunits only. The main characteristics of these two systems and their differences with 
type I R-M systems are highlighted in (Table 1.1). HsdS (S) is the specificity subunit 
that enables any type I R-M complex to recognize specific base sequences. HsdM (M) is 
the modification subunit that adds methyl group in a sequence-dependent manner and 
HsdR (R) is the restriction subunit that cleaves the DNA under certain conditions (Tock 
& Dryden, 2005). The three subunits of type I R-M system can form two forms of 
complexes; modification complex and restriction complex. Both complexes recognize an 
asymmetric, bipartite sequence. The modification complex is composed of M and S 
subunits in the stoichiometric ratio of 2:1 (M2S1), whereas the restriction complex is 
composed of all R, M and S subunits in the stoichiometric ratio of 2:2:1 (R2M2S1). The 
modification complex can only modify the DNA in a sequence-dependent manner, 


























Fig. 1.6. Fate of foreign DNA depends on the methylation status of the recognition 
sequence. Panel A: The type I R-M system is a complex composed of three subunits: 
HsdS (S), HsdM (M) and HsdR (R). The S subunit provides sequence specificity to the 
complex, the M subunit has the active site to methylate specific bases within the 
recognition site, whereas the R subunit has the active site to cleave the DNA. The three 






















methylate or cleave the DNA depending upon its methylation status. Panels B and C: 
The foreign DNA can be hemi-methylated or unmethylated (methylation status denoted 
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Table 1.1. Characteristics of different R-M systems. The characteristics of different 
R-M systems are highlighted (Kruger & Bickle, 1983; Tock & Dryden, 2005). The 
methylation activity of the R-M systems described in the table occurs with the 
recognition sequence, whereas the site for DNA restriction varies according to the type 
of R-M systems. Adenine is methylated at N6 position, whereas cytosine is methylated 













































































methylation status of the recognition sequence. If the DNA is hemi-methylated, the 
restriction complex methylates a specific base in the complementary strand, and only if 
the DNA is unmodified or inappropriately modified in both strands, the restriction 
complex cleaves the DNA (Fig. 1.6) (Murray, 2000). The type I R-M complex requires 
AdoMet, Mg2+ and ATP as cofactors. HsdM provides binding interface for AdoMet, 
whereas HsdR provides binding interface for Mg2+ and ATP. AdoMet acts as the methyl 
donor and is the only cofactor required for the modification activity. However, all of 
AdoMet, Mg2+, and ATP are required for restriction activity (Table 1.1) (Meselson & 
Yuan, 1968; Tock & Dryden, 2005).  
 
Restriction of foreign DNA by type I R-M systems leading to specific activity involve a 
series of steps. In general, the enzyme complex gets activated by binding to AdoMet and 
the activated complex binds to DNA. Upon binding to ATP, the complex can recognize 
methylation status in recognition site. If DNA is methylated, the complex is released 
from DNA. If DNA is hemi-methylated, a specific base in recognition site in the 
complementary strand in methylated. If DNA is unmethylated, DNA is translocated and 
cleaved several kb away from the recognition site, accompanied by ATP hydrolysis (Fig. 








Bacterial host may contain any specific type I R-M system. Depending upon the 
restriction background of the host, the DNA of progeny phage will have sequence 
specific modification (Fig. 1.7). On the contrary, if the bacterial host does not have any 
functional type I R-M system, the DNA of progeny phages will not have any sequence 
specific modification. If the sequence specificity of the type I R-M system of the new 
host is same, then the modified phage DNA, upon ejection into host cytoplasm, is not 
cleaved, and the phage can establish infection efficiently. In another case, if the phage 
DNA is unmethylated at the recognition sequence of the type I R-M system of the new 
host, phage DNA is cleaved and phages have lower plating efficiency (Fig. 1.7). 
 
Phages have evolved with diverse mechanisms to overcome the type I R-M system 
mediated DNA cleavage. The mechanisms of how paradigm phages such as T3, T4, T7, 
Mu, , and P1 protect their genome from host type I R-M system mediated DNA 


































Fig. 1.7. Unmethylated phage DNA is cleaved by host type I R-M system. 
Depending upon the restriction background of host, the phage propagated in the host 
could have modification in a particular recognition sequence (modification denoted by 
★). Upon infection of a new host, phage DNA is encountered by the type I R-M system 
of the new host. If the recognition sequence of this type I R-M system in the phage 
DNA is modified, the DNA is not cleaved and the phage can plate efficiently. In other 
case, if phage DNA is unmodified at the recognition sequence, then it is cleaved and the 





    
Table 1.2. Antirestriction mechanism of phages. Phages have diverse mechanisms 
of overcoming the type I R-M system of their bacterial host. Some mechanisms of 
well-studied phages have been mentioned in the table. See text for details.  




Dimer of Ocr mimics the phosphate backbone of 
B-form DNA and binds to the type I R-M complex, 
inactivating its function. T3 ocr also hydrolyzes 
SAM, a co-factor for type I R-M system. 
(Studier & Movva, 1976; 
Kruger & Bickle, 1983; 
Atanasiu et al., 2002) 
T-even N/A 
Hypermodification of DNA: The cytosine of 
genome is replaced by hydroxymethyl cytosine, 
which is again glucosylated. 
(Volkin, 1954; Kornberg 
et al., 1961; Kruger & 
Bickle, 1983) 
Mu Mom Acetimidation of adenine in genome. (Kruger & Bickle, 1983) 
 Ral 
Enhances methylation function of type I R-M 
complex. 
(Zabeau et al., 1980; 
Kruger & Bickle, 1983) 
P1 DarB 
Proposed to methylate DNA upon ejection into host 
cytoplasm. 
(Iida et al., 1987; Piya et 
al., 2017) 














Phages T3 and T7 protect DNA from type I R-M system by expressing protein gp0.3. 
The protein gp0.3, also called Ocr (Ocr for overcome classical restriction), is one of the 
early proteins expressed following T3 and T7 infection (Studier, 1973). The dimer form 
of Ocr mimics the size, shape and charge of bent B-form DNA and inhibits the type I R-
M complex by directly binding to the DNA binding region of the complex (Walkinshaw 
et al., 2002). The binding affinity of the type I R-M complex to Ocr is stronger than that 
for DNA (Samson et al., 2013). Because of this direct interaction between Ocr and type I 
R-M complex, the type I R-M complex cannot bind to DNA, and hence it is unable to 
degrade foreign DNA (Tock & Dryden, 2005). T3 Ocr protein also inhibits the type I R-
M system by hydrolyzing AdoMet, which is a co-factor required for the biological 
activity of type I R-M system (Studier & Movva, 1976; Spoerel et al., 1979). In the 
absence of AdoMet, the type I R-M system cannot be activated to degrade foreign DNA 
(Tock & Dryden, 2005).  
 
The ability of the T-even phages, T2, T4 and T6, to evade restriction provides an 
example of how phage-host interactions has shaped evolution. These phages  incorporate 
an unusual base hydroxymethylcytosine (HMC) in its genomic DNA (Volkin, 1954; 
Lehman & Pratt, 1960; Kornberg et al., 1961; Kruger & Bickle, 1983). Because of the 







restriction complexes that have cytosine in the recognition sequence. To overcome this 
feature of T-even phages, host cells have acquired the modification-dependent systems 
(MDSs) such as McrA, McrBC and Mrr that can cleave hydroxymethylated DNA 
(Raleigh & Wilson, 1986). Interestingly, DNA of T-even phages are also glucosylated at 
HMC, hence these DNAs are also protected against these MDSs (Volkin, 1954; Lehman 
& Pratt, 1960; Kornberg et al., 1961; Kruger & Bickle, 1983). However, a prophage 
encoded two-component system consisting of proteins, GmrS and GmrD (Gmr for 
glucose-modified restriction), which can degrade glucosylated HMC, have been found in 
E. coli strain CT596. To protect DNA from GmrS-D restriction systems, T-even phages 
inject hundreds of virion-associated internal protein I (IPI), which inactivate the nuclease 
activity of the GmrS-D restriction systems (Abremski & Black, 1979; Rifat et al., 2008; 
Labrie et al., 2010).  
 
A peculiar epigenetic modification is present in phage Mu DNA, which make its DNA 
insensitive to restriction from type I R-M complex because of the function of phage gene 
mom (mom for modification of Mu). Owing the gene function of mom, ~15% of adenine 
residues in Mu DNA is modified by acetimidation (Kruger & Bickle, 1983).  
 
The genome of phage  contains the gene ral (for restriction alleviation) that contributes 
to protecting DNA from type I R-M systems (Zabeau et al., 1980). The antirestriction 
protein Ral enhances the modification activity of type I R-M complex, thereby lowering 




Loenen & Murray, 1986; Samson et al., 2013). Because of this, cleavage of  DNA by 
the type I R-M complex is alleviated. 
 
Following infection of its E. coli host, phage P1 injects Dar (for defense against 
restriction) proteins to protect its DNA from host type I R-M system (Iida et al., 1987). 
Iida et al. discovered that two P1 loci provided restriction protection against a subset 
type I R-M system and hence, were named accordingly. DarA protected P1 DNA from 
EcoA-mediated restrictioon, and DarB protected P1 DNA from EcoB- and EcoK-
mediated DNA cleavage. Dar proteins are virion-associated and act only in cis. 
However, they can protect any DNA that is packaged into P1 capsids. Packaging of 
DarB into virions was known to be dependent on the presence of DarA because darA- 
phages were phenotypically darB- (Iida et al., 1987). DarA is synthesized as a high-
molecular-weight precursor and is proteolytically processed at the N-terminus. Only the 
processed form of DarA is packaged into P1 virions (Streiff et al., 1987). The genes 
encoding these Dar proteins were found in two distinct regions of P1 genome (Lobocka 
et al., 2004). The genes near darA and including darA itself, were also shown to affect 
virion morphogenesis, but the phenotype was not distinctly assigned to any gene (Iida et 
al., 1998). All three of these type I R-M systems have specific recognition site and 







   
Table 1.3. Recognition sequence of type I R-M 
systems. Three type I R-M systems used in our study has 
their own sequence specificity. The recognition sequence 
for any type I R-M system is bipartite. There are two 
groups of specific sequences: One in the 5' end and the 
other in the 3' end. These two groups are separated by 
non-specific bases. The red face A (5' group) is 
methylated by the type I R-M complex in the positive 
strand, whereas the complementary base A in the to the 
bold face T (3' group) is methylated in the negative 
strand (Loenen et al., 2014). There are different number 
of recognition sites in the P1 genome for these type I R-
M systems. 
Type I R-M 
System 
Recognition sequence       
(5'-3') 
Number of sites 
in P1 genome 
EcoA GAG(N7)GTCA 2 
EcoB TGA(N8)TGCT 20 
EcoK AAC(N6)GTGC 11 















Abortive infection  
Even when phages survive the R-M and CRISPR-Cas systems, other bacterial defense 
systems such as abortive infection and assembly interference can still prevent phage 
infection cycle (Chopin et al., 2005; Seed, 2015). Compared to other bacterial defense 
systems, abortive infection results in the death of host cell, thus this defense system is 
also referred to as altruistic death of host cells to prevent phage multiplication so that the 
surrounding bacterial population can be protected from phage predation (Fineran et al., 
2009). The phage  encoded Rex system is the best characterized abortive infection 
system. Upon activation, the Rex system depolarizes the membrane resulting in lowered 
cellular ATP concentration, which ultimately stops all cellular processes and thus 
prevents phage multiplication (Parma et al., 1992). Several other abortive systems have 
also been reported to directly target different stages of the phage infection cycle such as 
DNA replication (Emond et al., 1997), phage transcripts (Parreira et al., 1996), and 
inducing early lysis (Durmaz & Klaenhammer, 2007).  
 
Assembly interference 
The assembly of certain phage particles can also be prevented by the action of phage-
inducible chromosomal islands (PICIs) such as Staphylococcus aureus pathogenicity 
islands (SaPIs) (Seed, 2015). Unlike above described abortive infection, this type of 
assembly interference still allows cellular processes to proceed, resulting in the 
formation of phage-like, but non-infectious particles (Tallent et al., 2007; Fillol-Salom et 




by the infection of specific helper phages and contribute to lateral gene transfer (Lindsay 
et al., 1998). Upon induction of PICIs, replication of target phage is limited by the 
elements of PICIs, which redirect phage replication to PICI replication and use phage 
encoded structural proteins to package PICI-specific DNA, resulting in the formation of 
non-infectious, phage-like particles (Ram et al., 2012). The PICIs have a well-conserved 
genetic organizations and are specially characterized by absence of structural and lysis 
genes (Fillol-Salom et al., 2018).  
 
A similar PICI-like element (PLE) has been reported in Vibrio cholera as well. It has 
been shown that phage ICPI overcomes Vibrio PLE by encoding a CRISPR-Cas system 
in the phage genome, which targets the PLE genome (Seed et al., 2013). 
 
Assembly of capsid-associated proteins 
The Dar antirestriction proteins of P1 and IP1 antirestriction proteins of T4 are 
comparable in that both of these proteins are assembled into the mature virions and are 
injected into the host cells during the infection cycle to protect phage DNA from 
restriction (Iida et al., 1987; Rifat et al., 2008). Contrary to scarce information available 
on P1 head morphogenesis, there is wealth of information available on T4 head 
morphogenesis. There are several instances where phages are found to deliver proteins to 
host cells, in addition to the genetic material. The well-studied Salmonella enterica 
phage P22 also injects proteins following infection of the host cells (Jin et al., 2015). 




proteins”), which are essential for infection, and have been shown to be injected into the 
host cells (Jin et al., 2015). Both IPs of T4 and E proteins of P22 are assembled in the 
virion capsids during initial stages of capsid morphogenesis (Thomas & Prevelige, 1991; 
Leiman et al., 2003). 
 
The assembly pathway of prokaryotic viruses shares a significant similarity. The capsid 
morphogenesis in most bacteriophages and eukaryotic viruses such as herpesviruses and 
adenoviruses start with the formation of a protein shell that is later packed with the 
genetic material. The steps involved in capsid morphogenesis of different phages T4, 
P22, HK97 are different, but in general this process requires portal, major capsid and 
scaffolding proteins. The portal proteins occupy one of the twelve vertices of icosahedral 
phage capsids and form a dodecameric ring (Aksyuk & Rossmann, 2011; Veesler & 
Johnson, 2012). The portal proteins act as a nucleation factor and recruits major capsid 
and scaffolding proteins to form a protein procapsid shell of correct size and shape. The 
scaffolding protein core, which could be made of one or multiple proteins, determines 
the size and shape of the capsid for a phage. The scaffolding proteins are also required 
for the incorporation of internal proteins such as IPs of T4 and E proteins of P22 in the 
procapsid shell (Veesler & Johnson, 2012; Mateu, 2013). Since the morphogenesis 
pathway of P1 has not been studied in a great detail, there is no information on the role 
of portal and scaffolding proteins in capsid size determination and incorporation of other 




that the virion-associated antirestriction components of P1 are assembled in the capsid 
following a definite pathway (Chapter II). 
 
Questions to be addressed 
Interest in P1 antirestriction system, DarB in particular, stems from the results of 
bioinformatic analysis that indicates that P1 DarB-like proteins are conserved (Gill et al., 
2011). Most of these DarB-like proteins are associated with mobile DNA elements such 
as plasmids, conjugative transposons, insertion sequences, integrative conjugative 
elements or genomic islands. This suggests that these DarB-like proteins might protect 
these DNA elements when they are mobilizing across hosts with different restriction 
background. In some cases, these DNA elements are associated with virulence factors, 
antibiotic resistance or phenotypic conversion, which raises public health concern, thus 
the genetic and biochemical study of DarB is of great significance (Gill et al., 2011).  
 
Using P1 and its E. coli host with different type I R-M systems, the mechanism of how 
P1 antirestriction system protects its genome from type I R-M system mediated DNA 
cleavage will be studied. As described above, phage P1 ejects Dar proteins into its host 
to protect its DNA from host type I R-M systems. The original study reported by Iida et 
al. in 1987 implies DarA and DarB as the constituent proteins of P1 antirestriction 
system.  In addition, in 1998, Iida et al. reported that some genes in the darA operon 
affected capsid morphogenesis. However, the phage mutants used in those studies were 




thus ascribing a phenotype to a particular gene was ambiguous. Throughout this study a 
 Red-mediated genetic recombineering approach was used to construct isogenic gene 
deletions in P1 prophage and plasmid-based complementation system to verify the 
phenotypes. In Chapter II, several genes are interrogated to determine if components 
other than the darA and darB operons are important in the antirestriction system. It has 
been demonstrated that hdf, ddrA and ddrB from the darA operon and ulx from the darB 
operon form this multicomponent antirestriction system. Besides, it has been shown that 
these genes encode virion-associated proteins and these proteins are incorporated in the 
mature virions following a definite pathway. Moreover, the roles of hdf and darA in 
head-size determination of P1 virions have also been established. Building up from our 
findings described in Chapter II, P1 antirestriction system has been further characterized 
in Chapter III. Chapter III has three parts: In the first part, P1 genes of unknown 
functions have been tested for their role in protecting P1 DNA from type I R-M systems. 
In the second part, it has been determined that the antirestriction proteins are 
incorporated in the virions before packaging of DNA. More importantly, a few N-
terminal residues of the antirestriction protein DarB were found to be significant in 
directing the incorporation of DarB into P1 virions. In the third part, expression and 
purification of DarB have been optimized to obtain DarB for testing the biochemical 
mechanism of antirestriction function.  
 
Understanding phage-host relationship is crucial for several reasons. Food and 




products. Thus, the emerging phage population, which could propagate on the selected 
bacterial strains, have to be constantly evaluated to ensure continuous product 
development (Labrie et al., 2010). Moreover, due to the emergence of antibiotic resistant 
bacteria, phage therapy, the use of phages to treat bacterial pathogens, is receiving 
renewed interest. Classical phage biology has relied on isolating novel phages from 
environmental sources for any bacterial strains. With the advances in systems and 
synthetic biology, the concept of synthesizing phages with a broader host range and 
host-independence have been proposed. As co-evolutionary arms race between phages 
and bacteria result in spectacular host-phage interactions, it is crucial to understand these 
relationships to successfully engineer any phages. Since bacteria can readily become 
resistant to phages by mutating the receptors, it is important to characterize the receptors 
so that phages targeting different receptors can selected for therapeutic purposes. 
Because of the adaptability of phage genomes, most of the sequenced phage genes are of 
unknown function. Since the genetic material of phages is ejected into the host cells in 
each infection cycle, efforts should be made to understand the essentiality of these genes. 
More importantly, phages also use internal host factors such as chaperones, transcription 
factors during infection cycle. These interactions must be understood especially in 
context of therapeutic phages so that robust phages that do not rely completely on host 
factors can be engineered and selection of phage resistant bacteria can be limited  





Chapter IV discusses application of high-throughput genetic screen to study host-phage 
interactions of novel E. coli phages, LL5 and LL12, belonging to TLS- and rV5-like 
group, respectively. Receptors for these two phages have been characterized and it has 
been discovered that two chaperones, PpiB and SecB, are required for efficient infection 







THE MULTICOMPONENT ANTIRESTRICTION SYSTEM OF PHAGE P1 IS 
LINKED TO CAPSID MORPHOGENESIS1  
 
Introduction 
Bacteriophage P1 was discovered by G. Bertani in 1951 as a temperate phage residing in 
Escherichia coli strain “Li” (Bertani, 1951). P1 is a myophage of the order Caudovirales, 
with a 94 kilobase (kb) unit genome of linear dsDNA (Lobocka et al., 2004); unlike most 
other known temperate phages, P1 lysogenizes E. coli as a circular plasmid maintained 
at one copy per host chromosome (Ikeda & Tomizawa, 1968; Rosner, 1972). P1 has also 
played a major role in molecular genetics as the premier generalized transducing phage 
of E. coli (Lennox, 1955; Calendar, 1988).  
 
In Caudovirales phages such as P1, the infection cycle begins with the adsorption of the 
phage to the host surface and the ejection of phage DNA into the host cell. Bacteria have 
several mechanisms to defend themselves against phage infection, including restriction 
and modification (R-M) systems that recognize and cleave foreign DNA in a site-
specific manner (Fig. 2.1A).  These systems are broadly divided into three categories, 
type  I, II and III, which are distinguished by their subunit makeup, DNA cleavage 
                                                 
1 Reprinted with permission from “The multicomponent antirestriction system of phage P1 is linked to 
capsid morphogenesis” by Piya D., Vara L., Russell W.K., Young R. and Gill J.J., 2017. Mol Microbiol. 




mechanisms and the nature of their DNA recognition sequences (Kruger & Bickle, 1983; 





















Fig. 2.1. The antirestriction system of phage P1 protects DNA from type I 
restriction and modification (R-M) mediated cleavage. Reprinted with permission 
from Piya et al., 2017. Panel A. Phage infection begins with the translocation of the 
linear 95 kb P1 genome from the phage head into the host cytoplasm.  Depending on 
the bacterial host where phages are propagated, specific bases in the phage DNA are 
methylated (denoted as stars). If the methylation pattern in the DNA matches the 
specificity of the host type I R-M system, the DNA is protected from cleavage (left), 
resulting in normal plating efficiency.  If the phage DNA is unmethylated (or 
improperly methylated), the DNA is cleaved by the host type I R-M system (middle), 
resulting in reduced plating efficiency. Iida et al. (1987) demonstrated that in P1, 
virion-associated proteins (triangles) can protect P1 DNA from type I restriction, even 
if it is unmodified (right). It is believed that at least some of these virion-associated 



























Fig. 2.1 Continued. Panel B. Partial genomic map of P1 shows genes associated with 
the antirestriction system. Rectangular blocks represent genes, and those above the 
black line are transcribed rightwards, and genes below the line are transcribed 
leftwards. Besides the previously described darA and darB, several other genes are 
associated with the P1 antirestriction system. The dar genes (grey) are organized in 
two separate predicted transcriptional units. One transcript contains darB and ulx 
(darB operon, driven by the P
darB
 promoter) and the other contains hdf, darA, ddrA and 
ddrB (darA operon, driven by P
dar
).  The ruler at the bottom of the figure corresponds 





Type I R-M systems are composed of three subunits, HsdR (R), HsdM (M) and HsdS (S) 
(Hsd for host specificity of DNA). These subunits can form two different oligomeric 
complexes; R2M2S1, which can catalyze both restriction and modification, and M2S1, 
which can only catalyze modification (Suri et al., 1984; Murray, 2000). The HsdS 
subunit recognizes specific, bipartite DNA sequences of 13-15 bp, the HsdM subunit 
recognizes the modification status in the recognition DNA sequences and the HsdR 
subunit catalyzes DNA cleavage at a non-specific location up to a few kb away from the 
recognition sequence, if DNA is unmethylated or is methylated inappropriately (Murray, 
2000). Unlike type I R-M systems, type II R-M systems have independent restriction and 
modification enzymes. These restriction enzymes cleave DNA basepairs within the 
recognition sites if the DNA is not appropriately modified (Bickle & Kruger, 1993). 
Similar to type II R-M systems, type III systems are comprised of separate modification 
and restriction subunits. The modification subunit can function by itself as a 
modification methylase. However, a complex of modification and restriction subunits is 
required for endonuclease function, in which DNA cleavage occurs 25-27 bp away from 
the recognition site (Tock & Dryden, 2005). 
 
P1 encodes the virion-associated proteins DarA and DarB (dar standing for defense 
against restriction), which are required to protect the P1 genomic DNA (gDNA) from 
restriction by host type I R-M systems (Fig. 2.1A) (Iida et al., 1987). DarA, with a 
predicted molecular mass of 69 kDa, is expressed late in the lytic cycle and is processed 




has a predicted molecular mass of 251 kDa and appears to be incorporated into the virion 
intact (Iida et al., 1987). Iida et al. demonstrated by plaque assay that DarA is required 
for protection of DNA against restriction by the EcoA type I R-M system and DarB is 
required for protection against the EcoB and EcoK systems. The efficiency of plating 
(EOP) of P1 darA mutants was reduced in EcoA, EcoB and EcoK strains whereas the 
EOP of P1 darB mutants was reduced only in EcoB and EcoK strains. Because 
complementation studies indicated that the Dar proteins function only in cis, it has been 
proposed that these are ejected into the host cell along with phage DNA at the initiation 
of infection, where they exert their antirestriction activity (Fig. 2.1A) (Iida et al., 1987). 
The antirestriction proteins synthesized during the phage lytic cycle only act in the 
following infection cycle, and the antirestriction activity is not specific to P1 gDNA, but 
any DNA that is packaged into the P1 virion (Iida et al., 1987). Since darA- phages also 
exhibit the darB- phenotype and darA- virions lack both DarA and DarB proteins, it 
appears that DarA is required for the incorporation of DarB into the P1 capsid (Iida et 
al., 1987). The 2,255-residue DarB contains an identifiable N-terminal methyltransferase 
domain and a central DExD-like helicase domain, enzymatic functions that could be 
imagined to play a direct role in the protection of DNA from restriction (Lobocka et al., 
2004).  Bioinformatic analysis of DarB revealed that it is widely distributed among 
bacteria, primarily associated with mobile DNA elements including phages, plasmids 
and conjugative transposons (Gill et al., 2011). It has been proposed that DarB could 




DNA elements from type I R-M system-mediated cleavage during their transfer between 
hosts. 
 
To further explore the antirestriction system of phage P1, we used a recombineering 
approach to create isogenic deletion mutants of darA, darB, and other P1 genes with 
previously unknown function including hdf, ddrA, ulx and ddrB. The results are 
discussed in terms of a network of proteins involved in the assembly of P1 antirestriction 
system and their effects on capsid morphogenesis. 
 
Materials and methods 
Bacterial strains and phages 
The bacterial strains and the parent phage P1CMclr100 used in this study were obtained 
from the Coli Genetic Stock Center, Yale University, and are listed in Table 2.1. P1CM 
is a derivative of P1kc that acquired chloramphenicol resistance from the R-factor R14 
(Kondo & Mitsuhashi, 1964). P1CMclr100, hereafter referred to simply as P1, is a 
thermoinducible mutant of P1CM (Rosner, 1972). All phage mutants used in this study 
are single-gene deletions of P1.  Unless otherwise noted, E. coli strains were cultured on 
LB broth [10 g L-1 Bacto Tryptone (BD), 5 g L-1 Bacto yeast extract (BD), 10 g L-1 NaCl 
(Avantor)] or LB agar (LB broth amended with 15 g L-1 Bacto agar) at 37 °C. P1 
lysogens were cultured and maintained at 30 °C on LB amended with 10 µg mL-1 
chloramphenicol (LB cm) or 10 µg mL-1 chloramphenicol plus 30 µg mL-1 kanamycin 




   
Table 2.1. Bacterial strains, phages and plasmids. Reprinted with permission from Piya et al., 
2017. 
Strains, phages or 
plasmids 
Genotype or relevant characteristic Reference/source 
E. coli strains   
WA2379 leu- met- lac- rA- mA- (Arber & Wauters-Willems, 
1970) / The Coli Genetic 
Stock Center (CGSC), Yale 
University  
W3110 F- - rpoS(Am) rph-1 Inv(rrnD-rrnE) rK+ mK+ (Iida et al., 1987; Hayashi et 
al., 2006) / CGSC 
WA921 thr- leu- met- lac- rK- mK-  (Wood, 1966; Arber & 
Wauters-Willems, 1970) / 
CGSC 
WA960 thrB+ leu- met- lac- rB+ mB+ (Wood, 1966; Arber & 
Wauters-Willems, 1970) / 
CGSC 
BW25113(pKD46) F- l- rpoS(Am) rph-1 rrnB3 ΔlacZ4787 
hsdR514 Δ(araBAD)567 Δ(rhaBAD)568 
(Baba et al., 2006) / CGSC 
BW25141(pKD4) lacIq rrnBT14 ΔlacZWJ16  ΔphoBR580 hsdR514 
ΔaraBADAH33 ΔrhaBADLD78 galU95 endABT333 
uidA(ΔMluI)::pir+ recA1 
(Datsenko & Wanner, 2000) / 
CGSC 
MG1655 lacIq1tonA::Tn10 (Park et al., 2006) / Lab stock 
Phages   
P1ΔdarB in-frame deletion of darB in P1CMclr100 This study 
P1Δulx in-frame deletion of ulx in P1CMclr100 This study 
P1ΔdarA in-frame deletion of darA in P1CMclr100 This study 
P1Δhdf in-frame deletion of hdf in P1CMclr100 This study 
P1ΔddrA in-frame deletion of ddrA in P1CMclr100 This study 
P1ΔddrB in-frame deletion of ddrB in P1CMclr100 This study 
P1Δhxr in-frame deletion of hxr in P1CMclr100 This study 
Plasmids   
pdarB P1 darB cloned into pBAD24 This study 
pulx P1 ulx cloned into pBAD24 This study 
pdarA P1 darA cloned into pBAD24 This study 
phdfam_darA_ddrAam P1 hdf_darA_ddrAgene fragment cloned into 
pBAD24 and amber mutations introduced to 
9th codon in hdf and 28th codon in ddrA 
This study 
phdf P1 hdf cloned into pBAD24 This study 
pddrA P1 ddrA cloned into pBAD24 This study 
pddrB P1 ddrB cloned into pBAD24 This study 
pulx-CFLAG P1 ulx with C-terminal FLAG-tag fusion 





   
Production of phage lysates 
Phage lysates were produced by thermal induction of P1 lysogens.  Lysogenic strains 
were grown at 30 °C in LB cm to OD550 0.5 - 0.6. P1 was thermally induced by shifting 
the culture to 42 °C in a shaking water bath for 60-75 min (Iida & Arber, 1977). The 
crude lysate was harvested when the OD550 fell to ~0.2, by centrifugation of the culture  
at 10,000 x g, 10 min, 4°C and sterilized by passage through a 0.22 µm syringe filter 
(Millipore).   
 
Lysogenization  
Lysogens of P1 and its mutants were produced as previously described (Rosner, 1972) 
with minor modifications. A fresh overnight culture of the desired E. coli lysogenization 
host was supplemented with 5mM CaCl2, and 100 µL of the culture was mixed with 100 
µL of an undiluted phage lysate (~108-109 PFU mL-1) and incubated at RT for ~20 
minutes. The phage-host mixture was then plated to LB cm and a CMR colony was 
selected after overnight incubation at 30 °C and purified by restreaking.  The same 
procedure was used for producing lysogens of P1 deletion mutants, with the exception 
that plating was conducted on LB cm+kan. 
 
Generation of PCR fragments for single-gene deletions 
All primers (table 2.2) used in PCR were ordered from Integrated DNA Technologies. 
The plasmid pKD4 has an FRT-flanked kan gene which was used at the source of the 




Table 2.2. Primers. Reprinted with permission from Piya et al., 2017. 
Forward primer 5'-3' Reverse primer 5'-3' Usage 
tttgtcaaAaccgacctgtccg ggacaggtcggtTttgacaaaa
ag 
To mutagenize EcoP1 site in 
kanamycin resistance gene in 
pKD4. The nucleotides in 
capital letters represent the 
mutation that is introduced. 
ggttttatggacagcaagcg gcttccatccgagtacgtg Sequencing primers to verify 














acaccatcatgttccgaagg Sequencing primers to verify 









To knockout darB from P1 
genome 
aggaggatgttgtcccgttc tttcagtaatcgcccgcgtag Sequencing primers to verify 













tccgtagcacaccagtggatc Sequencing primers to verify 









To knockout ddrA from P1 
genome 
ggatatgcaaagcactgacatgg ccgtccagagtattggatacc Sequencing primers to verify 









To knockout hxr from P1 
genome 
tatacccgccagcctcagtaag ctgcggcggttataggttcc Sequencing primers to verify 















Table 2.2. Primers. Continued   
Forward primer 5'-3' Reverse primer 5'-3' Usage 
cgaaagacgcaatcaagacg tgatctgctcccattcttcg Sequencing primers to verify 









To knockout ddrB from P1 
genome 

















































To make amber mutation in 
the 9th codon of hdf 
cgagtggctaggagttgctg caactcctagccactcgcgg To make amber mutation in 







To clone ulx with C-terminal 
FLAG-tag fusion into 
pBAD24 






avoid restriction by the Type III R-M system resident in the P1 chromosome, an EcoP1 
site normally present in the kan gene was removed by following protocol from 
QuikChange site-directed mutagenesis kit (Agilent Technologies) changing G608 to A 
in a silent mutation.  To generate FRT-flanked kan insert for gene deletion, the 3’-ends 
of the forward and reverse primers were designed to match the priming sites 
gtgtaggctggagctgcttc and atgggaattagccatggtcc of pKD4 (Datsenko & Wanner, 2000). 
The 5’ ends of both forward and reverse primers were synthesized to include 50 nt 
homology to the P1 genome up- and downstream of the targeted gene. The flanking 
regions were chosen to retain the first and last several codons of the targeted genes to 
avoid polar effects (Datsenko & Wanner, 2000). PCR reactions were performed using 
Phusion Hi-Fidelity PCR Master Mix (New England Biolabs), following the 
manufacturer’s recommended protocol. The PCR products were gel purified by using the 
QIAquick Gel Extraction Kit (Qiagen). 
 
Generation of single-gene knockout mutants  
The phage lambda Red recombinase mediated homologous recombination method was 
used to generate isogenic single-gene knock-out P1 mutants (Datsenko & Wanner, 
2000). P1 was lysogenized into BW25113(pKD46) and a colony resistant to both 
chloramphenicol and ampicillin was selected. BW25113(pKD46) lysogenized with P1 
was grown in LB amended with 100 µg mL-1 ampicillin and 10 µg mL-1 
chloramphenicol to OD550 0.1, 1 mM L-arabinose was added to induce Red proteins, and 




electrocompetent as described previously (Datsenko & Wanner, 2000). Each 
electroporation reaction contained 300 ng of gel-purified DNA and 100uL competent 
cells in a 0.1 cm cuvette and was transformed in a Bio-Rad MicroPulserTM electroporator 
following the manufacturer’s protocol. Cells were recovered in 1 mL SOC for 2 hours at 
30 oC and plated to LB cm+kan at 30 °C overnight. CMR and KanR colonies were 
selected and mutations were verified by PCR amplifying a DNA region spanning the kan 
insertions and sequencing across the insertion junctions (Baba et al., 2006).  These 
lysogens were then induced as above and the mutant P1 phages were lysogenized into E. 
coli strain MG1655 as described above for maintenance of the strains. 
 
Complementation of phage mutants   
Phage knockouts were complemented in trans by induction of lysogens containing both 
the mutant prophages and vectors expressing the deleted genes.  Complementing genes 
were amplified by PCR from a P1 DNA template (Table 2.1) and cloned into pBAD24 at 
its XbaI and HindIII sites using standard molecular biology techniques (Guzman et al., 
1995). The primers used for PCR are listed in table 2.2. Ligation products were 
transformed into competent E. coli 5-alpha cells (New England Biolabs) and selected by 
plating on LB agar amended with 100 µg mL-1 ampicillin. The plasmids were extracted 
as described above and were verified by sequencing before transformation into the r-m- 
strain WA921. Complemented phages were prepared by thermal induction of mutant 
phage from WA921 lysogens containing the corresponding complementing vector 




added to the culture at the time of temperature shift to 42 °C to induce protein expression 
from the complementing plasmids. The phage lysate was used to determine Efficiency of 
Plating (EOP) on restricting and non-restricting hosts as described below. 
 
Efficiency of Plating (EOP) Assay 
All phages used in EOP assays were induced from modification-deficient WA921 
lysogens. Assays were conducted as previously described with few modifications (Arber 
& Dussoix, 1962; Mise & Arber, 1976; Iida et al., 1987).  Host cells, grown to OD550 0.4 
- 0.5 in tryptone broth (10 g L-1 Bacto tryptone, 5 g L-1 NaCl) amended with appropriate 
antibiotics, were incubated with 10 mM CaCl2 for 30 minutes at RT.  Phage were 
adsorbed to 300 μL of host cells for 20 minutes at RT.  The cells and phage were then 
plated using the soft agar overlay method using LB (Lennox) plates (10 g L-1 Bacto 
tryptone, 5 g L-1 NaCl, 5 g L-1 Bacto yeast extract, g L-1 Bacto agar) containing 2.5 mM 
CaCl2 as the bottom plates with 4 mL lawns of tryptone top agar (10 g L
-1 Bacto 
tryptone, 5 g L-1 NaCl, 7 g L-1 Bacto agar).  Plaques were counted after overnight 
incubation at 42 °C. EOP was calculated as the ratio of plaques appearing on the lawn of 
the restricting strain to the number of plaques on WA921 lawns. The EOP of each phage 
mutant was normalized to the EOP of parental P1 on the same plating strain. In 
complementation assays, EOPs were normalized to P1 induced from WA921(pBAD24). 






Purification of virions by CsCl isopycnic centrifugation 
P1 or P1 mutant was induced in 1L LB as described above. The crude lysate was 
centrifuged in JA10 rotor for 15 minutes at 17000 x g and the supernatant was filter 
sterilized. The lysate was concentrated by 24-hour centrifugation in JA10 rotor at 14000 
x g at 4°C. The pellet was soaked in SM buffer (50 mM Tris-HCl pH 7.5, 100 mM NaCl, 
8 mM MgSO4) at 4°C and extracted after 48 hours. 10 µg mL
-1 DNase (Sigma) was 
added to the concentrated phage and left at RT for 30 minutes. Phages were then purified 
by equilibrium centrifugation in Cesium chloride as previously described (Boulanger, 
2009). The phage bands were extracted with 18-gauge needles and dialyzed against SM 
buffer in Slide-A-Lyzer 3500 MWCO dialysis cassettes (Thermo Scientific). Small 
volumes of pre-dialysis samples were saved and used to measure refractive index in an 
Abbe Refractometer. Refractive indices were converted to density (g cc-1) by comparing 
to standard CsCl density-refractive index correlation table.  
 
SDS-PAGE analysis 
For SDS-PAGE analysis of phage proteins, samples were prepared as described 
previously, with slight modification (Boulanger, 2009). Approximately 2 x 1010 PFU of 
CsCl purified P1 were loaded per lane. For antirestriction P1 mutants, protein loading 
was normalized to equal amounts of tail sheath protein (57 kDa). Phages were heated in 
boiling water for 10 minutes to release DNA from the capsid and samples were then 
treated with DNase I at 37 °C for 2 hours. The samples were denatured by heating in 




glycine SDS-PAGE gel (Life Technologies) (Laemmli, 1970). PageRuler Unstained 
Broad Range Protein Ladder (Thermo Scientific) was used as molecular mass standard. 
The gel was stained with SYPRO Ruby (Thermo Scientific), following the 
manufacturer’s recommended protocol for maximum sensitivity. The gel was imaged 
with Fotodyne gel imager. 
 
Proteomic analysis  
Proteins associated with the virion were identified by mass spectrometry (MS) of the 
protein bands excised from SDS-PAGE gel as described previously (Gill et al., 2011). 
Briefly, ~1011 PFU of phage P1 was prepared and loaded into 4-20% Tris-glycine SDS-
PAGE as described above. Coomassie-stained bands were excised, subjected to 
reduction with dithiothreitol and alkylation with iodoacetamide. The samples were 
treated with ~0.4 µg trypsin (Thermo Scientific) and digested peptides were 
concentrated and desalted using C18 ZipTips (Millipore). The samples were spotted 
manually onto a matrix-assisted desorption ionization (MALDI) target (Genomic 
Solutions) using α-cyano 4-hydroxycinnamic acid. MALDI-MS and MS/MS analysis 
were conducted against the NCBI-nr database as described previously (Gill et al., 2011). 
P1 DarB, DarA and Hdf were identified by this method. 
  
The virion-associated DdrB was identified by liquid chromatography-tandem mass 
spectrometry (LC-MS/MS) in collaboration with the Protein Chemistry Lab at Texas 




4-20% Tris-glycine SDS-PAGE and stained with SyproRuby as described above. The 
gel region missing protein band in P1ΔddrB lanes and corresponding protein band from 
P1 lanes were excised. The samples were processed for LC-MS/MS as described before 
(Shevchenko et al., 2006). LC-MS/MS was performed on a LTQ Orbitrap Velos/ETD 
mass spectrometer (Thermo Fisher) equipped with a NanoLC 2-D HPLC system 
(Eksigent). The results were analyzed using Mascot (Matrix Science) and X!Tandem 
(The GPM). Scaffold (Proteome Software) was used to validate MS/MS based peptide 
and protein identifications. The SDS-PAGE band was annotated based upon its presence 
in P1 and absence in P1ΔddrB lanes. 
 
Transmission Electron Microscopy  
Phages were stained with 2% uranyl acetate and imaged in a JEOL 1200 EX 
transmission microscope under 100 kV accelerating voltage as previously described 
(Valentine et al., 1968; Gill et al., 2011).  Side-to-side head diameters perpendicular to 
the axis of the tail were measured electronically using ImageJ (Schneider et al., 2012) 
and converted to nm against images of a carbon grating replica of known dimensions 
(Ted Pella, cat# 607). 
 
Results and discussion 
Genomic context of the P1 antirestriction system 
The genome of phage P1 was completed in 2004 (NC_005856.1), showing the positions 




As shown in the partial P1 genetic map (Fig. 2.1B) the 1,920 bp darA gene is located in 
a polycistronic operon with its expression driven by LPdar (LP for late promoter) 
(Guidolin et al., 1989b), and darB (6,768 bp) is located ~10 kb downstream of darA in a 
separate operon driven by PdarB (Lobocka et al., 2004).  The darA gene is located 
immediately downstream of hdf, and upstream of ddrA, ddrB and hxr. The genes lydA 
and lydB, upstream of hdf, are known to function as the phage holin and antiholin, 
respectively (Schmidt et al., 1996). Two operons are located between the dar operons: 
one containing the transcript of the phage’s SAR endolysin lyz (Xu et al., 2004) and 
another on the opposite strand encoding the predicted phage portal, portal protease and 
single-stranded DNA binding protein (Lobocka et al., 2004).  The darB gene is upstream 
of ulx and the lysogeny maintenance gene lxc (Lobocka et al., 2004). 
 
The genes shown in grey in Fig. 2.1B were deleted and replaced with kan markers by a 
lambda Red recombineering approach (Datsenko & Wanner, 2000).  Initially darA and 
darB were deleted, followed by hdf, ddrA, ddrB, hxr and ulx. Because lydAB, lyz, lxc and 
the phage structural proteins Prt and Pro already had assigned functions, they were not 
considered to be relevant to this study and were not studied further.  Deletion of hxr 
produced no detectable antirestriction phenotype against EcoA, EcoB or EcoK (data not 







darB and ulx provide protection against EcoB and EcoK  
The antirestriction phenotypes associated with P1 darA and darB were first reported in 
1987 (Iida et al., 1987): P1, when propagated on a modification-deficient host, exhibited 
a slight (less than ten-fold) reduced efficiency of plating (EOP) on EcoA and EcoK 
lawns and an EOP of ~10-2 on EcoB. Under the same conditions, P1darA- plated at an 
EOP ~10-4 to 10-5 on all three restrictive hosts, whereas P1darB- was restricted (EOP ~ 
10-4) only on EcoB and EcoK.   
 
The previously reported darB- phenotype, defined as severely reduced plating efficiency 
on EcoB and EcoK hosts, was recapitulated in an isogenic deletion of darB (Fig. 2.2A).  
As previously reported, P1∆darB did not exhibit an antirestriction defect in the EcoA 
host. In addition to reproducing the darB phenotype, the antirestriction defect in 
P1∆darB could be efficiently complemented in trans by inducing the mutant phage from 
a lysogen of the non-modifying host strain WA921 carrying the plasmid pdarB, 
expressing DarB from an arabinose-inducible promoter (Fig. 2.2A).  In this 
complementation system, the progeny phage could incorporate the DarB protein 
expressed from the plasmid in the propagating host and produce the antirestriction 
phenotype upon infection of a restricting strain. Phages complemented in this way could 
only express the antirestriction phenotype for their first infection cycle.  Complemented 
mutant phage that were re-propagated on WA921 exhibited the same EOP as the original 
P1∆darB when plated to all three of the restricting strains (data not shown), indicating 


























A  B 
Fig. 2.2. darB and ulx are required for protection of P1 against EcoB and EcoK 
restriction. Reprinted with permission from Piya et al., 2017. Parental P1 or isogenic 
deletion mutant phages were thermally induced from lysogenized modification-deficient 
WA921 containing either empty pBAD24 or the respective complementing plasmid. 
Phages were then plated on E. coli hosts containing the Type I EcoA, EcoB, or EcoK R-
M systems and WA921; efficiency of plating (EOP) for each phage was calculated as 
the ratio of plaques formed on lawns of the R-M-containing strains to the plaques 
formed on WA921. The EOP data shown have been normalized to the EOP of parental 
P1 induced from WA921 containing pBAD24. Panel A: the relative EOP of P1ΔdarB 




 in EcoB and EcoK strains, respectively (gray bars). 




 in EcoB and EcoK 
strains respectively (gray bars).  The restriction phenotype associated with both darB 
and ulx could be complemented in trans (white bars). No notable phenotype was 
observed in the EcoA strain.  The data shown are averages of three biological replicates 




phage propagation.  The reduced EOP of P1∆darB in EcoB and EcoK cells indicates that 
in the absence of DarB, P1 DNA, after being ejected into host cells, is susceptible to 
EcoB and EcoK restriction, but is protected from EcoA restriction.   
 
Other genes near darB were examined for their possible role in antirestriction. The gene 
ulx (146 codons; ulx for upstream of lxc (Lobocka et al., 2004)) is located between darB 
and lxc and was previously of unknown function. P1∆ulx showed a partial darB-like  
restriction phenotype, with EOP attenuated approximately 10-fold less than for P1∆darB 
(Fig. 2.2B). The ulx-associated restriction phenotype could also be complemented in 
trans (Fig. 2.2B). In both darB and ulx deletions, complementation produced slightly 
higher EOP’s than the parent P1 phage, suggesting complementation could provide a 
greater copy number of protein available for incorporation into the virion and subsequent 
greater protection against restriction. The plaque sizes for both P1ΔdarB and P1Δulx 
were comparable to P1. Moreover, a double deletion mutant of darB and ulx showed 
plating deficiency similar to P1ΔdarB (data not shown). Thus, both darB and ulx are 
required for full protection of P1 DNA against EcoB and EcoK restriction.   
 
darA, hdf and ddrA contribute to protection against EcoA, EcoB and EcoK 
In agreement with previous work, the isogenic deletion P1∆darA had reduced EOP when 
plated on strains expressing EcoA, EcoB or EcoK (Fig. 2.3A). Relative to P1, the EOP 
of P1∆darA was decreased by ~10-3, 10-2 or 10-4 in cells expressing EcoA, EcoB or 





















partially complemented in trans by darA alone, and the EcoB and EcoK phenotypes 
were not affected. It was previously reported that darA mutants could be complemented 
to nearly wt levels in trans by a P1 DNA fragment containing darA, along with the 
upstream gene hdf and the downstream gene ddrA of the darA operon (Iida et al., 1998). 
In our experiments, P1∆darA was more efficiently complemented in trans by a construct 
A  B C 
Fig. 2.3. hdf, darA and ddrA are required for protection of P1 against EcoA, EcoB 
and EcoK restriction. Reprinted with permission from Piya et al., 2017. Phages 
were induced and EOP assays were performed as described previously. The EOP data 
shown have been normalized to EOP of parental P1 induced from modification deficient 







 in EcoA, EcoB and EcoK strains respectively (dark gray bars). The 
darA-associated restriction phenotype could be complemented partially by a plasmid 
bearing only darA (light gray); stronger complementation was observed with a plasmid 





(white bars).  Panels B and C: Both P1Δhdf and P1ΔddrA 
exhibited a darA-like restriction phenotype (gray bars). The restriction phenotypes of 
both hdf and ddrA could be complemented in trans (white bars). The data shown are 




containing darA, hdf and ddrA (data not shown). Better complementation in presence of 
hdf and ddrA raised a possibility of the polar effects of darA deletion, in which the 
restriction phenotype observed could either be associated with hdf or ddrA, the other 
genes present in the complementing plasmid. In order to rule out the roles of Hdf and 
DdrA in complementation, nonsense mutations were introduced in both hdf and ddrA to 
prevent their expression. Same degree of complementation was observed with 
phdfam_darA_ddrAam (Fig. 2.3A).   The low efficiency of complementation exhibited by 
the pdarA vector may be due to instability of the mRNA transcript containing darA 
alone, as the longer DNA fragments included on phdfam_darA_ddrAam and the previously 
reported P1 DNA fragment provided better complementation. 
 
Previous studies of darA and darB function used P1 mutants that contained either IS 
insertions or deletions that often spanned hdf and ddrA (Iida et al., 1987). To determine 
if these genes could also play a role in the protection of P1 DNA from host restriction, 
the isogenic mutants P1∆hdf and P1∆ddrA were created and evaluated for their 
antirestriction phenotypes.  Both P1∆hdf and P1∆ddrA showed darA-like phenotypes, 
with sensitivity to EcoA, EcoB and EcoK restriction similar to that exhibited by 
P1∆darA (Fig. 2.3B and 2.3C).  Unlike darA, the hdf and ddrA phenotypes could both be 
fully complemented in trans by vectors containing hdf or ddrA alone (Fig. 2.3B and 
2.3C). The plaque sizes for both P1∆hdf and P1∆darA were smaller than that of P1, 





ddrB modulates the EcoB and EcoK antirestriction phenotype  
Having determined the restriction phenotypes in ulx, hdf and ddrA mutants, we tested 
other genes located within the darA and darB operons (Fig. 2.1B). Surprisingly an 
isogenic deletion of ddrB was found to have a ~10-fold higher EOP on cells expressing 
EcoB or EcoK than that of the parental P1 (Fig. 2.4).  This phenotype could again be 
complemented in trans by a vector containing ddrB alone, with the EOP returning to ~3 
in the complemented phage. Deletion and complementation of ddrB produced no notable 
phenotype on EcoA strains.  Both ulx and darB are similar to ddrB in this regard, in that  
their deletion affects susceptibility to EcoB and EcoK restriction, with no apparent effect  
on EcoA strains (Fig. 2.2). It seems likely that ddrB exerts its phenotype via action on 
Ulx and/or DarB, either by regulating the copy number of these proteins incorporated 
into the virion, or by modulating their activity after the antirestriction system is deployed 
in the host cell.   
 
Virion proteomics of P1 and its mutants 
It was shown previously that P1darA- phages fail to package DarB (Iida et al., 1987), 
leading to the conclusion that, in addition to being required for protection of DNA 
against EcoA, DarA is also required for incorporation of DarB into the virion. In the 
present study, multiple genes in addition to darA and darB have been identified with 
roles in the antirestriction phenotype of P1. These phenotypes can be placed into two 




and darB-like, in which EOP is affected only on EcoB and EcoK strains. In order to 





















Fig. 2.4. ddrB negatively affects the darB phenotype. Reprinted with permission 
from Piya et al., 2017. Phages were induced and EOP assays were performed as 
described previously. The EOP data shown have been normalized to EOP of parental P1 
induced from modification-deficient WA921 containing pBAD24. Unlike the other 
restriction phenotypes described, disruption of ddrB increased the relative EOP of the 
phage in EcoB and EcoK strains by approximately 10-fold compared to wild-type P1 
(gray bars).  This effect did not extend to EcoA strains, suggesting that DdrB negatively 





proteomic analysis of purified virions was conducted (Fig. 2.5). Protein bands 
corresponding to DarB, Hdf, DarA and DdrB could be assigned by mass spectrometry 
analysis (underlined in Fig. 2.5A). The protein band corresponding to DdrA is assigned 
based on missing band density corresponding to its predicted protein molecular mass in 
lanes of P1ΔddrA virions compared to the parental P1. The protein band corresponding 
to Ulx was assigned based on western blotting of purified P1Δulx virions complemented 
with a Ulx-FLAG fusion (Inclan et al., 2016) (Fig. 2.6). 
 
Disruption of darB resulted in the loss of DarB and Ulx (Fig. 2.5), indicating only Ulx is 
dependent on DarB for incorporation.  Coupled with the conserved domains present in 
DarB, the EcoB and EcoK phenotypes observed for P1∆darB (Fig. 2.2A) suggests that 
DarB is directly responsible for EcoB and EcoK antirestriction activity. Band 
densitometry indicates P1∆ulx packages only ~15% of the DarB as the parental P1 (data 
not shown).  Thus, DarB can be packaged into the virion in the absence of Ulx but 
packaging efficiency is greatly reduced. This reduced packaging of DarB is consistent 
with the ~10-fold weakened antirestriction phenotype exhibited by P1∆ulx compared to 
































Fig. 2.5. Comparative SDS-PAGE of parental P1 and isogenic mutants suggests 
cascading dependencies for protein incorporation into the P1 virion. Reprinted 
with permission from Piya et al., 2017. Panel A: SDS-PAGE of parental P1 and 
antirestriction mutants. Molecular masses of the size standard are provided in kDa on 
the left.  Relevant protein bands are labeled on the left; proteins that have been 
identified by mass spectrometry are underlined.  DdrA is assigned based on the missing 
band density in the gel image and predicted molecular mass, and Ulx is assigned based 
on western blotting of P1Δulx complemented with Ulx-FLAG with anti-FLAG 
antibody.  At the bottom of the figure, the restriction sensitivity phenotypes of the P1 
mutants are indicated: B, K (sensitive to EcoB and EcoK restriction), or A, B, K 




B               
P1 
proteins 
P1 and antirestriction mutants 
P1 ∆darB ∆ulx ∆ddrB ∆hdf ∆darA ∆ddrA 
DarB + - (+) + - - - 
DarA + + + + - - + 
DdrB + + + - - - - 
Hdf + + + + - - + 
Ulx + - - + - - - 
DdrA + + + + - - - 

















Fig. 2.5 Continued. Panel B: The table summarizes protein presence or absence in 
P1 mutants. P1Δulx shows a faint DarB band, which suggests that DarB can be 
incorporated in the absence of Ulx, albeit inefficiently. When either hdf or darA is 
disrupted, P1 fails to package both Hdf and DarA, suggesting that Hdf and DarA are 


























Fig. 2.6. Identification of Ulx band in SDS-PAGE of P1 virions. Reprinted with 
permission from Piya et al., 2017. Ulx protein band in P1 virions was identified by 
western blot on P1∆ulx complemented with functional Ulx fused to FLAG-tag on C-
terminal end. The protein samples for SDS-PAGE were normalized and prepared as 
described in materials and methods. The samples were loaded in 4-20% Tris-glycine 
(Thermo Scientific) in order as shown above. After SDS-PAGE, the gel was cut into 
two halves. One half was stained with SyproRuby as described earlier and the other 
half was used for western blot following standard protocol (Green & Sambrook, 2012). 
In brief, SDS-PAGE resolved proteins were transferred to PVDF membrane (GE 
Healthcare) overnight at 30V. The membrane was blocked with 1% blocking buffer and 
probed with Anti-FLAG primary antibody (Thermo Scientific) and HRP-conjugated 
secondary antibody. The membrane was developed with SuperSignal West Femto 







Compared to the parental P1, a single ~50 kDa band is missing in the P1∆ddrB virion; 
this species was confirmed as DdrB by mass spectroscopy analysis. Aside from this 50 
kDa species, all bands including those corresponding to DarB, Ulx, DarA, Hdf, and 
DdrA are present, indicating that no other virion proteins are dependent upon DdrB for 
their incorporation. Since ddrB encodes a protein with a predicted molecular mass of 
~109 kDa, the appearance of DdrB at a position corresponding to 50 kDa suggests that 
the protein is proteolytically processed for incorporation into the virion; no ~109 kDa 
band corresponding to DdrB was observed in SDS-PAGE.  Based on MS-MS analysis of 
the gel slice containing this predicted DdrB band from the parental P1, high peptide 
coverage (5 to 27-fold, covering 88% of residues) was observed for the N-terminal 
portion of the protein sequence, with coverage dropping abruptly after residue 421 (1 to 
3-fold, covering ~42% of residues), suggesting that it is primarily the N-terminal portion 
of the DdrB protein that is present in the P1 virion.  Cleavage of the protein at a position 
at or shortly after 421 would result in a ~46 kDa product, which matches closely the 
observed 50 kDa DdrB band. Presumably some small amount of the C-terminal fragment 
somehow remains with the virions, and this fragment would also be ~50 kDa and co-
migrate with the C-terminal portion. The phenotype associated with ddrB deletion is an 
increase in protection against EcoB and EcoK restriction.  One possibility is that the 
absence of DdrB allows for incorporation of more DarB into the virion, providing 
greater antirestriction activity.  However, band densitometry does not convincingly show 
greater DarB band intensity in ddrB mutants (data not shown).  An alternative 




either case, the role of DdrB in the P1 antirestriction system is not clear, as its presence 
appears to counterintuitively hinder the fitness of P1 as measured by its ability to 
overcome host restriction.   
 
As shown in Fig. 2.5, P1∆hdf, P1∆darA and P1∆ddrA virions all fail to incorporate 
DarB, DdrB and Ulx. EcoB and EcoK restriction sensitivity of these mutants can be 
explained by the absence of DarB because DarB is most likely responsible for EcoB and 
EcoK antirestriction activity as discussed above. However, hdf, darA and ddrA mutants 
are also all sensitive to EcoA restriction, which suggests that one of these three genes are 
responsible for the EcoA antirestriction activity of P1.  Deletion of either hdf or darA 
results in virions missing both Hdf and DarA, which indicates that these proteins are co-
dependent for virion incorporation. Both the P1∆hdf and P1∆darA virions are also 
missing DdrA in addition to DarB, DdrB and Ulx mentioned above.  It was suggested 
that DarA is responsible for EcoA protection (Iida et al., 1987), however, DarA was 
found to be present in P1∆ddrA virions, which are sensitive to EcoA restriction (Figs. 
2.5, 2.3C). This suggests that DarA is not solely responsible for protection from EcoA 
restriction as previously proposed. Aside from DarB, DdrB and Ulx, the only protein 
observed to be absent in P1∆ddrA is DdrA itself.  Thus, DdrA may be the protein that 
protects P1 DNA from EcoA-mediated endonuclease activity, although it is not clear if 
DarA and Hdf are also required for DdrA activity or are simply required for 





Band densitometry was performed on SyproRuby-stained SDS-PAGE of P1 using 
ImageJ (Schneider et al., 2012) to estimate the copy numbers of P1 antirestriction 
system components associated with the virion.  These calculations suggest that there are 
~45 DarB, ~100 DarA, ~40 DdrB and ~400 Hdf molecules in the average P1 virion 
(Table 2.3).  The copy number of Ulx and DdrA could not be estimated due to their low 
mass and band intensity.  These values indicate that P1 capsids contain ~35 MDa of 
major capsid protein and a combined mass of ~28 MDa of Dar proteins (DarB, DarA, 
DdrB and Hdf) per virion, indicating the Dar proteins contribute to a significant 
proportion of the mass of P1 heads. 
 
Morphological defects are linked to hdf and darA 
Under normal conditions, P1 is known to produce three morphological head size variants 
termed “big” (P1B, ~86 nm), “small” (P1S, ~65 nm) and “minute” (P1M, ~47 nm) 
(Walker & Anderson, 1970). The P1B variant (hereafter referred to as “normal” head 
size or P1N) packages the complete genome and is infectious, while P1S and P1M are 
defective as they can package only ~40% and ~10% of the P1 genome, respectively 
(Walker & Anderson, 1970). The proportion of P1S virions has been reported to vary 
depending upon the host, with P1 lysates induced from E. coli K-12 containing 20-37% 







Table 2.3. Copy number of virion-associated proteins of P1 antirestriction 
system. Reprinted with permission from Piya et al., 2017. The copy number of 
constituent proteins of P1 antirestriction system was determined by densitometry on 
SyproRuby stained SDS-PAGE of P1 and mutants using ImageJ. The predicted copy 
number of tail sheath protein was determined based on the number of striations 
previously reported (six copies per striation, 54 striations) (Walker & Anderson, 1970) 
and used as an internal standard in all calculations.  The molecular mass of tail sheath, 
DarB, and Hdf were determined from the predicted translational product of their 
respective genes. The molecular mass of DarA was determined based on the 
processing of product of darA into the mature form found in virions (Streiff et al., 
1987). Finally, the molecular mass of major capsid protein (MCP) and DdrB were 
estimated based on their migration on SDS-PAGE. The copy number of MCP was also 
calculated from densitometry as a quality check; there are predicted to be 955 copies 
of the MCP per virion based on the previously reported T=16 P1 capsid symmetry 
(Walker & Anderson, 1970). The copy number of MCP as determined by 
densitometry is ~17% lower than expected, which provides some indication of the 
accuracy of this analysis.  Data is shown for analyses of two replicate SDS-PAGE 
gels. 
Phage P1 proteins 
Molecular 
Mass (kDa) 
Copy number per virion 
Total predicted protein 
mass per virion (MDa) Repeat 1 Repeat 2 Average 
Tail Sheath 57 324* 324* 324* 18 
Major Capsid Protein 44 769 819 794 35 
DarB 252 41 47 44 11 
DarA 59 108 102 105 6 
DdrB 50 40 34 37 2 
Hdf 22 426 371 399 9 
*: predicted copy number based on literature; this number was used as the basis for 

























In isopycnic gradient purification of P1 and its antirestriction mutants, variations in 
banding patterns were observed in some of the mutant phages, particularly P1Δhdf and 
P1ΔdarA (Fig. 2.7). These mutants exhibited more intense bands at regions in the 
gradients corresponding to lighter buoyant densities than the parental P1, which 
suggested that the disruption of these genes also affected viral morphogenesis. The 
phage bands were extracted whenever possible and the head size of purified phages were 
measured from negative-stained TEM images and their distribution is described in Fig. 
2.7. 
Fig. 2.7. Purification of virions using Cesium chloride isopycnic gradient 
centrifugation. Reprinted with permission from Piya et al., 2017. Parental P1 and 
mutants were purified by using isopycnic gradient of Cesium chloride as described 
earlier.  The phage bands were extracted using a syringe and refractive index was 
measure using Abbe Refractometer. The refractive index was converted to density (g 
cc-1) by comparison with standard CsCl density-refractive index correlation table. The 
corresponding phage bands indicated with bold-face densities were used for 
comparative SDS-PAGE analysis shown in Fig. 5. The phage bands corresponding to 
grey-color densities denote tail-less phage heads. After dialysis, virions from all 
extracted bands were imaged under TEM and head size survey was conducted as 
described earlier. The major population of head-size variants present in each phage 
bands is indicated after density, separated by a colon (:). “N” denotes normal head size 
virions, “S” denotes small head size virions, and “M” denotes mixed population of 





In order to study the effects of antirestriction gene deletions on the overproduction of 
P1S virions, the parental and mutant phages were induced from lysogens of E. coli 
MG1655 and a head-size survey was conducted for each phage by measuring the 
diameters of several hundred phage heads photographed from negative-stain TEM 
images prepared from the phage lysates.  Observed phage head diameters ranged from 
52 nm to 95 nm (Fig. 2.8).  In accordance with previous reports, head diameters >67 nm 
were classified as “normal” (i.e., P1N) and head diameters ≤67 nm were classified as 
small (P1S) variants. Virions with “minute” (P1M) head size were rarely observed and 
were excluded from classification. All phages produced heads of a bimodal size  
distribution, with a smaller size class of ~60 nm and a normal size class centered around 
~80 nm (Fig. 2.8, Table 2.4). As shown in Fig. 2.8, the parental P1 produced virions 
with ~82% normal-sized heads and ~18% small heads, in agreement with previous 
observations of P1 (Walker & Anderson, 1970). In lysates of P1Δhdf and P1ΔdarA this 
relationship was essentially inverted, with P1Δhdf producing ~85 % small-headed 
virions and P1ΔdarA producing ~82% small-headed virions.  Other phage mutants 
produced small heads at frequencies similar to the parental P1, ranging from 14.1% for 
P1ΔddrB to 28.1% for P1ΔdarB, however this variation is within the range previously 






























Fig. 2.8. Head size variation in parental P1 and mutants. Reprinted with 
permission from Piya et al., 2017. Lysates of phage P1 contain virions of two major 
head size classes. The virions of >67 nm head diameter have been classified as 
“normal” and those of ≤ 67 nm as “small”. Panel A: Transmission electron 
micrograph (TEM) showing typical normal head (left) and small head (right) virions.  
Panel B: The diameters of parental P1 and antirestriction mutant virions were 
measured from TEM images. The X-axis in each histogram denotes the head size 
diameter in nm and the Y-axis denotes the percentage of virions of each head size 
present.  The phage genotype (parental P1 or antirestriction mutant) and the number 
of virions measured are denoted in the upper right of each histogram. On the right, the 
percentages of virions falling into the small and normal head size classes for each 
phage mutant are summarized. The darB, ulx, ddrB and ddrA mutants have similar 
head size distributions as parental P1, while this distribution is reversed in hdf and 
































    
Table 2.4.  Mutations in phage P1 antirestriction genes affect head 
morphogenesis. Reprinted with permission from Piya et al., 2017. Lysates of phage 
P1 and its antirestriction mutants were observed by negative stain TEM and head 
diameters of the phage populations were measured.  Phage heads were placed into two 
size classes, small (≤ 67 nm) and normal (> 67 nm).  P1 hdf and darA mutants 





Dimension of small head 
(nm) (Average ± S.D.) 
Dimension of normal heads 
(nm) (Average ± S.D.) 
P1 765 60 ± 3 79 ± 4 
∆darB 303 59 ± 3 78 ± 4 
∆ulx 301 60 ± 3 80 ± 4 
∆ddrB 290 61 ± 3 81 ± 3 
∆hdf 359 58 ± 3 77 ± 4 
∆darA 316 60  ± 3 78 ± 4 
∆ddrA 302 60 ± 4 80 ± 5 
















Previous work has shown that deletion of the entire darA operon, or transposon 
insertions within lydA and darA, resulted in overproduction of P1S virions in a 
phenotype denoted Vad- (for viral architecture determinant) (Iida et al., 1998). Based on 
the data presented here, the Vad- phenotype can be assigned to two genes within the 
darA operon, hdf and darA.  These genes are directly adjacent to each other (Fig. 2.1B) 
and are the earliest non-lysis genes present in the Pdar transcript.  Deletion of either 
gene results in the failure to incorporate any of the other virion-associated antirestriction 
components (Fig. 2.5), and the loss of antirestriction activity against EcoA, EcoB and 
EcoK (Fig. 2.3).  The presence of the Vad- phenotype in both P1Δhdf and P1ΔdarA 
indicates that both Hdf and DarA play important roles in determining head size during 
P1 morphogenesis.  
 
In many viruses (bacteriophages such as P22, T2,  and eukaryotic viruses such as HSV-
1 and other herpesviruses), assembly of the major capsid protein into phage heads of the 
correct size and shape is guided by a scaffolding protein, resulting in a spherical 
immature procapsid (Mateu, 2013).  Studies in phages T4, P22 and  have shown that 
procapsids are assembled initially without any DNA (King et al., 1980).  During 
procapsid maturation and concomitant DNA packaging, the scaffolding protein is lost 
from the capsid (Dokland, 1999).  Absence of functional scaffolding proteins results in 
aberrant capsid assembly or no assembly at all  (Dokland, 1999; Aksyuk & Rossmann, 
2011). No major scaffold protein has been identified for P1 (Lobocka et al., 2004). 




2.8), suggesting that Hdf and DarA play roles in directing proper capsid assembly, most 
likely at the time of procapsid formation. However, Hdf and DarA are still present in 
mature virions (Fig. 2.5) and hence do not fit the classical definition of scaffolding 
proteins which are present in viral proheads but absent in mature virions (Dokland, 
1999). Moreover, the presence or absence of these proteins do not result in strict 
phenotypes: the deletion of hdf or darA still produces ~20% normal-sized phage heads, 
and the parental P1 containing intact hdf and darA produces ~20% aberrant capsids.  Hdf 
and DarA may not play a direct role in the observed antirestriction activity of P1, but 
rather their absence prevents the incorporation of the other antirestriction system 
components.   
 
Since the absence of either Hdf or DarA was found to induce greater production of small 
head-sized virions, we wished to determine if the small head-size progeny of parental P1 
are capable of incorporating Hdf and DarA.  Comparative SDS-PAGE band intensities 
of P1N and P1S virions suggest that small-head phages incorporate ~65% of the major 
capsid and ~40% of the DarB proteins relative to normal P1N virions (Fig. 2.9).  These 
numbers are comparable to what would be expected from a reduction in head diameter 
from 80 nm to 60 nm, with concomitant reductions of capsid surface area by ~56% and 
capsid volume by ~42%.  While the P1S virions are capable of incorporating both DarA 
and Hdf, band densitometry suggests that P1S heads incorporate only ~14% and ~12% 
of DarA and Hdf proteins, respectively, relative to P1N (Fig. 2.9).  At this point it is 



















Percent band intensities of 







MCP 62 68 65 
DarB 38 44 41 
DarA 14 14 14 
Hdf 16 8 12 





Fig. 2.9. Comparative SDS-PAGE of P1N and P1S virions. Reprinted with 
permission from Piya et al., 2017. P1N, P1S and P1darA small head-size virions 
were extracted from isopycnic CsCl gradients, run on 12% Tris-glycine SDS-PAGE 
and stained with SyproRuby as described above. Band intensities in each lane were 
normalized to the tail sheath band and densitometry was performed on the major 
capsid protein (MCP), DarB, DarA and Hdf bands in ImageJ.  As expected, bands 
corresponding to DarB, DarA, and Hdf were not observed in P1darA small head-size 
virions.  This analysis was repeated twice and the relative band intensities measured 




Hdf and DarA, or if lower amounts of Hdf and DarA are incorporated into proheads that 
have already committed to the smaller size. 
 
The incorporation of the P1 antirestriction proteins into the capsid appears to be linked 
to the early stages of capsid morphogenesis. All of the virions run on SDS-PAGE in Fig. 
2.5 were taken from CsCl bands corresponding to normal phage buoyancy (1.46-1.48 g 
cc-1, Fig. 2.7) and electron microscopy surveys of these fractions confirmed that they 
contained >95% normal head size P1N virions (data not shown).  Even though the 
P1Δhdf and P1ΔdarA virion proteomes shown in Fig. 2.5 are the minority fraction of the 
phage lysate containing normal-sized heads, the downstream antirestriction components 
DdrA, DdrB, DarB and Ulx are still absent from the virions, demonstrating that the 
formation of normal-sized heads is in itself not sufficient for incorporation of these 
antirestriction proteins. This suggests that it is Hdf and DarA themselves, and not their 




The P1 Dar system is composed of multiple proteins: Hdf, DarA, DdrA, DdrB, DarB and 
Ulx. The role of Hdf and DarA in antirestriction system is unique because they are also 
essential for the production of normal head-size virions. In the presence of Hdf and 
DarA, ~80% of P1 progeny are of normal head-size and ~20% are of small head-size 



























Fig. 2.10. Models of P1 head-size determination and antirestriction component 
incorporation. Reprinted with permission from Piya et al., 2017. Panel A: The 
parental P1 with intact darA and hdf produces ~80% normal head-size (P1N) and ~20% 
small head-size (P1S) progeny.  In the absence of either Hdf or DarA, this ratio is 
inverted, producing progeny with mostly (~80%) aberrant small heads.  Panel B: 
Incorporation of P1 antirestriction system components follows a distinct pathway. The 
pathway presumably begins with the initiation of prohead formation by the phage portal 
and scaffold proteins, followed by co-incorporation of Hdf and DarA into the prohead.  
In addition to exacerbating the head-size defect as shown in Panel A, the absence of Hdf 
or DarA prevents the incorporation of all downstream Dar components.  The 
incorporation of Hdf and DarA does not confer protection against EcoA, EcoB or EcoK 
restriction.  Incorporation of DdrA appears to be the next step, as ddrA mutants 
incorporate only DarA and Hdf. Incorporation of DdrA provides protection against 
EcoA restriction. The incorporation of DarB, DdrB and Ulx is difficult to separate into 
separate steps, but packaging of DarB into virions provides protection against EcoB and 
EcoK restriction.  Ulx appears to be an enhancer of DarB packaging as ulx mutants 





















of either Hdf or DarA (Fig. 2.8). Because the absence of either Hdf or DarA results in a 
high abundance of aberrant small capsids, it is probable that these proteins play a role in 
the early stages of prohead formation.  The proteins Hdf, DarA and DdrA are required 
for the protection of phage DNA from restriction by the EcoA Type I R-M system, and 
DarB is required for protection against EcoB and EcoK.  Ulx enhances the antirestriction 
phenotype of DarB, and DdrB appears to negatively affect this activity by an unknown 
B 




mechanism (Fig. 2.10B).  All of these phenotypes could be complemented in trans.  
Proteomic analysis of isogenic P1 mutants shows a clear order of incorporation for each 
component into the mature virion, as illustrated in (Fig. 2.10B).  In this proposed model, 
Hdf and DarA are incorporated first in a co-dependent manner, shortly after prohead 
initiation.  The absence of either Hdf or DarA results in failure to incorporate any of the 
other antirestriction proteins.  Following Hdf and DarA, DdrA is incorporated, followed 
by DarB, DdrB and Ulx.  The incorporation of these last three proteins are not strictly 
co-dependent: the absence of DarB results in no apparent Ulx incorporation, but absence 
of Ulx results only in reduced DarB incorporation.  This behavior suggests that Ulx acts 
as a chaperone or packaging factor to increase the amount of DarB incorporated into the 
virion.  The presence of DdrB results in reduced antirestriction activity, presumably by 
negatively affecting DarB but the mechanism is not known. 
  
Given the incorporation of these proteins into the P1 virion and the cis-acting nature of 
the antirestriction phenotype, it is evident that the P1 antirestriction system must exert its 
activity upon infection of the host cell (Iida et al., 1987).  Since it is difficult to imagine 
how these proteins could act while still in the confines of the capsid, they must be 
introduced into the host cytoplasm via the phage tail upon infection.  It is not a 
requirement that all six of the antirestriction proteins described here be translocated into 
the cytoplasm to perform some direct protective action.  Some proteins, particularly the 
more upstream components such as DarA and Hdf, likely only serve to ensure the 




only two proteins are required to account for the observed phenotypes: one that provides 
protection against EcoA, and one that protects against EcoB and EcoK.  Based on 
bioinformatic evidence, DarB is the likely candidate to provide EcoB and EcoK 
protection as the predicted methyltransferase and helicase domains of DarB suggest a 
possible enzymatic mechanism to provide protection from host restriction.  The protein 
or proteins responsible for the observed anti-EcoA activity are more difficult to assign.  
DdrA is one candidate, as phage lacking DdrA contain DarA and Hdf but do not express 
any antirestriction activity.    
 
The translocation of phage proteins from the head into the host cytoplasm is a known 
feature in several Caudovirales phages.  The capsid of the temperate Salmonella 
Typhimurium podophage P22 contains three internal proteins, gp16, gp20, and gp7, that 
leave the confines of the capsid to perform their function of assisting in translocation of 
DNA across host membranes (Jin et al., 2015).  Coliphage N4 is known to translocate its 
~380 kDa DNA-dependent RNA polymerase from the phage head into the host 
cytoplasm early in the infection process (Choi et al., 2008). Perhaps the closest analog to 
the P1 system shown in this work is the paradigm coliphage T4, whose heads contain 
three non-essential internal proteins, IPI, IPII and IPIII (Black & Ahmad-Zadeh, 1971).  
The ~10 kDa T4 IPI is ejected into the host cytoplasm during phage infection and 
protects the incoming phage DNA by inhibiting a glucosyl-hmC DNA-specific 
restriction endonuclease (Bair et al., 2007). The proteins of the Dar system are 




cytoplasm, where they protect P1 DNA from cleavage by Type I R-M systems.  In our 
study of the P1 antirestriction system, we determined that the incorporation of the P1 
antirestriction proteins follow a distinct pathway that involves at least six proteins. We 
also found that proteins involved in the assembly pathway influence head 
morphogenesis. Phage P1 is the first reported instance, to our knowledge, where the 







CHARACTERIZATION OF P1 GENES OF UNKNOWN FUNCTION AND 
PACKAGING OF DARB INTO P1 PROCAPSIDS 
 
Introduction 
Bacteriophages (phages) are natural predators of bacteria. The constant evolutionary 
arms race between bacteria and phages has led to development of diverse defense and 
counter-defense strategies against each other (Labrie et al., 2010). Caudovirales phages 
such as P1 initiate the infection cycle by adsorption to host receptors, followed by 
ejection of DNA into host cytoplasm. Bacterial restriction and modification (R-M) 
systems provide a barrier to foreign DNA, including phage DNA, by cleaving 
inappropriately modified DNA. Based upon subunit stoichiometry, DNA specificity and 
restriction mechanisms, R-M systems are broadly categorized as type  I, II and III. 
(Kruger & Bickle, 1983; Loenen et al., 2014). Please refer to Chapter I of this 
dissertation for detailed information on mechanisms of action of restriction-modification 
systems. 
 
To avert DNA cleavage by the bacterial R-M systems, phages have evolved with diverse 
antirestriction mechanisms (Tock & Dryden, 2005). Enterobacteriaceae phage P1 
protects its DNA from type I R-M system mediated DNA cleavage by injecting Dar 
proteins into host. Earlier reports indicated that Dar system was composed of two 




et al., 1987; Lobocka et al., 2004). It was determined from plating assays that P1 darA 
mutants are severely restricted in host with type I EcoA, whereas P1 darB mutants are 
severely restricted in host with type I EcoB or EcoK systems (Iida et al., 1987). Recent 
study has shown that several gene in darA and darB operons, including darA and darB 
themselves, encode components of P1 antirestriction system. P1 mutants deleted for ulx 
show darB-like restriction phenotype, whereas mutants deleted for hdf or ddrA show 
darA-like phenotype (Fig. 3.1). Moreover, Hdf and DarA, which were shown to be 
required for incorporation of all Dar proteins, were also found to affect capsid size 
determination (Piya et al., 2017). Since multiple genes in two distinct operons comprise 
the Dar system, we hypothesized that P1 genes from other different operons might 
influence P1 antirestriction system. We also interested to see if any other P1 genes could 
affect capsid size determination.  
 
Genetic evidence has established that DarB is required for protection of P1 DNA from 
type I EcoB and EcoK systems following ejection of DNA into host (Iida et al., 1987; 
Piya et al., 2017). Presence of DarB in mobile genetic elements suggest that DarB could 
protect these elements from restriction during their transfer across different hosts in 
nature (Gill et al., 2011). Biological function of DarB has been studied in context of 
phage P1 only. However, little is known about the assembly of DarB into P1 procapsids 





P1 Dar system is encoded in two operons, separated by genes of unrelated functions, 





















Fig. 3.1. Genome map of P1. Rectangular blocks in the figure represent P1 genes. 
The genes above the black line are transcribed towards right, whereas those below the 
black line are transcribed towards left. The genes darB, ulx, hdf, darA, ddrA, and 
ddrB encoding known components of P1 antirestriction are indicated. P1 genes of 
unknown function that were knocked out in this study are colored red or grey. P1 
mutants knocked out for genes in red color did not form plaques and were not tested 
for plating efficiency. P1 mutants knocked out for genes in grey color formed plaques 
and were lysogenized into E. coli strain WA921. Thermally induced lysates were 
tested for plating efficiency in E. coli strains with type I EcoA, EcoB or EcoK system. 
The genes encoding major structural components are indicated for reference. The 





antirestriction system. In order to identify other components of the P1 antirestriction 
system, if any, a library of P1 mutants knocked out for genes of unknown function was 
constructed. In order to further examine the incorporation of Dar components into 
mature virions, P1 mutants defective for DNA packaging was constructed. Several 
truncations of DarB were also generated to study mechanisms of its incorporation into 
P1 capsids. Moreover, we have optimized purification of DarB to elucidate reaction 
mechanisms in vitro. 
 
Materials and methods 
Bacterial strains and phages 
The bacterial strains and phages used in this study are listed in Table 3.1. All phage P1 
mutants used in this study are isogenic gene deletions of P1CMclr100, simply referred to 
as P1 (Rosner, 1972). Unless specified otherwise, E. coli strains, were cultured in LB 
broth or LB agar at 37 °C as described before (Piya et al., 2017). Culture was grown at 
30 °C to maintain P1 lysogen and shifted to 42 °C to thermally induce P1. As needed, 
the medium was supplemented with 10 µg mL-1 chloramphenicol (LB cm), 30 µg mL-1 
kanamycin (LB kan) or 100 µg mL-1 ampicillin (LB amp).  
 
Generation of single gene P1 knockout mutants 
Single-gene deletions knockout library of P1 was constructed by using  Red 
recombinase mediated homologous recombination method as described before  




Table 3.1. Bacterial strains, phages and plasmids 
Strains, phages or 
plasmids 
Genotype or relevant characteristic Reference/source 
E. coli strains   
WA2379 leu- met- lac- rA- mA- (Arber & Wauters-
Willems, 1970) / 
The Coli Genetic 
Stock Center, Yale 
University (CGSC) 
W3110 F- - rpoS(Am) rph-1 Inv(rrnD-rrnE) rK+ mK+ (Iida et al., 1987; 
Hayashi et al., 
2006) / CGSC 
WA921 thr- leu- met- lac- rK- mK-  (Wood, 1966; 
Arber & Wauters-
Willems, 1970) / 
CGSC 
WA960 thrB+ leu- met- lac- rB+ mB+ (Wood, 1966; 
Arber & Wauters-
Willems, 1970) / 
CGSC 
BW25113(pKD46) F- l- rpoS(Am) rph-1 rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 
Δ(rhaBAD)568 
(Baba et al., 2006) 
/ CGSC 
BW25141(pKD4) lacIq rrnBT14 ΔlacZWJ16  ΔphoBR580 hsdR514 ΔaraBADAH33 
ΔrhaBADLD78 galU95 endABT333 uidA(ΔMluI)::pir+ recA1 
(Datsenko & 
Wanner, 2000) / 
CGSC 
MG1655 lacIq1tonA::Tn10 (Park et al., 2006) / 




P1ΔdarA in-frame deletion of darA in P1CMclr100 (Piya et al., 2017) 
P1ΔdarB in-frame deletion of darB in P1CMclr100 (Piya et al., 2017) 
P1ΔdarAΔpacA in-frame deletion of pacA in PΔdarA This study 
P1ΔdarBΔpacA in-frame deletion of pacA in PΔdarB This study 
P1Δprt in-frame deletion of prt in P1CMclr100 This study 
P1Δpro in-frame deletion of pro in P1CMclr100 This study 
P1ΔpmgA in-frame deletion of pmgA in P1CMclr100 This study 
P1ΔpmgB in-frame deletion of pmgB in P1CMclr100 This study 
P1ΔpmgC in-frame deletion of pmgC in P1CMclr100 This study 
P1ΔpmgF in-frame deletion of pmgF in P1CMclr100 This study 
P1ΔpmgG in-frame deletion of pmgG in P1CMclr100 This study 
P1ΔupfA in-frame deletion of upfA in P1CMclr100 This study 
P1ΔupfB in-frame deletion of upfB in P1CMclr100 This study 






Table 3.1. Continued. 
Strains, phages or 
plasmids 
Genotype or relevant characteristic Reference/source 
P1Δuhr in-frame deletion of uhr in P1CMclr100 This study 
P1Δupl in-frame deletion of upl in P1CMclr100 This study 
P1Δdbn in-frame deletion of dbn in P1CMclr100 This study 
P1ΔpmgL in-frame deletion of pmgL in P1CMclr100 This study 
P1ΔpmgM in-frame deletion of pmgM in P1CMclr100 This study 
P1ΔpmgN in-frame deletion of pmgN in P1CMclr100 This study 
P1ΔpmgO in-frame deletion of pmgO in P1CMclr100 This study 
P1ΔpmgP in-frame deletion of pmgP in P1CMclr100 This study 
P1Δppp in-frame deletion of ppp in P1CMclr100 This study 
P1ΔpmgQ in-frame deletion of pmgQ in P1CMclr100 This study 
P1ΔpmgR in-frame deletion of pmgR in P1CMclr100 This study 
P1ΔpmgS in-frame deletion of pmgS in P1CMclr100 This study 
P1Δpap in-frame deletion of pap in P1CMclr100 This study 
P1ΔpmgT in-frame deletion of pmgT in P1CMclr100 This study 
P1ΔpmgU in-frame deletion of pmgU in P1CMclr100 This study 
P1ΔpmgV in-frame deletion of pmgV in P1CMclr100 This study 
P1ΔupfM in-frame deletion of upfM in P1CMclr100 This study 
P1ΔupfN in-frame deletion of upfN in P1CMclr100 This study 
P1ΔupfO in-frame deletion of upfO in P1CMclr100 This study 
P1ΔpdcA in-frame deletion of pdcA in P1CMclr100 This study 
P1ΔpdcB in-frame deletion of pdcB in P1CMclr100 This study 
   
Plasmids   
pCP20 FLP+,  cI857+,  pR Repts, ApR, CmR  
(Cherepanov & 
Wackernagel, 
1995) / Zeng Lab 
pdarB P1 darB cloned into pBAD24 (Piya et al., 2017) 
pdarB 1-1750 

















Table 3.1. Continued. 
Strains, phages or 
plasmids 
Genotype or relevant characteristic Reference/source 
pdarB 5-2255 
















P1 darB fragment cloned into pBAD24 to express truncated DarB 
residues 25-2255 
This study 
pMB838 source of gentamicin resistance cassette 
Addgene / Lab 
stock 
pBAD24g pBAD24 with gentamycin resistance cassette This study 
ppro P1 pro cloned into pBAD24g This study 
ppmgA P1 pmgA cloned into pBAD24g This study 
ppmgB P1 pmgB cloned into pBAD24g This study 
ppmgC P1 pmgC cloned into pBAD24g This study 
ppmgG P1 pmgG cloned into pBAD24g This study 
ppmgR P1 pmgR cloned into pBAD24g This study 
pETDuet-1 Protein expression vector 
Millipore Sigma / 
Lab stock 
pETDuet_darB P1 darB cloned into pETDuet-1 This study 
pETDuet_2x-
His_darB 





gene fragment encoding 2x-His_DarB cloned into pBAD24 This study 
pFTSKi-tetR-
mCherry 
template for PCR amplification of tetR-mCherry 
(Shao et al., 2017) 
/ Zeng Lab 
pBAD24_darBN9 
Derivative of pBAD24 constructed to express recombinant proteins 





Derivative of pBAD24 constructed to express recombinant proteins 





tetR-mCherry cloned into pBAD24_darBN9 This study 
pBAD24_darBN3
0_tetR-mCherry 






BW25113(pKD46). P1 lysogens were grown in LB cm + amp. At OD550 = 0.1, 1 mM L-
arabinose was added to induce Red proteins and cells were cultured up to  OD550 0.5-0.6. 
At this point, the culture was harvested, and cells were made electrocompetent. Cells 
were transformed with gel purified DNA (QIAquick Gel Extraction Kit), which was 
obtained by PCR amplification of EcoP1R FRT-flanked kan gene from plasmid pKD4. 
The primers to amplify kan gene were designed to include homology regions to P1 DNA 
and pKD4 priming sites, as described before. The transformed cells recovered in LB at 
30 °C for 2 h. After overnight incubation at 30 °C, CmR and kanR colonies were selected, 
and mutations were confirmed by PCR and sequencing (Piya et al., 2017). The primers 
used to amplify kan inserts are listed in Table 3.2. 
 
Flp-mediated excision of kan insert and generation of double-gene knockout mutants 
All single-gene deletion mutants of P1 were generated by replacing respective genes 
with kan gene flanked with FRT (Flp recombination target) sites as described above. 
Saccharomyces cerevisiae encoded Flp enzyme mediates recombination between these 
FRT sites, enabling excision of the antibiotic resistance gene (Cherepanov & 
Wackernagel, 1995). E. coli MG1655 strain lysogenized with either P1ΔdarA or 
P1ΔdarB was made electrocompetent and transformed with plasmid pCP20 as 
previously described (Cherepanov & Wackernagel, 1995; Datsenko & Wanner, 2000). 
Lysogens of either P1ΔdarA or P1ΔdarB mutants are CmR and KanR, and plasmid 
pCP20 transformants are CmR and AmpR. P1ΔdarA or P1ΔdarB lysogens transformed 




Table 3.2. Primers and synthetic DNA fragments 
Primers     





To PCR amplify gentamicin 















To PCR amplify synthetic DNA 
fragments designed to introduce 





To clone darB fused with 2x His-tag 







To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 






To clone darB into pBAD24 to 








To knockout pacA from P1 genome 
tccgcacgtatctgattgattg gtcttcccaaacaacacatcag
c 
Sequencing primers to verify pacA 








Table 3.2. Continued. 








To knockout prt from P1 genome 
ccgtatttaatcggcgctcg ggcgaccgtgaccgtaatag Sequencing primers to verify prt 








To knockout pro from P1 genome 
ttacctgttcagcgatgtgc gctattgtatgcagggcttc Sequencing primers to verify pro 








To knockout pmgA from P1 
genome 
tgaaacgaagcggctgtttg gatataaagccttcagccagc Sequencing primers to verify pmgA 








To knockout pmgB from P1 
genome 
cttccggcttaaccaaactg tcccgaatacctgcaagctc Sequencing primers to verify pmgB 








To knockout pmgC from P1 
genome 
aacacaacgcccattaaagg tcaacttcgacagagaactgc Sequencing primers to verify pmgC 








To knockout pmgF from P1 
genome 
ttagtaccgaagatgtgactgctg agctgaacccgacacatattgc Sequencing primers to verify pmgF 








To knockout pmgG from P1 
genome 
aggttgttcgtaacggtgag ttcaggaatttgcgacgtgc Sequencing primers to verify pmgG 
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To knockout upfA from P1 genome 
aatttaacgccgacgccgac tttccctccagcacacatcg Sequencing primers to verify upfA 








To knockout upfB from P1 genome 
tcccgtagagagcgaaccac ggcttgctttagctgatgacg Sequencing primers to verify ufpB 








To knockout upfC from P1 genome 
tgcatctgacgactccaaac gctggtaatagtgtcgggatag Sequencing primers to verify upfC 








To knockout uhr from P1 genome 
atacttgccacgtcatcacc tttgtttcgcgctttgcttc Sequencing primers to verify uhr 








To knockout upl from P1 genome 
gggaaataaggttgcggtgc cgcaggaacgaccaataaacg Sequencing primers to verify upl 








To knockout dbn from P1 genome 
aggacgcagacctgattatg gcattcatctcttccgcagg Sequencing primers to verify dbn 








To knockout pmgL from P1 
genome 
gtgctttgggttgtagtgattg agtgctcgcaatttccgtcg Sequencing primers to verify pmgL 
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To knockout pmgM from P1 
genome 
cagaaagcaggcacaggtcg aggcgagcattcatttcagc Sequencing primers to verify pmgM 








To knockout pmgN from P1 
genome 
gtgcagaacaagcgattacc ggaatctccctcccggtatg Sequencing primers to verify pmgN 








To knockout pmgO from P1 
genome 
cgataagtggttgtatgctgc gaagcacagaacgccatctc Sequencing primers to verify pmgO 








To knockout pmgP from P1 
genome 
cggctatgactgttctctgc gcaatagttccagacattcgac Sequencing primers to verify pmgP 








To knockout ppp from P1 genome 
tgaacctggctttccatatcg tatccggtcggaacaactcg Sequencing primers to verify ppp 








To knockout pmgQ from P1 
genome 
caccgggcaagaaactatcg gcgatacctggtgatgacatg Sequencing primers to verify pmgQ 








To knockout pmgR from P1 
genome 
ggccgatgttgtggaacctg gcatctccgctgactgaacc Sequencing primers to verify pmgR 
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To knockout pmgS from P1 
genome 
ggctgatcgcctttgttacg atgcagcctgtcttccgttg Sequencing primers to verify pmgS 








To knockout pap from P1 genome 
cgaattgggtttagaggaaacagc tttcacttcgcctttcatgc Sequencing primers to verify pap 








To knockout pmgT from P1 
genome 
acgttaatggtcagggagtatg cgtgcgtctcatctgatctc Sequencing primers to verify pmgT 








To knockout pmgU from P1 
genome 
ggcatcacgcattctgttgg cccggttacgtctgttcttg Sequencing primers to verify pmgU 








To knockout pmgV from P1 
genome 
cacccagcaattacgagaaag cgcctgttattagccagattc Sequencing primers to verify pmgV 








To knockout upfM from P1 genome 
gtacccaccagcacatacag ttatctgccttgccgtgc Sequencing primers to verify upfM 








To knockout upfN from P1 genome 
tggctaataacaggcgcatc ccttatcccgttcttcctgac Sequencing primers to verify upfN 
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To knockout upfO from P1 genome 
tggattcggtgaaagaaagtcg gcagattctctggttgctcg Sequencing primers to verify upfO 








To knockout pdcA from P1 genome 
aagtctccgccacctacctg ccgtcttccatgtgctcgatta
ac 
Sequencing primers to verify pdcA 








To knockout pdcB from P1 genome 
gtcccgtgaagcgttaaagatg agaagagatttagtgcggatca
tg 
Sequencing primers to verify pdcB 
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To PCR amplify synthetic DNA 
fragments designed to introduce N-


















Synthetic DNA fragment to 







Synthetic DNA fragment to 
introduce 9 N-terminal DarB 







Synthetic DNA fragment to 
introduce 30 N-terminal DarB 
residues into pBAD24 












from pCP20 by thermal induction since the gene is under control of  cI857 repressor 
(Cherepanov & Wackernagel, 1995). However, thermal induction of Flp was not desired 
in our system as this would induce lysogenized P1 mutants as well. It was reported that 
basal level of Flp induction was sufficient to excise FRT-flanked regions, hence this 
strategy was applied (Cherepanov & Wackernagel, 1995). Lysogens of P1 mutants, 
transformed with pCP20 were grown overnight in LB amp + cm at 30 °C. The overnight 
culture was streaked on LB amp + cm plates to get isolated colonies, from which KanS 
colonies were selected from patch plating. To ensure that the selected KanS colonies 
were lysogens of P1 mutants, virions production by thermal induction was tested. The 
induced P1 mutants were lysogenized into E. coli MG1655 for maintenance of the 
strains, as previously described and selected as CmR colonies (Piya et al., 2017). The 
excision of kan gene was further verified by sequencing. 
 
In order to knock out additional genes, P1 mutants were lysogenized into E. coli 
BW25113(pKD46) and selected as CmR and AmpR colonies; additional gene was 
disrupted with FRT-flanked kan gene, as described above. 
 
Efficiency of plating (EOP) assay 
All phages used in EOP assays were lysogenized into E. coli WA921 and phages were 
induced, as previously described (Piya et al., 2017). EOP assays were conducted 




Phages were diluted 10-fold in SM buffer and 10 L from each dilution was spotted on 
the soft agar overlay of the host strains. 
 
Plasmid construction  
The plasmid pBAD24 was engineered to provide gentamicin resistance as described 
below. The gentamicin resistance cassette was PCR amplified from plasmid pMB838 
with primers designed to have AatII and SacI restriction sites on 5’ end of forward and 
reverse primers, respectively. Similarly, the backbone of plasmid pBAD24 was PCR 
amplified with primers designed to have SacI and AatII restriction sites on 5’ end of 
forward and reverse primers, respectively. All PCR reactions were conducted using 
Phusion Hi-Fidelity PCR Master Mix (New England Biolabs), following the 
manufacturer’s recommended protocol. The gentamicin resistance cassette was ligated 
into pBAD24 backbone using standard molecular biology techniques. P1 genes prt, pro, 
pmgA, pmgB, pmgC, pmgG and pmgR were cloned into pBAD24g (g for gentamicin 
resistance). These genes were PCR amplified using primers with XbaI and HindIII 
restriction sites on 5’ end and were ligated into respective restriction sites in pBAD24g 
following standard molecular biology techniques. 
 
P1 darB was cloned into pETDuet-1 (Millipore Sigma) for expression and subsequent 
purification of recombinant DarB by immobilized metal affinity chromatography 
(IMAC). The plasmid pETDuet_darB was further engineered to express DarB with 2x 




pETDuet-1 vector from lac operator (downstream of T7 transcription start-1) to T7 
promoter-2 was obtained, with some modifications. An additional His-tag was 
introduced downstream of the native His-tag, separated by a linker Gly-Ser-Ser. The 
introduced His-tag was followed by Ser-Gln to maintain similarity with the native 
reading frame of pETDuet-1 backbone. Other regions of the pETDuet-1 backbone was 
not altered. The PCR amplified synthetic DNA fragment was ligated into XbaI and SacI 
sites in pETDuet_darB following standard molecular biology techniques. To test for the 
function of recombinant DarB in vivo, DNA fragment encoding DarB with N-terminal 
2x His-tag was amplified from pETDuet_2x-His_darB with primers designed to have 
XbaI and HindIII restriction sites on 5’ end and ligated into pBAD24 following standard 
molecular biology techniques. 
 
To determine capsid targeting sequence in DarB, primers were designed with homology 
to different regions of P1 darB so that several N- and C-terminal residues would be 
truncated in the expressed mutant DarB. For constructing plasmid expressing DarB with 
N-terminal truncations, the start codon ATG was included in the forward primers, 
whereas for C-terminal truncations, the stop codon TAA was included in the reverse 
primers. The 5’ end of forward and reverse primers were designed to include XbaI and 
HindIII restriction sites. The amplified PCR product was ligated into XbaI and HindIII 





In order to determine if the selected N-terminal residues of DarB were sufficient to 
target foreign proteins to P1 capsids, two derivatives of plasmid pBAD24 were 
constructed. Synthetic DNA fragments that encompassed regions of plasmid pBAD24 
from 50 bp upstream of NheI restriction site to 50 bp downstream of HindIII restriction 
site, with some modifications, were ordered. The RBS was modified to “aggaggt”, 
followed by 8 arbitrary nucleotides. The nucleotides encoding the N-terminal 9 or 30 
residues of DarB (including the first residue Met) were added downstream of the 
arbitrary nucleotides. The pBAD24 multiple cloning sites from EcoRI to HindIII were 
added downstream of darB specific nucleotides. Both synthetic DNA fragments were 
PCR amplified and ligated into NheI and HindIII restriction sites of pBAD24 using 
standard molecular biology techniques. The two pBAD24 derivatives, pBAD24_darBN9 
and pBAD24_darBN30 can be used to clone any genes to express recombinant proteins 
with selected DarB residues fused to the N-terminus. In this study, tetR-mCherry was 
PCR amplified with primers designed to have EcoRI and KpnI restriction sites on the 5’ 
end and ligated into respective restriction sites of pBAD24_darBN9 and 
pBAD24_darBN30. Primers and synthetic DNA used in this study are listed in Table 
3.2. 
 
Determination of capsid targeting sequence of DarB 
Plasmids expressing proteins of interest were transformed into electrocompetent E. coli 
strain WA921 and transformed cells were selected as AmpR colonies after overnight 




P1ΔdarB  and lysogens were selected  on LB amp + cam + kan, as previously described 
(Piya et al., 2017). Phage lysates were produced from these P1ΔdarB lysogens as  
previously described, with minor modifications (Piya et al., 2017). Lysogenic strains 
were grown at 30 °C in LB amp + cam + kan to OD550 0.4-0.6 and P1ΔdarB was 
thermally induced at 42 °C. 1 mM L-arabinose (Sigma-Aldrich) was also added at the 
time of thermal induction. Samples were collected 30 min post-induction and analyzed 
by SDS-PAGE to check the expression of proteins from the plasmids. The lysates were 
harvested as described previously (Piya et al., 2017). The phages were purified by CsCl 
isopycnic centrifugation and the packaging of proteins into capsids were analyzed by 
SDS-PAGE of virions. 
 
Purification of virions by CsCl isopycnic centrifugation 
Phages were thermally induced in 500 mL LB supplemented with appropriate 
antibiotics. Phages were concentrated 100-fold by centrifugation and purified by CsCl 
isopycnic centrifugation as described (Piya et al., 2017). 
 
Size exclusion chromatography of P1 procapsids 
P1 mutants disrupted for DNA packaging (P1ΔpacA) were thermally induced from 
lysogens and lysates were harvested as described before. Protein components were 
precipitated from lysates by addition of ammonium sulfate to a final saturation of 60% 
(Simpson, 2006). The pellet was resuspended in SM buffer, passed through 0.22 m 




100/300 GL (GE Healthcare). The void volume fractions, comprising P1 proheads and 
tails, were collected and analyzed by SDS-PAGE.  
 
IMAC protein purification 
E. coli BL21(DE3) cells were transformed with plasmid pETDuet_2x-His_darB as 
previously described (Green & Sambrook, 2012; Piya et al., 2017) with minor 
modifications. BL21(DE3) cells were concentrated 10x while making them 
electrocompetent and were transformed with ~2 ng of pETDuet_darB-12His. Cells were 
recovered in 1mL LB for 1 h at 37 °C and plated to LB amp overnight at 37 °C.  Single 
ampR colony was selected and grown overnight on LB amp. A fresh culture was started 
in LB amp by 100-fold dilution of the overnight culture. At ~ OD550 0.6-0.8, culture was 
placed on ice for ~15 mins, 1mM IPTG was added to induce protein synthesis, followed 
by overnight incubation at 16 °C. Culture was harvested by centrifugation at 5000 x g 
for 20 mins and washed with cold LB. After additional centrifugation at 5000 x g for 20 
mins, cell pellets were stored in -80 °C until further processing. 
 
Cell pellet from 1 L IPTG-induced BL21(DE3) culture was thawed in ice and 
resuspended in ~30 mL of sonication buffer [50 mM Tris-Cl pH 8.0, 500 mM NaCl, 
15% (v/v) glycerol, 10 mM imidazole], followed by addition of 1 mg mL-1 chicken egg 
white lysozyme (Sigma-Aldrich),  100 g mL-1 bovine pancreas DNase I (Sigma-
Aldrich), SIGMAFAST protease inhibitor (Sigma-Aldrich), 1mM MgSO4 and 0.01% 




followed by centrifugation for 15 min at 10000 x g at 4°C. The supernatant fraction that 
contained soluble recombinant DarB was mixed with 5 mL bed volume of pre-
equilibrated Ni-NTA agarose resin (Qiagen) in a shaking platform for ~16 h at 4 °C. 
DarB bound to Ni-NTA agarose resin was purified by gravity-flow chromatography.  
Non-specific proteins bound to resin was eluted with IMAC wash buffer (50 mM 
Sodium phosphate pH 7.4, 500 mM NaCl) with gradient concentration of imidazole (20 
mM, 50 mM, 60 mM, 70 mM, 80 mM, 100 mM). The target protein was eluted with 
elution buffer (50 mM Sodium phosphate pH 7.5, 500 mM NaCl, 500 mM imidazole). 
The elution fraction was concentrated, and buffer exchanged (50 mM Sodium phosphate 
pH 7.4, 150 mM NaCl) in 50 kDa molecular weight cutoff centrifugal filters (Amicon). 
The concentrated protein was stored in 20% glycerol (v/v) at -20°C until further use 




Phage samples for SDS-PAGE analysis were prepared as previously described (Piya et 
al., 2017). For other protein samples, DNase I treatment was omitted. The gels were 
stained with either SYPRO Ruby (Thermo Scientific) or Coomassie (GE Healthcare). 
 
Transmission electron microscopy 
Samples for electron microscopy were stained with 2% uranyl acetate and imaged in a 




Microscopy and Imaging Center, Texas A&M University, College Station (Valentine et 
al., 1968). Crude lysates of P1 procapsids were concentrated 10-fold in 50 kDa MWCO 
centrifugal filters (Amicon) for imaging. 
 
Results and discussion 
P1 genes of unknown function are not involved in antirestriction system 
The first reported antirestriction phenotype of phage P1 demonstrated that two P1 genes 
darA and darB, comprised the P1 antirestriction system (Iida et al., 1987). It has been 
shown that darA and darB are present in two distinct operons in P1 genome (Lobocka et 
al., 2004). Recent work has shown that along with darA and darB, other genes present in 
the operons encoding these two genes, hdf, ddrA, ddrB and ulx are associated with the 
P1 antirestriction system (Fig. 3.1) (Piya et al., 2017). Moreover, hdf and darA have 
been depicted to be involved in determination of head size during virion morphogenesis 
(Piya et al., 2017). 
 
Since the genes encoding P1 antirestriction system were present in two different operons 
in P1 genome, it was hypothesized that genes elsewhere in the P1 genome could be 
involved in providing protection against type I R-M systems. The identity of the 
antirestriction protein protecting P1 DNA from the type I EcoA system is still not clear. 
Moreover, proteins Hdf and DarA from the P1 antirestriction system were also found to 
affect capsid morphogenesis (Piya et al., 2017). P1 capsid morphogenesis has not been 




(Lobocka et al., 2004; Piya et al., 2017). Despite the role of Hdf and DarA in 
determining normal P1 capsid size, they do not fit the classical definition of scaffolding 
proteins, as both Hdf and DarA are still present in the mature virions (Piya et al., 2017). 
We attempted to study the role of other P1 genes in antirestriction system and virion 
morphogenesis. There are several genes in P1 genomes for which any definitive function 
has not been assigned. The genes that were suggested to have unknown function or 
putative morphogenetic functions were of interest to us (Lobocka et al., 2004). Isogenic 
deletions of 29 such genes in P1 genome were made and the role of each gene was 
interrogated in relation to P1 antirestriction system and virion morphogenesis (Fig. 3.1).  
 
Successful isogenic deletions of these 29 genes in P1 lysogens suggest that these genes 
do not affect stability of P1 lysogens. P1 mutants deleted for genes pmgA, pmgB, pmgC, 
pmgG or pmgR did not form plaques on  lawns of E. coli host, suggesting these genes are 
essential for lifecycle of P1. The essentiality of these five genes has not been verified by 
in trans complementation.  
 
The remaining 24 gene knockout mutants of P1 were able to form plaques on lawns of E. 
coli host. These P1 mutants were lysogenized into E. coli WA921 strain and phage 
lysogens were induced to check for restriction phenotype. It has been established that the 
EOP of P1ΔddrA is severely reduced in cells with type I EcoA, EcoB or EcoK systems 
as virions P1ΔddrA mutants are unable to incorporate antirestriction proteins in capsids 




compared to the EOP of P1ΔddrA to study roles played by those genes in antirestriction. 
In this study, the EOP of P1ΔddrA was reduced by ~10-3, 10-4 or 10-4 in E. coli strains 
with type I EcoA, EcoB or EcoK systems respectively. The EOP of all other phage 
mutants appeared ~1 in E. coli strain with type I EcoA system and ~10-1 - 10-2 in E. coli 
strains with type I EcoB or EcoK systems (Fig. 3.2). This suggests that the antirestriction 
system of these mutants were not compromised and these phage mutants were able to 
employ antirestriction system to protect DNA from type I R-M system mediated DNA 
cleavage  following infection of the respective host. 
 
Dar proteins are packaged into P1 capsids before DNA 
The Dar antirestriction system of P1 is different from other studied antirestriction 
systems as Dar proteins act strictly in cis (Iida et al., 1987). These Dar proteins are 
incorporated into capsids during virion morphogenesis and at least some proteins must 
be delivered into the host cytoplasm during phage infection, where they protect DNA 
from host restriction (Iida et al., 1987; Piya et al., 2017). Recent work has revealed that 
Dar antirestriction proteins are incorporated into P1 capsids in a specific order during 
virion morphogenesis (Piya et al., 2017). The assembly pathway of most phages in 
Caudovirales order bear similarity in that assembly starts with prohead, which is 
eventually filled with genetic material (Aksyuk & Rossmann, 2011). Phage P1 is not 
unique in packaging proteins into the head which are later transferred to the host 
cytoplasm on infection. Phage T4 also has several internal proteins packaged into 




into scaffolding core, followed by procapsid shell formation and DNA packaging (Hong 





















Fig. 3.2. P1 genes of unknown function are not required for antirestriction. Phage 
P1 or mutants were lysogenized into restriction-modification deficient E. coli strain 
WA921. The lysogens were thermally induced and tested for plating efficiency in E. 
coli strains with type I EcoA, EcoB or EcoK R-M systems. The EOP of parental P1, 






 in strains with type I 
EcoA, EcoB or EcoK systems respectively, whereas the EOP of P1ΔddrA, with 








 in strains with type I 
EcoA, EcoB or EcoK systems respectively. The EOP of all other P1 mutants 
generated in this study appeared normal compared to the EOP of P1ΔddrA, 
suggesting that these genes do not play any roles in protecting P1 DNA from the type 






























into procapsids by a packaging complex, composed of small (TerS) and large (TerL) 
subunits (Aksyuk & Rossmann, 2011). The DNA packaging complex of P1, which is 
composed of proteins encoded by pacA and pacB, cleave P1 DNA concatamers at pac 
sites located within the coding region of pacA (Fig. 3.3A) (Skorupski et al., 1992). In the 
absence of either PacA or PacB, DNA cannot be packaged into P1 procapsids and virion 
morphogenesis is stalled at the procapsid stage (Skorupski et al., 1992).  
 
In order to determine if the antirestriction proteins are incorporated into P1 procapsids 
before DNA, pacA was deleted from P1 prophage. These  ΔpacA prophages were then 
induced and procapsids were purified by ammonium sulfate precipitation followed by 
size exclusion chromatography as described above in materials and methods. These 
methods are suitable for purification of macromolecular complexes, hence both 
procapsids and tails are purified in these fractions. These procapsid/tail fractions as well 
as CsCl purified intact parental P1 virions were then analyzed by SDS-PAGE (Fig. 
3.3B). Previously identified virion-associated Dar proteins, DarB, DarA, DdrB and Hdf, 
have been labelled. Other proteins, Ulx and DdrA, which are also associated with the 
Dar antirestriction system are not seen in this SDS-PAGE because of their small size and 
low copy number. It has been established that DarB can be incorporated into virions 
efficiently only in the presence of all other Dar proteins. Thus, the presence of DarB is 




























Fig. 3.3. P1 antirestriction components are incorporated into P1 procapsids 
before DNA. Panel A: The image represents a partial genomic map of P1 showing 
genes pacA and pacB, required for DNA packaging during virion morphogenesis. 
Both pacA and pacB are transcribed rightwards. The ruler at the bottom represents the 
nucleotide position as in the published P1 genome (NC_005856.1). The gene pacA 
was deleted from P1 genome in this study. Panel B: Large macromolecular structures 
present in thermally induced lysates of P1ΔpacA and P1ΔdarA_ΔpacA were 
concentrated by ammonium sulfate precipitation and fractionated by size exclusion 
chromatography. The void volume from size exclusion chromatography, consisting of 
P1 procapsids and tails, was collected and analyzed by 12% Tris-glycine SDS-PAGE. 
P1 virions, purified by cesium chloride isopycnic centrifugation, were also run in 
SDS-PAGE for comparison. The protein bands corresponding to the components of 
P1 antirestriction system seen in the SDS-PAGE have been annotated. Presence of 
proteins bands corresponding to DarB, DarA, DdrB and Hdf in the lane of P1ΔpacA 
indicates that these antirestriction components are packaged into P1 procapsids before 































purified intact P1 virions and P1ΔpacA fractions, the band corresponding to DarB is 
visible. However, it is possible that this visible protein band of DarB in P1ΔpacA lane is 
not associated with the procapsids, but co-purified from the lysates at the applied 
ammonium sulfate concentrations (Wingfield, 2001). In order to rule out this possibility, 
procapsid/tail components of P1ΔdarA_ΔpacA were also purified from crude lysates and 
were analyzed simultaneously (Fig. 3.3B). P1ΔdarA virions are unable to package DarB, 
thus it is expected that P1ΔdarA_ΔpacA procapsids also cannot package DarB  (Piya et 
al., 2017). However, the darB gene is intact in the genome of the P1ΔdarA prophage, 
thus DarB is synthesized normally when lysogens of P1ΔdarA are thermally induced, 
despite DarB not being incorporated into capsids (Fig. 3.4). A protein band 
corresponding to DarB is not visible in the lane of P1ΔdarA_ΔpacA, indicating that 
DarB proteins are not incorporated into procapsids, and also are not purified along with 
procapsid/tail fractions by this technique despite being present in lysates. As mentioned 
above, in the absence of PacA, virion morphogenesis is stalled at the procapsid stage as 
the DNA packaging event is disrupted. Hence, comparative analysis of protein bands of 
P1ΔpacA and P1ΔdarA_ΔpacA mutants suggest that DarB and thus other antirestriction 
proteins are packaged into procapsids before DNA. 
 
Electron densities in transmission electron micrographs of P1 procapsids suggest 
presence of other internal proteins 
In negative-stained transmission electron micrographs (TEM) of P1ΔpacA lysates, 


























Fig. 3.4. DarB is synthesized in P1ΔdarA mutants. E. coli MG1655 lysogens of P1 
and P1ΔdarA were cultured in 30 °C up to OD
550 
0.4-0.5 and thermally induced at 42 
°C. Samples were collected before and at 15, and 30 min post-thermal induction. 0.3 
OD equivalent of samples were loaded in 8% Tris-glycine SDS-PAGE and gel was 

























Fig. 3.5. P1 procapsids show electron densities suggesting presence of protein 
contents. Images shown are representative negative-stained transmission electron 
micrographs of procapsids of P1 (A), P1ΔdarA (B and C) and P1ΔdarB (D), 
generated by deletion of DNA packaging component pacA from P1 genome. Since 
these mutants are defective in DNA packaging, the presence of electron density can be 
corroborated to presence of proteins. Presence of electron density in P1ΔdarA (B and 
C) and P1ΔdarB (D) indicate these densities correspond to proteins other than Dar 
proteins. These electron densities are also seen in both normal (B) and small (C) size 






electron densities inside these protein shells. In a complete virion, this electron density 
inside capsid suggests packaged DNA (Chapter II, Fig 2.8). However, P1ΔpacA is 
defective in DNA packaging, thus it is extremely unlikely that this density is from the 
packaged DNA. It has been demonstrated that P1 Dar proteins are localized into P1 
capsids and contribute significantly to the mass of the virion (Iida et al., 1998; Piya et 
al., 2017). Hence, we speculated that these densities correspond to the internal Dar 
proteins. However, the electron densities were still conspicuous in the negative-stained 
micrographs of both P1ΔdarB_ΔpacA (Fig. 3.5D) and P1ΔdarA_ΔpacA (Fig. 3.5B and 
3.5C). P1ΔdarB virions are missing DarB and Ulx, whereas P1ΔdarA virions are 
missing all known proteins of P1 Dar system (Piya et al., 2017). Thus, it can be 
concluded, from SDS-PAGE and TEM analysis of P1ΔdarA_ΔpacA procapsids, that the 
electron densities visible in P1 procapsids do not correspond to the antirestriction 
proteins. Negative-stained TEM images of phage P22 and T4 procapsids also show 
similar electron density inside the capsid shells that correspond to scaffolding protein 
core (King et al., 1973; Traub & Maeder, 1984; Black & Rao, 2012). Thus, it is possible 
that the density observed in P1 procapsids also correspond to the scaffolding core, which 
might be removed during DNA packaging (Fig. 3.5). 
 
Comparative SDS-PAGE analysis protein bands of P1ΔpacA and P1ΔdarA_ΔpacA show 
that the lanes of these procapsids contain protein bands (marked with arrows) that are 
absent in the lanes of CsCl purified intact P1 virions (Fig. 3.3B). Procapsids of other 




cleaved and are not present in mature virions (Dokland, 1999). These protein bands in 
P1 procapsid lanes could be the constituents of the P1 scaffolding core. Because of the 
limitations of the technique applied in this study to obtain procapsids, it is also possible 
that some protein bands in the procapsids lanes of Fig. 3.3B are contaminating host 
proteins, thus the identity of these proteins need to be confirmed by mass spectrometry. 
 
N-terminal residues of DarB provides signal for capsid targeting 
Phages such as T4 and P22 incorporate internal proteins into capsids during early stages 
of capsid morphogenesis (Hong & Black, 1993; Jin et al., 2015). The capsid-associated 
phage T4 internal protein III (IPIII) is directed to the assembly core by specific N-
terminal residues, designated as capsid targeting sequence (CTS) (Showe & Black, 1973; 
Mullaney & Black, 1996). Since DarB is also packaged into the P1 capsid, it is possible 
that DarB has a CTS that directs nascent DarB to P1 procapsids. To determine if DarB is 
directed to capsid assembly by any specific residues, mutant DarB truncated at the N- 
and/or C-terminus were expressed from a plasmid-based system. Full-length DarB 
consists of 2255 residues, with a mass of ~250 kDa. Initially, three versions of 
truncations were constructed: a C-terminal truncation, with DarB containing residues 1-
1750 (DarBt 1-1750), an N-terminal truncation, with DarB containing residues 90-2255 
(DarBt 90-2255) and both N- and C-terminal truncations, with DarB containing residues 
90-1750 (DarBt 90-1750). The truncated DarB was induced in P1ΔdarB lysogen and the 




truncated DarB. Two conserved domains of DarB were kept intact while constructing all 
truncated versions.  
 
EOP assays shows that none of these truncated DarB restored the antirestriction 
phenotype of P1ΔdarB mutant (Fig. 3.6A). In order to determine if the truncated DarB 
was expressed, whole cell samples of induced lysogens were analyzed via SDS-PAGE 
(Fig. 3.7A). DarB expressed from parental P1 is not visible because of the sensitivity of 
the staining procedure. However, the presence of DarB in P1virions is evident from the 
normal EOP of P1 in strains with type I EcoB or EcoK (data not shown). Protein bands 
corresponding to expressed protein were visible for all truncations suggesting that  DarB 
truncations were expressed at a higher level from plasmid-based system compared to wt 
DarB expressed from its native locus in P1.  
 
To determine if any of these DarB truncations were packaged into virions, P1ΔdarB 
virions complemented in trans with DarB truncations were purified by CsCl isopycnic 
gradient centrifugation and analyzed by SDS-PAGE. Of the three truncations, protein 
bands corresponding to only DarBt 1-1750 was visible in the SDS-PAGE of virions. 
Protein bands corresponding to two other truncations, DarBt 90-1750 and DarBt 90-
2255, were not visible. This suggests the N-terminal ~89 residues of DarB are required 
for targeting DarB into capsid during capsid morphogenesis (Fig. 3.8A). However, since 



























Fig. 3.6. Plating efficiency of P1ΔdarB complemented with truncated DarB. In 
order to test for packaging signal in DarB, several N- and C-terminal truncations of 
DarB were constructed and tested for their ability to complement restriction 
phenotype. The empty vector pBAD24 or pBAD24 cloned with darB fragments were 
transformed into E. coli strain WA921 and lysogenized with P1ΔdarB. The phage 
lysates were obtained as described in materials and methods and were tested for 
restoration of plating efficiency on E. coli strains with type I EcoA, EcoB or EcoK R-
M systems. The EOP data shown have been normalized to P1 induced from strain 
WA921 transformed with plasmid pBAD24.  Panel A: The relative EOP of P1ΔdarB 




 in EcoB and EcoK strains respectively (red bars). The 
EOP was restored to normal levels by full length DarB (green bars). None of the 
truncated DarB was able to restore the EOP (grey bars). Panel B: As described in 
panel A, the EOP of P1ΔdarB was reduced in strains with EcoB and EcoK strains (red 
bar) and the EOP was restored to normal levels by full length DarB (dark green bar). 
N-terminal truncation of DarB containing residues 5-2255 was able to restore plating 
deficiency in EcoB and EcoK strains (light green bar). None of the other truncations 
restored plating deficiency in EcoB and EcoK strains (grey bars). In both panels A 
and B, the plating efficiency was not affected in EcoA strain. The data shown are 































































Fig. 3.7. Truncated DarB can be expressed. For both panels A and B, E. coli strain 
WA921 was transformed with empty plasmid pBAD24 or plasmid encoding full 
length or truncated DarB as denoted. Transformed cells were lysogenized with P1 or 
P1ΔdarB as indicated. Phages and protein production from plasmids were induced 
simultaneously, as described before. Samples were collected ~30 min post-induction 
and analyzed by SDS-PAGE and Coomassie staining to check for protein induction 
from plasmids. Both full-length and truncated versions of DarB are induced from the 




























Fig. 3.8. N-terminal residues of DarB provide signal for capsid targeting. For both 
panels A and B, phages P1 or P1ΔdarB were lysogenized into E. coli strain WA921 
containing respective plasmid. Phages and proteins from plasmids were induced 
simultaneously as described before. Phages were purified by cesium chloride isopycnic 
gradient centrifugation and analyzed by SDS-PAGE, followed by SyproRuby staining. 
Panel A: DarB
t 
1-1750 is incorporated into P1ΔdarB virions. Panel B: DarB
t 
5-2255 is 
packaged into P1ΔdarB virions. All other truncations of DarB are not packaged into 

































uncertain if DarBt 1-1750 can be ejected into host cells during infection. Moreover, 
DarBt 1-1750 is missing ~500 C-terminal residues. Even though there is no identifiable 
conserved domain within these C-terminal 500 residues of DarB, these 500 residues 
might be necessary for folding of DarB into native conformation or for establishing other 
protein-protein or protein-DNA interactions to perform its functions. 
 
Once we established that N-terminal residues of DarB are required for capsid 
localization, we sought to determine the specific residues required for this purpose. 
Several constructs were produced to express truncated DarB translated from specific N-
terminal residues: 5 (DarBt 5-2255), 10 (DarBt 10-2255), 15 (DarBt 15-2255), 20 (DarBt 
20-2255) and 25 (DarBt 25-2255). Of these truncations, only DarBt 5-2255 was able to 
complement the antirestriction phenotype of P1ΔdarB (Fig. 3.6B). SDS-PAGE of the 
induced lysogens showed that other four truncated DarB proteins were expressed from 
plasmids as well (Fig. 3.7B). P1ΔdarB virions complemented with these series of 
truncated DarB were purified as described above and analyzed by SDS-PAGE. Protein 
band corresponding to DarBt 5-2255 was visible in SDS-PAGE, which corelates to why 
DarBt 5-2255 was able to complement antirestriction phenotype of P1ΔdarB. Neither of 
the truncated DarB starting with residues 10, 15, 20, and 25 were packaged into the 
virions (Fig. 3.8B). This suggests that N-terminal amino acid sequences of DarB 






Purification of DarB 
Genetic evidence suggests that DarB protects P1 DNA from host type I R-M system 
mediated DNA cleavage, following infection (Iida et al., 1987; Piya et al., 2017). 
However, biochemical mechanisms of DNA protection have not been elucidated. More 
importantly, it is not known if DarB needs any interacting partners to perform its 
biological role. Bioinformatic analysis shows that P1 DarB consists of a 
methyltransferase and a DExH helicase domain (Gill et al., 2011). Based on the presence 
of conserved domains, biochemical activity of DarB can be predicted, however this must 
be confirmed in vitro.  Since much of this future work will depend on the ability to 
obtain purified DarB protein, we sought to purify DarB by using affinity 
chromatography. Optimization of purification steps would also facilitate the study of the 
interacting partners of DarB by conducting pull-down assays (Green & Sambrook, 
2012).  
 
Initial attempts were made to purify DarB by cloning P1 darB into expression vector 
pETDuet-1 in-frame with the native His-tag. However, eluted DarB was not of high 
purity. Other available tags, glutathione S-transferase (GST) (GE Healthcare), maltose-
binding protein (MBP) (New England Biolabs) and chitin binding domain (CBD) (New 
England Biolabs) were explored by fusing them to the N-terminus of DarB. Fusion of 
these tags to DarB produced varying results: inefficient binding of recombinant DarB to 
purification resin (GST-tag), toxicity (MBP-tag) and no protein expression (CBD-tag). 




tag did not provide sufficient binding affinity to the recombinant DarB. Hence, an 
additional His-tag was introduced into the backbone of pETDuet-1, downstream of the 
native His-tag, resulting in the production of recombinant DarB with 2x His-tag in its N-
terminus (2x-His_DarB). The recombinant DarB has the following residues on its N-
terminus: MGSSHHHHHHGSSHHHHHHSQDPNSSS (the underlined residues indicate 
His-tag) 
 
Affinity purification of recombinant 2x-His_DarB yielded protein with significant purity 
as determined by SDS-PAGE analysis (Fig. 3.9). Even though His-tags are smaller 
compared to other affinity tags, they can still affect biochemical properties of 
recombinant proteins (Booth et al., 2018). Thus, we sought to determine if 2x-His_DarB 
can complement the restriction phenotype of P1ΔdarB. The gene encoding 2x-His_DarB 
was PCR amplified and cloned into pBAD24 vector to test for function of 2x-His_DarB 
in vivo. EOP assays suggest that 2x-His_DarB can restore the restriction phenotype of 
P1ΔdarB (Fig. 3.10). Thus, it can be inferred that 2x His-tag fused to N-terminus of 
DarB does not affect the biochemical activity of DarB significantly, at least in vivo.  
 
Conclusions 
In Chapter 2 of this dissertation, it was demonstrated that P1 antirestriction is comprised 
of multiple components, in addition to the established darA and darB (Iida et al., 1987; 
Piya et al., 2017). Moreover, the role of hdf and darA in head size determination during 


























Fig. 3.9. IMAC purification of P1 DarB. E. coli BL21(DE3) strain was transformed 
with the expression plasmid pETDuet_2x-His_darB and protein production was 
induced by addition of 1 mM IPTG. BL21(DE3) cells expressing 2x His_DarB were 
sonicated and the supernatant (Sup) was applied to Ni-NTA agarose resin. Flow-through 
(FT) fraction was collected and non-specific proteins bound to the resin was washed 
with buffer containing increasing gradient of imidazole. 2x His_DarB bound to Ni-NTA 
resin was eluted with buffer containing 500 mM imidazole. All fractions were collected 










































Fig. 3.10. DarB with 2x His-tag fused to N-terminus is functional. Phages for 
complementation were induced as described before. The EOP of P1ΔdarB is reduced 
in E. coli strains with EcoB or EcoK systems, as demonstrated before (red bar). DarB 
with 2x His-tag fused to its N-terminus can restore the plating defect of P1ΔdarB in 
strains with EcoB or EcoK systems suggesting that the N-terminal fusion of 2x His-





morphogenesis. As the components of the P1 Dar system were distributed in two 
operons in P1 genome (Piya et al., 2017), we sought to interrogate genes in other 
operons for their role in antirestriction and/or capsid morphogenesis. We targeted P1 
genes of unknown function for this study. Isogenic deletion knockouts of these genes 
were created in P1 lysogens and induced virions were tested for restriction phenotype in 
E. coli hosts with type I EcoA, EcoB or EcoK systems by conducting plating assays 
(Fig. 3.1). The efficiency of plating (EOP) of all of these P1 mutants were comparable to 
the EOP of parental P1, which suggests that the antirestriction system is intact in these 
mutants (Fig. 3.2). Thus, these P1 genes do not appear to contribute to the activity of the 
P1 antirestriction system.  
 
Lysates of knockout mutants of five P1 genes pmgA, pmgB, pmgC, pmgG and pmgR did 
not form plaques on lawns of their E. coli host (Fig. 3.1), indicating that these five genes 
are essential for plaque formation under laboratory conditions. At this stage, it is too 
early to ascribe any functions to these genes as plaque non-forming phenotype of these 
mutants still needs to be complemented. Genes pmgA, pmgB, pmgC and pmgG are found 
in vicinity of other genes encoding tail components. Although it is tempting to speculate 
that these genes encode components of tail assembly based on their location in P1 
genome, it might be misleading to do so as genes encoding components of same pathway 
are not organized together in P1 genome. After complementing the phenotype pertaining 
to those genes, lysates of mutant virions may be analyzed by transmission electron 





Virions such as P22 and T4 incorporate several internal proteins into procapsids during 
earlier stages of capsid morphogenesis, followed by DNA packaging (Bazinet & King, 
1988; Arisaka, 2005; Aksyuk & Rossmann, 2011). By disrupting DNA packaging in P1, 
virion morphogenesis was stalled at formation of procapsids and tail and both procapsids 
and tails were purified in same fraction. Comparative SDS-PAGE analysis of the 
procapsids/tail fractions of P1ΔpacA and P1ΔdarA_ΔpacA suggest that P1 antirestriction 
components are packaged before DNA (Fig. 3.3).  
 
P1 Dar proteins are incorporated in capsids and at least one of these, DarB, is injected 
into the new host during infection. As phage DNA ejected into host are packaged in the 
inner space of capsids, it can be extrapolated that these Dar proteins are also packaged in 
the same space. It was demonstrated in Chapter 2 of this dissertation that P1 Dar proteins 
occupy a significant mass in the capsid (Piya et al., 2017), which suggests that not 
having Dar proteins inside of P1 procapsids will leave more space for DNA to be 
packaged. Virions of P1ΔdarA cannot package any of the Dar proteins, thus internal 
space in P1ΔdarA procapsids is likely to be greater than those of P1 procapsids. Since P1 
packages DNA into procapsids by headful mechanism (Bachi & Arber, 1977; Lobocka 
et al., 2004), virions of P1ΔdarA should be able to package more DNA than P1, which 





The internal volume of P1 procapsids, as seen in negative-stained EM images, has an 
asymmetrically distributed electron density, suggestive of proteins because P1 
procapsids constructed in this study are unable to package DNA (Fig. 3.5). Procapsids 
harvested at similar stages of virion morphogenesis in other phages such as P22 and T4 
also show similar electron densities, which are attributed to the scaffolding core. 
However, this scaffolding core of both P22 and T4 occupy most of the space inside of 
procapsid, compared to partial space in P1 (King et al., 1973; Traub & Maeder, 1984). 
This suggest that the scaffolding core of P1 is either proteolytically processed and the 
fragments are removed before the start of DNA packaging or there is a novel mechanism 
associated with head morphogenesis. Identification of proteolytic processing enzyme 
and scaffolding proteins associated with P1 head morphogenesis, if there is any, would 
assist in studying P1 capsid morphogenesis.  
 
Comparative SDS-PAGE analysis of CsCl purified mature P1 virions and P1 
procapsids/tail fractions show few proteins bands that are only present in P1 
procapsids/tail fractions. These new protein bands present in the lanes of procapsids/tail 
fractions are suggestive of constituents of scaffolding core, as this core is processed and 
removed during later stages of capsid morphogenesis (Dokland, 1999). However, due to 
the limitations of current purification methods, P1 procapsids and tail components are 
purified in same fractions. Moreover, these fractions may contain contaminating host 




PAGE if these proteins bands are still present in the lanes of procapsids and can be 
identified by mass spectrometry. 
 
P1 antirestriction protein DarB is incorporated into capsid in a definite pathway 
involving other capsid-associated proteins as well (Piya et al., 2017). By analyzing 
incorporation of DarB mutants, truncated for several residues at N- or C- terminus, into 
P1ΔdarB virions, we have determined that N-terminal residues ranging from 5th to 9th 
are essential for packaging of DarB into P1 capsids (Fig. 3.8B). Residues that are crucial 
for  targeting proteins into capsids have also been found in other phages. Phage T4 
capsids contain hundreds of copies of internal proteins (IPI, IPII and IPIII) (Black & 
Ahmad-Zadeh, 1971). It has been determined that IPIII is incorporated into T4 
procapsids with a capsid targeting sequence (CTS) present in N-terminus of this protein 
(Mullaney & Black, 1996). Moreover, the CTS can also direct other foreign proteins to 
be packaged into T4 capsids and these foreign proteins are further injected into new host 
during T4 infection (Hong & Black, 1993; Mullaney & Black, 1996). Although DarB N-
terminal residues 5th-9th seem to be required for packaging of DarB into P1 virions, it is 
not evident if those residues are sufficient. Fusion of foreign proteins to the respective 
N-terminal residues of DarB could tell if these particular residues are sufficient for 
packaging any protein into P1 capsids. Moreover, fusion of fluorescent proteins could be 
advantageous as injection of these fusion proteins into new host following P1 infection 





Although it has been established that DarB protects P1 DNA from type I R-M system 
mediated DNA cleavage following ejection of DNA into host cytoplasm (Iida et al., 
1987; Piya et al., 2017), biochemical mechanism behind this protection has not been 
determined. Because of the presence of conserved methyltransferase and helicase 
domains in DarB, it may be hypothesized that DarB methylates and/or translocates along 
DNA following ejection of both DarB and DNA into new host (Lobocka et al., 2004; 
Gill et al., 2011). In order to determine the activity of DarB in vitro, we sought to purify 
DarB using affinity chromatography. By fusion of 2x His-tag to N-terminus of P1 DarB, 
recombinant DarB could be purified, by immobilized metal affinity chromatography, to 
sufficient purity to conduct enzyme assays (Fig. 3.9). Moreover, we have also shown 
that 2x His-tag fusion to DarB does not abolish its biological activity (Fig. 3.10). In vitro 
enzyme assays can now be conducted to determine the biochemical mechanism of how 
DarB protects DNA from type I R-M system mediated restriction. 
 
Many proteins can perform biological functions only when they are associated with 
other protein subunits forming a complex. Thus, it cannot be ruled out yet that DarB 
could only function in presence of other protein subunits. In the type I R-M system 
complex, DNA specificity is provided by HsdS subunit (Murray, 2000). Since DarB has 
been shown to protect DNA against other type I R-M systems from Salmonella as well, 
it is plausible that DarB might interact with HsdS subunit of type I R-M complex (Iida et 
al., 1987). Moreover, other proteins from Dar system might be co-injected with DarB 




same strategy can be applied to set up pull-down assays to determine interacting partners 
of DarB. Setting up in vitro enzyme assays for DarB may be worthwhile, only after 





CHAPTER IV  
GENOME-WIDE SCREENS REVEAL ESCHERICHIA COLI GENES 




Escherichia coli was discovered by the German microbiologist Theodor Escherich, in 
the study of infant gut microbes (Escherich, 1988). Because of several traits such as 
easily culturable, short doubling time, E. coli has been used as a model organism for 
understanding basic biology as well as for biotechnology applications. E. coli is a 
member of Enterobacteriaceae, and is related to other pathogens such as Salmonella, 
Klebsiella, Serratia and Yersinia. E. coli is a facultative aerobe, and along with other 
obligate anaerobes, forms a part of commensal gut flora (Blount, 2015). These 
commensal E. coli strains do not cause disease in human host, barring 
immunocompromised individuals. However, there are several strains of E. coli that have 
acquired virulence factors and cause diseases with symptoms, ranging from mild 
discomfort to life-threatening. Depending upon disease etiology, these strains have been 
categorized into several pathotypes: enteropathogenic E. coli (EPEC), 
enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroaggregative 
E. coli (EAEC), enteroinvasive E. coli (EIEC), and diffusely adherent E. coli (DAEC) 





This study aims to study phage-host interactions between E. coli and two virulent 
phages, LL5 and LL12, which were isolated against ETEC host strains. ETEC strains 
can be distinguished from other E. coli pathotypes by the presence of two toxins: heat-
labile enterotoxins (LTs) and heat-stable enterotoxins (HTs). These strains might express 
only one or both of those toxins (Kaper et al., 2004). These enterotoxins induce 
traveler’s diarrhea (TD), characterized by watery diarrhea, for which the symptoms 
could range from mild to severe (Kaper et al., 2004). TD is one of the most common 
illnesses contracted by people from developed countries travelling to less developed 
countries of the world. TD is also accompanied by other symptoms such as nausea, 
vomiting, abdominal pain, fever or blood in stool (Taylor et al., 2017). The causative 
agent of TD varies in different geographical regions; Campylobacter spp. is the primary 
one in Southeast Asia whereas ETEC is the major one in the Latin America, Africa, 
south Asia and the Middle East (Tribble, 2017). Besides, other bacterial pathogens such 
as EAEC, Shigella spp., non-typhoidal Salmonella spp., and viruses and parasites have 
also been reported to cause TD (Taylor et al., 2017; Tribble, 2017). TD has been, so far, 
successfully treated with antibiotics, but the global increase in the emergence of the 
antibiotic resistance in bacteria warrants evaluation of alternative treatment approaches 
(Tribble, 2017). 
 
Bacteriophages (phages) are the natural predators of bacteria. Due to emergence of 
multidrug resistant pathogens and limitation in the discovery of antibiotics, there has 




application of phages to treat pathogenic bacteria (Young & Gill, 2015). Phage therapy 
could be a solution to increasing antibiotic resistance incidence in the causative agents of 
TD. Phage infection cycle starts with adsorption of phages to host receptors, ejection of 
phage genetic material into host, replication of genetic material and production of phage 
structural components, followed by lysis of host cells to liberate progeny phages to 
surroundings. As bacteria are constantly preyed upon by these phages, bacteria are 
evolved with diverse defense mechanisms to thwart phage infection (Labrie et al., 2010). 
Hence, for phage therapy to succeed, the necessity of thorough understanding of phage-
host interactions cannot be overstated. 
 
Phage replication needs to be very robust because phage infection cycle is short. Phages 
may not carry all genes required for necessary functions because there is a limitation in 
their genome size. Therefore, to have an efficient replication cycle, phages utilize 
various host functions. For instance, phages need quick and abundant chaperone power 
so that the assembly of virions can be completed before host lysis (Georgopoulos, 2006). 
Same holds true for eukaryotic viruses as well. Before the advent of modern genetic 
tools, phage-host interactions were studied using classic genetic tools. Despite these 
classic approaches being powerful, it does have its limitations as these techniques are 
labor-intensive and lengthy. With the availability of modern genetic resources, the large-
scale host-phage interactions can be studied efficiently. By applying these modern 
genetic approaches, a number of genome-wide screens have been conducted to study 




Influenza virus (Hao et al., 2008), phage λ (Maynard et al., 2010) and phage T7 (Qimron 
et al., 2006).  
 
We conducted forward-genetics screen of phages, LL5 and LL12 against the Keio 
collection to characterize any host function that is required for efficient phage 
replication. The Keio collection is a library of single-gene deletions of all non-essential 
genes in E. coli K-12 strain BW25113 (Baba et al., 2006). This screen will help in 
understanding host-virus interaction (Maynard et al., 2010) by revealing host factors 
involved in infection and replication of LL5 and LL12. The phages will not be able to 
infect and propagate efficiently in a host devoid of certain crucial functions, resulting in 
these mutant hosts outgrowing the WT host, upon simultaneous infection of the phages. 
Identification of host factors required for phage propagation is crucial for the 
development of therapeutic phages because the bacterial host can develop resistance to 
phages by mutating the host factors, resulting in absolute protection from phage 
infection and propagation. If the knowledge about host factors is available, then the 
phage genome can be engineered to include those factors so that there is reduced 
dependency in the host genome encoded factors (Qimron et al., 2006). More 
importantly, if the host receptors can be characterized for individual phages, phage 
cocktails, composed of phages targeting different host receptors, can be prepared, which 
will improve the efficacy of phage therapy. Understanding host-virus interaction is very 




robust phages (Qimron et al., 2006). The results of this screen are discussed in terms of 
host factors required for infection and propagation of phages LL5 and LL12. 
 
Materials and methods 
Bacterial strains and plasmids  
The Keio collection was purchased from Thermo Scientific (Baba et al., 2006). Strains 
from the ASKA library used for complementation were purchased from National 
BioResource Project (NIG, Japan) (Kitagawa et al., 2005). The parental E. coli strain 
BW25113 was obtained from Ry Young (Texas A&M University, College Station, TX). 
E. coli strains from the Keio collection and their transductants were cultured in LB 
(Lennox) broth [10 g L-1 Bacto tryptone (BD), 5 g L-1 Bacto yeast extract (BD), 5 g L-1 
NaCl (Avantor)] or LB agar [LB broth amended with 15 g L-1 Bacto agar (BD)] at 37 °C 
amended with 30 μg mL-1 kanamycin (LB kan) and strains containing plasmids from the 
ASKA library were maintained on LB amended with 10 μg mL-1 chloramphenicol (LB 
cm). Plasmid DNA from ASKA library strains was extracted using a QIAprep Spin 
Miniprep Kit (Qiagen). In complementation experiments with the ASKA plasmids, LB 
plates and top agar were supplemented with 0.05 - 0.1 mM IPTG to induce protein 
expression (Kitagawa et al., 2005). 
 
Phage isolation and culture 
The phages LL5 and LL12 were isolated against clinical isolates of enterotoxigenic E. 




were isolated by the enrichment method (Gill et al., 2012) from filter-sterilized (0.22 
μm) wastewater influent collected in College Station, TX in 2011. Both phages were 
subsequently cultured using E. coli strain DH5α as host. Phage lysates were prepared by 
the confluent plate lysis method (Adams, 1959) using LB (Miller) bottom plates (10 g L-
1 Bacto tryptone, 5 g L-1 Bacto yeast extract, 10 g L-1 NaCl, 15 g L-1 Bacto agar) and top 
agar consisting of 10 g L-1 tryptone, 10 g L-1 NaCl, 5 g L-1 Bacto agar.  Phages were 
harvested and stored as filter-sterilized (0.22 µm) lysates in lambda diluent (25 mM Tris-
HCl pH 7.5, 100 mM NaCl, 8 mM MgSO4, 0.01% w/v gelatin) at 4 ºC (Green & 
Sambrook, 2012). 
 
Plaque assays were conducted using both spot titer and full-plate titration methods 
(Adams, 1959). For spot titers, phages were diluted ten-folds and 10 μL of each dilution 
was spotted on solidified lawns of 4 ml top agar inoculated with 100 μL of a fresh 
overnight host culture prepared as described above. For full-plate titers, 100 μL of 
phages diluted ten-folds were mixed with 100 μL of host culture in 4 ml of molten top 
agar and poured over LB plates as described above. Plaques were enumerated after 16-
18 h incubation at 37 °C. The efficiency of plating (EOP) was calculated as the ratio of 
the number of plaques appearing on the lawn of a test strain to the number of plaques on 







Phage genome sequencing and annotation 
Phage DNA was purified from high-titer lysates by a modified Wizard DNA purification 
kit (Promega) as previously described (Summer, 2009).  Phage LL5 was sequenced by 
454 pyrosequencing at the Emory GRA Genome Center (Emory University, GA); 
trimmed FLX Titanium sequence reads were assembled into a single contig at 19.9-fold 
coverage using Newbler 2.5.3 (454 Life Sciences) at default settings.  Phage LL12 was 
sequenced by Illumina TruSeq as unpaired 100-base reads; reads were quality-controlled 
by FastQC (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and assembled 
with Velvet 1.1 (Zerbino, 2010) into a single contig at 28.3-fold coverage. Assembled 
phage contigs were confirmed to be complete by PCR using primers facing off each end 
of the contig and sequencing of the resulting products. Structural annotation was 
conducted using Glimmer3 (Delcher et al., 1999) and MetaGeneAnnotator (Noguchi et 
al., 2008) with tRNAs predicted by ARAGORN (Laslett & Canback, 2004) or 
tRNAscan-SE (Lowe & Chan, 2016) and gene functions predicted by InterProScan 
(Jones et al., 2014) or Conserved Domain Database (Marchler-Bauer et al., 2017), 
TMHMM (http://www.cbs.dtu.dk/services/TMHMM), BLASTp (Camacho et al., 2009) 
and HHpred (Soding et al., 2005). Phage genome annotation was conducted using the 
Phage Galaxy instance hosted by the Center for Phage Technology at Texas A&M 
University (cpt.tamu.edu).  The annotated phage genomes were deposited in NCBI 






Transmission electron microscopy 
Phages were stained with 2% uranyl acetate and imaged in a JEOL 1200EX transmission 
electron microscope (TEM) under 100 kV accelerating voltage at the Texas A&M 
University Microscopy and Imaging Center, as previously described (Valentine et al., 
1968; Piya et al., 2017). The size parameters of phages were measured electronically 
using ImageJ (Schneider et al., 2012). 
 
Screening and confirmation of phage-insensitive mutants 
In order to optimize the input phage concentrations and incubation times, phages LL5 
and LL12  stocks were diluted ten-folds in fresh LB and 160 µL of each dilution was 
aliquoted into 96-well sterile transparent polystyrene flat-bottom plates (Greiner Bio-
one).  The plates were then inoculated with the Keio parental strain BW25115 using a 
96-pin replicator (Phenix) and incubated at 37 °C for 6, 8, 10 and 18 hrs. The optical 
density (OD) at 550 nm was measured in a Tecan M200 plate reader at each time 
interval and the average OD was analyzed to determine the lowest phage concentration 
that inhibited bacterial growth.  
 
The Keio collection consists of 90, 96-well plates containing two independently-
generated sets of 3,985 single-gene knockouts in the E. coli BW25113 background 
(Baba et al., 2006).  The Keio strains were replicated into 96 well sterile polypropylene 
U-bottom microplates (Greiner Bio-one) containing LB kan + 8% glycerol using sterile 




frozen at -80 ºC.  These plates were used as the working stocks for the following screens. 
The odd- and even-numbered plates have identical gene deletion mutants created by 
independent experiments (Baba et al., 2006), and only the odd-numbered 45 plates were 
used for the initial screen. Initial screens were conducted in 96-well sterile transparent 
polystyrene flat-bottom plates (Greiner Bio-one).  Phages LL5 and LL12 were diluted in 
fresh LB to obtain working stocks of 106 PFU/mL for LL5 and 103 PFU/mL for LL12. 
160 µL of the phage working stocks were aliquoted into all wells, Keio strains were 
inoculated into the phage lysates from the 96-well working stocks with 96-pin 
replicators, and the plates were incubated for 8 hours at 37 °C. The OD550 was measured 
and the wells with OD550 higher than the pre-determined cutoff values (0.2 for phage 
LL5 and 0.11 for phage LL12) were scored as positive for growth. 
 
The positive mutants obtained from the first screen were verified by repeating the assay 
with the same strains and their corresponding mutant strains from the even-numbered 
Keio collection plates, side-by-side with eight replicates per assay.  Mutants that 
returned mean OD550 above the designated cutoff in either the even- or odd-numbered 
set were retained for further characterization by measurement of phage efficiency of 
plating (EOP) by spot assays on soft agar lawns (Adams, 1959) as described above.  
EOP was calculated as the number of plaques observed on the mutant strain divided by 
the number of plaques observed on the parental E. coli strain BW25113.  Mutants with 
EOPs of less than 10-2 were confirmed by enumerating plaques on full plates.  When 




transduction using the kanamycin resistance cassette as the selectable marker (Thomason 
et al., 2007).  All gene disruptions were confirmed by PCR using primers flanking the 
predicted insert followed by sequencing of the PCR product to confirm disruption of the 
gene.  All mutants were complemented by transforming the original Keio mutant or its 
P1 transductant with a plasmid expressing the corresponding gene under control of the 
lac promoter; all complementing plasmids were obtained from the ASKA collection 
(NIG, Japan). 
 
Results and Discussion 
Isolation and characterization of phages LL5 and LL12 
Phages LL5 and LL12 were isolated from municipal wastewater in College Station, TX 
by enrichment against enterotoxigenic E. coli (ETEC) clinical isolates. Shortly after 
isolation, both phages were determined to plate efficiently on E. coli K-12 strains 
including MG1655, DH5α and the Keio parental strain BW25113 and these phages were 
subsequently propagated on E. coli  DH5α for the remainder of the study. 
 
Phages LL5 and LL12 have distinct morphology as observed by transmission electron 
microscopy (Fig. 4.1). LL5 is a siphophage with a head diameter of 61 nm (± 2 nm) and 
a flexible tail 156 nm (± 9.9 nm) in length.  Phage LL12 is a large myophage with head 




























Fig. 4.1. Transmission electron micrographs of phages LL5 and LL12. The grids for 
imaging were prepared as described in materials and methods. Panel A: Phage LL5 has 
a capsid diameter of 61 nm (±2 nm) and a tail length of 156 nm (±9.9 nm). Panel B: 
Phage LL12 has a capsid diameter of  86 nm (±2.4 nm) and a tail length of 112 nm 
(±4.1 nm). These size parameters are an average of ten measurements and the error 




LL5 has a genome of 49,788 bp with 88 predicted protein-coding genes and no tRNA 
genes.  The genome produced a circular assembly and was reopened be syntenic with 
other T1-like phages in the NCBI database such as TLS (NC_009540) and T1 
(NC_005833).  Thirty-three LL5 encoded proteins could be assigned putative functions 
(Table 4.1, Fig. 4.2A). Genes responsible for different stages of phage infection cycle 
have been identified in LL5, including a DNA primase/helicase (gp58), ATP-dependent 
helicase (gp60) and helicase (gp75). Structural proteins including the portal protein 
(gp31), major capsid protein (gp36), minor tail proteins (gp41, gp42, gp47, gp48), tail 
tube protein (gp43), tape measure protein (gp46), and tail fiber proteins (gp51, gp57) 
were identified. The small and large terminase subunits were identified as gp29 and 
gp30, respectively. Like its T1-like relatives, LL5 encodes a canonical lysis cassette 
composed of a holin (gp70), endolysin (gp71) and unimolecular spanin (gp72). 
 
Phage LL5 is closely related to the T1-like coliphage TLS (NC_009540) (German & 
Misra, 2001), with 96% sequence identity over 90% query coverage of the LL5 genome 
based on BLASTn analysis.  As would be expected given this close similarity, the LL5 
genome is syntenic with TLS, with 75 LL5 proteins having homologs in the TLS 
genome detectable by BLASTp with an E value of less than 10-5.  Phage LL5 encodes 
two predicted tail fiber proteins, gp51 and gp57, in a genomic arrangement similar to 
that found in phage TLS and T1.  LL5 gp51 is closely related to predicted tail fibers in 
other phages including gp51 of TLS (also called TspJ, YP_001285540, 98% identity), 


























Fig. 4.2. Genome maps of phages LL5 and LL12. The predicted genes of phages LL5 
(panel A) and LL12 (panel B) are represented as boxes, which are numbered to match 
locus number. The genes present in positive and negative DNA strands of phage 
genomes are separated by a line; the boxes above the line denote genes in the positive 
strand, whereas those below the line denote genes in the negative strand. Some of the 
predicted gene products playing important roles in phage infection cycle are indicated. 
The colored boxes represent genes predicted to perform similar functions. The scale bar 































Table 4.1. Proteins encoded by genome of phage LL5 
Gene Start End Strand Gene product 
CPT_LL5_01 365 652 + Conserved hypothetical protein 
CPT_LL5_02 664 1107 + Conserved hypothetical protein 
CPT_LL5_03 1104 1211 + Conserved hypothetical protein 
CPT_LL5_04 1224 1346 - Conserved hypothetical protein 
CPT_LL5_05 1415 1678 + Conserved hypothetical protein 
CPT_LL5_06 1830 2396 + Conserved hypothetical protein 
CPT_LL5_07 2456 2770 + Conserved hypothetical protein 
CPT_LL5_08 2843 2950 + Conserved hypothetical protein 
CPT_LL5_09 2954 3496 + Polynucleotide kinase/phosphatase 
CPT_LL5_10 3493 3669 + Conserved hypothetical protein 
CPT_LL5_11 3764 3973 + Hypothetical protein 
CPT_LL5_12 4047 4301 + Conserved hypothetical protein 
CPT_LL5_13 4298 4480 + Conserved hypothetical protein 
CPT_LL5_14 4473 5048 + Conserved hypothetical protein 
CPT_LL5_15 5140 5340 + Conserved hypothetical protein 
CPT_LL5_16 5342 5506 + Conserved hypothetical protein 
CPT_LL5_17 5508 5633 + Conserved hypothetical protein 
CPT_LL5_18 5626 5871 + Conserved hypothetical protein 
CPT_LL5_19 5883 6353 + Putative GntR-family transcriptional regulator 
CPT_LL5_20 6427 6630 + Conserved hypothetical protein 
CPT_LL5_21 6634 6939 + Conserved hypothetical protein 
CPT_LL5_22 6936 7253 + Conserved hypothetical protein 
CPT_LL5_23 7320 7448 + Conserved hypothetical protein 
CPT_LL5_24 7450 7677 + Conserved hypothetical protein 
CPT_LL5_25 7860 8069 + Conserved hypothetical protein 
CPT_LL5_26 8059 8220 + Conserved hypothetical protein 
CPT_LL5_27 8204 8386 + Conserved hypothetical protein 
CPT_LL5_28 8386 8616 + Conserved hypothetical protein 
CPT_LL5_29 8704 9228 + Terminase small subunit 
CPT_LL5_30 9240 10811 + Terminase large subunit 








Table 4.1. Continued.    
Gene Start End Strand Gene product 
CPT_LL5_31 10865 12151 + Portal protein 
CPT_LL5_32 12156 12827 + Conserved hypothetical protein 
CPT_LL5_33 12824 13933 + putative scaffold or prohead protease 
CPT_LL5_34 13946 14425 + Conserved hypothetical protein 
CPT_LL5_35 14469 14909 + Conserved hypothetical protein 
CPT_LL5_36 14999 15973 + Major capsid protein 
CPT_LL5_37 16035 16307 + Conserved hypothetical protein 
CPT_LL5_38 16354 16773 + Conserved hypothetical protein 
CPT_LL5_39 16770 17141 + Conserved hypothetical protein 
CPT_LL5_40 17134 17574 + Conserved hypothetical protein 
CPT_LL5_41 17564 17857 + Minor tail protein 
CPT_LL5_42 17884 18087 + Minor tail protein 
CPT_LL5_43 18102 18764 + tail tube protein 
CPT_LL5_44 18842 19156 + tapemeasure chaperone protein 
CPT_LL5_45 18842 19473 + tapemeasure chaperone protein frameshift product 
CPT_LL5_46 19511 22420 + tail tape measure protein 
CPT_LL5_47 22420 22767 + Minor tail protein 
CPT_LL5_48 22835 23593 + Minor tail protein 
CPT_LL5_49 23590 24312 + Tail tip assembly protein 
CPT_LL5_50 24305 24904 + Tail assembly protein 
CPT_LL5_51 24986 28762 + Tail fiber protein 
CPT_LL5_52 29018 29161 + Hypothetical protein 
CPT_LL5_53 29224 30279 + Exodeoxyribonuclease VIII 
CPT_LL5_54 30357 30647 + Conserved hypothetical protein 
CPT_LL5_55 30694 31356 + Recombinase 
CPT_LL5_56 31395 31820 + Single-stranded DNA binding protein 
CPT_LL5_57 31853 34363 - Tail fiber protein 
CPT_LL5_58 34495 35421 - DNA primase/helicase 
CPT_LL5_59 35479 36087 - Putative transcriptional regulator 







Table 4.1. Continued.    
Gene Start End Stran
d 
Gene product 
CPT_LL5_61 38152 38559 + VRR-NUC domain protein 
CPT_LL5_62 38549 38683 - Conserved hypothetical protein 
CPT_LL5_63 38631 38909 + Conserved hypothetical protein 
CPT_LL5_64 38911 39651 + Dam methylase 
CPT_LL5_65 39653 39883 + Conserved hypothetical protein 
CPT_LL5_66 39922 40119 + Conserved hypothetical protein 
CPT_LL5_67 40201 40341 + Conserved hypothetical protein 
CPT_LL5_68 40344 40823 + HNH endonuclease 
CPT_LL5_69 40907 42022 + Conserved hypothetical protein 
CPT_LL5_70 42152 42358 + Putative holin 
CPT_LL5_71 42358 42798 + glycoside hydrolase endolysin 
CPT_LL5_72 42845 43249 + unimolecular spanin protein 
CPT_LL5_73 43266 43460 - Conserved hypothetical protein 
CPT_LL5_74 43384 43776 - Conserved hypothetical protein 
CPT_LL5_75 43779 45359 - Helicase 
CPT_LL5_76 45427 45675 - Conserved hypothetical protein 
CPT_LL5_77 45672 46061 - Conserved hypothetical protein 
CPT_LL5_78 46063 46257 - Hypothetical protein 
CPT_LL5_79 46318 47013 - Site-specific DNA methylase 
CPT_LL5_80 47209 47448 - Conserved hypothetical protein 
CPT_LL5_81 47454 47675 - Conserved hypothetical protein 
CPT_LL5_82 47734 47901 - Conserved hypothetical protein 
CPT_LL5_83 48003 48134 + Hypothetical protein 
CPT_LL5_84 48131 48400 - Conserved hypothetical protein 
CPT_LL5_85 48428 48700 + Hypothetical protein 
CPT_LL5_86 48684 48878 - Conserved hypothetical protein 
CPT_LL5_87 48875 49078 - Conserved hypothetical protein 
CPT_LL5_88 49150 49428 - Conserved hypothetical protein 









phage lambda (NP_040600, 23% identity).  Approximately 3 kb downstream and on the 
opposite strand from gp51, gp57 is similar to other T1-like tail fibers only in its N-
terminal domain, with 46% identity to T1 FibB (YP_003919) from residues 1-290.  The 
C-terminal domain of gp57 is more closely related to tail fiber proteins found in T5-like 
phages such as DT57C and DT571/2 (Golomidova et al., 2015).  LL5 gp57 is 57% 
identical with a C-proximal region spanning residues 515 to 830 of the 1,076-residue 
DT57C LtfA protein (YP_009149889), which is within the host specificity region of this 
protein (Golomidova et al., 2016). 
 
The LL12 genome was determined to be 136,026 bp in length and encodes 213 predicted 
protein-coding genes and 7 tRNAs.  The genome produced a circular assembly and was 
reopened at a point between the genes encoding T4 RIIA and RIIB homologs, to retain 
its general synteny with other RIIAB-encoding myophages.  Analysis of the raw 
Illumina reads by PhageTerm (Garneau et al., 2017) suggests the presence of a non-
permuted terminal redundancy of 459 bp spanning bases 104,966 - 105,424 in the 
genome as presented here. This predicted terminal repeat is located in a non-coding 
region of DNA between two convergent transcripts and corresponds to the location of 
non-permuted terminal repeats observed in phage phi92 (Schwarzer et al., 2012).  Fifty 
LL12-encoded proteins could be assigned putative functions, as shown in Table 4.2 and 
Fig. 4.2B.  Major components for head morphogenesis including capsid protein (gp59), 
prohead protease (gp62), portal protein (gp63), and the large terminase subunit (TerL, 




Table 4.2. Proteins encoded by genome of phage LL12 
Gene Start End Strand Gene product 
CPT_LL12_001 1 1983 - rIIA protector from prophage-induced early lysis 
CPT_LL12_002 1980 2480 - Hypothetical conserved protein 
CPT_LL12_003 2530 2910 - Hypothetical conserved protein 
CPT_LL12_004 2920 4104 - MoxR ATPase 
CPT_LL12_005 4104 4373 - Hypothetical conserved protein 
CPT_LL12_006 4418 4798 - Hypothetical conserved protein 
CPT_LL12_007 4801 5058 - Hypothetical conserved protein 
CPT_LL12_008 5058 5414 - Hypothetical conserved protein 
CPT_LL12_009 5428 5700 - Hypothetical conserved protein 
CPT_LL12_010 5703 6602 - Putative alpha 1-3 fucosyltransferase 
CPT_LL12_011 6745 7722 + Anti-sigma factor 
CPT_LL12_012 7756 9216 + Putative metallopeptidase 
CPT_LL12_013 9232 9495 + Hypothetical conserved protein 
CPT_LL12_014 9495 9758 + Hypothetical conserved protein 
CPT_LL12_015 9758 10021 + Hypothetical conserved protein 
CPT_LL12_016 10023 10256 + Hypothetical conserved protein 
CPT_LL12_017 10272 10721 + Hypothetical conserved protein 
CPT_LL12_018 10718 10963 + Hypothetical conserved protein 
CPT_LL12_019 10966 11532 + Hypothetical conserved protein 
CPT_LL12_020 11588 11863 + Hypothetical conserved protein 
CPT_LL12_021 11866 12339 + Hypothetical conserved protein 
CPT_LL12_022 12336 12506 + Hypothetical conserved protein 
CPT_LL12_023 12537 12917 + Hypothetical conserved protein 
CPT_LL12_024 13081 13488 + Hypothetical conserved protein 
CPT_LL12_025 13492 13692 + Hypothetical conserved protein 
CPT_LL12_026 13740 19376 - Hypothetical conserved protein 
CPT_LL12_027 19425 21170 - Tail fiber protein 
CPT_LL12_028 21180 21446 - Hypothetical conserved protein 
CPT_LL12_029 21458 22501 - Tail fiber protein 












Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_031 22917 23501 - Tail fiber assembly protein 
CPT_LL12_032 23516 24556 - Tail fiber protein 
CPT_LL12_033 24569 26641 - Tail fiber protein 
CPT_LL12_034 26641 27327 - Hypothetical conserved protein 
CPT_LL12_035 27339 28829 - Baseplate protein 
CPT_LL12_036 28935 32534 - Tail fiber protein 
CPT_LL12_037 32534 32959 - Hypothetical conserved protein 
CPT_LL12_038 32959 33510 - Hypothetical conserved protein 
CPT_LL12_039 33512 34102 - Hypothetical conserved protein 
CPT_LL12_040 34200 34532 - Hypothetical conserved protein 
CPT_LL12_041 34532 38971 - Tail fiber protein 
CPT_LL12_042 39007 41604 - Tail fiber protein 
CPT_LL12_043 41606 42274 - Hypothetical conserved protein 
CPT_LL12_044 42284 43000 - Hypothetical conserved protein 
CPT_LL12_045 43013 43690 - Hypothetical conserved protein 
CPT_LL12_046 43690 44694 - Hypothetical conserved protein 
CPT_LL12_047 44694 45074 - Hypothetical conserved protein 
CPT_LL12_048 45086 45970 - Hypothetical conserved protein 
CPT_LL12_049 46075 48414 - Hypothetical conserved protein 
CPT_LL12_050 48469 48717 - Hypothetical conserved protein 
CPT_LL12_051 48729 49202 - Hypothetical conserved protein 
CPT_LL12_052 49366 49839 - Hypothetical conserved protein 
CPT_LL12_053 49850 51226 - Tail sheath protein 
CPT_LL12_054 51299 51850 - Hypothetical conserved protein 
CPT_LL12_055 51850 52275 - Hypothetical conserved protein 
CPT_LL12_056 52291 52749 - Hypothetical conserved protein 
CPT_LL12_057 52803 53423 - Hypothetical conserved protein 
CPT_LL12_058 53483 54307 - Hypothetical conserved protein 
CPT_LL12_059 54392 55399 - Major capsid protein 








Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_061 55858 56835 - Hypothetical conserved protein 
CPT_LL12_062 56835 57254 - Prohead protease 
CPT_LL12_063 57322 58878 - Portal protein 
CPT_LL12_064 58981 60847 - Terminase large subunit 
CPT_LL12_065 60847 61134 - O-spanin 
CPT_LL12_066 61131 61529 - I-spanin 
CPT_LL12_067 61635 61904 - Hypothetical conserved protein 
CPT_LL12_075 62861 63199 - Conserved hypothetical protein 
CPT_LL12_076 63451 63561 - Conserved hypothetical protein 
CPT_LL12_077 63546 63788 - Conserved hypothetical protein 
CPT_LL12_078 63865 64053 - Conserved hypothetical protein 
CPT_LL12_079 64064 64642 - Conserved hypothetical protein 
CPT_LL12_080 65303 65653 - Putative transcriptional regulator 
CPT_LL12_081 65701 66255 - Phosphoesterase 
CPT_LL12_082 66263 66673 - ATP-binding protein 
CPT_LL12_083 66792 67709 + RNA ligase and tail attachment protein 
CPT_LL12_084 67706 68056 + Hypothetical conserved protein 
CPT_LL12_085 68065 68826 + Putative Sir2-like protein 
CPT_LL12_086 68840 69553 + Putative Sir2-like protein 
CPT_LL12_087 69616 69924 + Conserved hypothetical protein 
CPT_LL12_088 69911 70180 + Conserved hypothetical protein 
CPT_LL12_089 70180 71463 + DNA ligase 











Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_091 72121 72327 + Conserved hypothetical protein 
CPT_LL12_092 72337 72801 + HNH endonuclease 
CPT_LL12_093 72794 73084 + Conserved hypothetical protein 
CPT_LL12_094 73144 73452 + Conserved hypothetical protein 
CPT_LL12_095 73445 74584 + Exodeoxyribonuclease 
CPT_LL12_096 74584 74916 + Conserved hypothetical protein 
CPT_LL12_097 74913 75542 + Hypothetical conserved protein 
CPT_LL12_098 75494 76099 + EndoVII packaging and recombination 
endonuclease 
CPT_LL12_099 76038 76259 + Conserved hypothetical protein 
CPT_LL12_100 76272 77255 + Putative DNA polymerase/exonuclease 
CPT_LL12_101 77301 78119 + Putative DNA N6-adenine methyltransferase 
CPT_LL12_102 78082 78540 + Hypothetical conserved protein 
CPT_LL12_103 78568 78759 + Hypothetical conserved protein 
CPT_LL12_104 78759 79373 + Hypothetical conserved protein 
CPT_LL12_105 79367 79960 + Hypothetical conserved protein 
CPT_LL12_106 79962 80162 + Hypothetical conserved protein 
CPT_LL12_107 80162 81145 + Thymidylate synthase 
CPT_LL12_108 81244 81705 + Hypothetical conserved protein 
CPT_LL12_109 81716 81946 + Hypothetical conserved protein 
CPT_LL12_110 81943 84258 + Ribonucleoside triphosphate reductase alpha 
chain 
CPT_LL12_111 84298 85386 + Ribonucleoside diphosphate reductase beta chain 
CPT_LL12_112 85390 85668 + Glutaredoxin 1 
CPT_LL12_113 85665 87788 + Anaerobic ribonucleoside triphosphate reductase 
CPT_LL12_114 87852 87968 + Hypothetical conserved protein 
CPT_LL12_115 87984 88088 + Hypothetical protein 
CPT_LL12_116 88120 88356 + Hypothetical conserved protein 
CPT_LL12_117 88353 88826 + Anaerobic ribonucleoside triphosphate reductase 
activating protein 
CPT_LL12_118 88883 88996 + Hypothetical conserved protein 
CPT_LL12_119 88993 89343 + Hypothetical conserved protein 








Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_121 90269 90580 + Hypothetical conserved protein 
CPT_LL12_122 90640 91689 + Clp ATP-dependent protease subunit 
CPT_LL12_123 91741 92274 + DNA methyltransferase 
CPT_LL12_124 92271 92555 + Hypothetical conserved protein 
CPT_LL12_125 92590 92829 + Hypothetical conserved protein 
CPT_LL12_126 92826 93224 + Hypothetical conserved protein 
CPT_LL12_127 93264 93497 + Hypothetical conserved protein 
CPT_LL12_128 93503 94027 + Hypothetical conserved protein 
CPT_LL12_129 94058 94294 + Hypothetical conserved protein 
CPT_LL12_130 94278 94430 + Hypothetical conserved protein 
CPT_LL12_131 94514 94699 + Hypothetical conserved protein 
CPT_LL12_132 94702 95157 + Hypothetical conserved protein 
CPT_LL12_133 95218 95565 + Hypothetical conserved protein 
CPT_LL12_134 95562 95849 + Hypothetical conserved protein 
CPT_LL12_135 95846 96040 + Hypothetical conserved protein 
CPT_LL12_136 96060 96245 + Hypothetical conserved protein 
CPT_LL12_137 96341 96637 + Hypothetical conserved protein 
CPT_LL12_138 96640 96921 + Hypothetical conserved protein 
CPT_LL12_139 96921 97145 + Hypothetical conserved protein 
CPT_LL12_140 97135 97389 + Hypothetical conserved protein 
CPT_LL12_141 97402 97800 + Hypothetical conserved protein 
CPT_LL12_142 97818 98108 + Hypothetical conserved protein 
CPT_LL12_143 98191 98508 + Sigma 54 modulation factor 
CPT_LL12_144 98646 98915 + Hypothetical conserved protein 
CPT_LL12_145 99007 99270 + Hypothetical conserved protein 
CPT_LL12_146 99275 99607 + Hypothetical conserved protein 
CPT_LL12_147 99607 100002 + Hypothetical conserved protein 
CPT_LL12_148 100082 100339 + Hypothetical conserved protein 
CPT_LL12_149 100340 100690 + Hypothetical conserved protein 








Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_151 101019 101306 + Hypothetical conserved protein 
CPT_LL12_152 101396 101659 + Hypothetical conserved protein 
CPT_LL12_153 101688 101828 + Hypothetical conserved protein 
CPT_LL12_154 101815 102066 + Hypothetical conserved protein 
CPT_LL12_155 102095 102400 + Hypothetical conserved protein 
CPT_LL12_156 102453 102779 + Hypothetical conserved protein 
CPT_LL12_157 102788 103087 + Hypothetical conserved protein 
CPT_LL12_158 103355 103660 + Hypothetical conserved protein 
CPT_LL12_159 103782 103997 + Hypothetical conserved protein 
CPT_LL12_160 106517 106936 - Hypothetical conserved protein 
CPT_LL12_161 107082 107345 - Hypothetical conserved protein 
CPT_LL12_162 107406 107678 - Hypothetical conserved protein 
CPT_LL12_163 107897 108208 - Hypothetical conserved protein 
CPT_LL12_164 108205 108396 - Hypothetical conserved protein 
CPT_LL12_165 108413 108703 - Hypothetical conserved protein 
CPT_LL12_166 108795 109010 - Hypothetical conserved protein 
CPT_LL12_167 109020 109124 - Hypothetical conserved protein 
CPT_LL12_168 109202 109447 - Hypothetical conserved protein 
CPT_LL12_169 109540 109719 - Hypothetical conserved protein 
CPT_LL12_170 109795 110028 - Hypothetical conserved protein 
CPT_LL12_171 110083 110367 - Hypothetical conserved protein 
CPT_LL12_172 110570 110920 - Hypothetical conserved protein 
CPT_LL12_173 110938 111237 - Hypothetical conserved protein 
CPT_LL12_174 111331 111531 - Hypothetical conserved protein 
CPT_LL12_175 111679 111798 - Hypothetical conserved protein 
CPT_LL12_176 111819 112058 - Hypothetical conserved protein 
CPT_LL12_177 112018 112389 - Hypothetical conserved protein 
CPT_LL12_178 112454 112834 - Hypothetical conserved protein 
CPT_LL12_179 112923 113546 - Hypothetical conserved protein 








Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_181 114102 114299 - Hypothetical conserved protein 
CPT_LL12_182 114289 114642 - Hypothetical conserved protein 
CPT_LL12_183 114717 114962 - Hypothetical conserved protein 
CPT_LL12_184 115052 115393 - Hypothetical conserved protein 
CPT_LL12_185 115473 115592 - Hypothetical conserved protein 
CPT_LL12_186 115673 116068 - Hypothetical conserved protein 
CPT_LL12_187 116151 116549 - Hypothetical conserved protein 
CPT_LL12_188 116614 116811 - Hypothetical conserved protein 
CPT_LL12_189 117664 117810 + Hypothetical conserved protein 
CPT_LL12_190 117913 118242 - Hypothetical conserved protein 
CPT_LL12_191 118239 118433 - Hypothetical conserved protein 
CPT_LL12_192 118426 118671 - Hypothetical conserved protein 
CPT_LL12_193 118681 119013 - Hypothetical conserved protein 
CPT_LL12_194 119023 119214 - Hypothetical conserved protein 
CPT_LL12_195 119278 119472 - Hypothetical conserved protein 
CPT_LL12_196 119469 119669 - Hypothetical conserved protein 
CPT_LL12_197 119723 120181 - Hypothetical conserved protein 
CPT_LL12_198 120171 120596 - Hypothetical conserved protein 
CPT_LL12_199 120665 120862 - Hypothetical conserved protein 
CPT_LL12_200 120958 121374 - Hypothetical conserved protein 
CPT_LL12_201 121437 122663 - Hypothetical conserved protein 
CPT_LL12_202 122663 123028 - Hypothetical conserved protein 
CPT_LL12_203 123112 123357 - Hypothetical conserved protein 
CPT_LL12_204 123375 123677 - Hypothetical conserved protein 
CPT_LL12_205 123667 124056 - Hypothetical conserved protein 
CPT_LL12_206 124056 124328 - Hypothetical conserved protein 
CPT_LL12_207 124392 124646 - Hypothetical conserved protein 
CPT_LL12_208 124723 125094 - Hypothetical conserved protein 
CPT_LL12_209 125105 125299 - Hypothetical conserved protein 








Table 4.2. Continued    
Gene Start End Strand Gene product 
CPT_LL12_211 125520 125825 - Hypothetical conserved protein 
CPT_LL12_212 125854 128907 - DNA polymerase A 
CPT_LL12_213 128966 131044 - DNA replicative helicase/primase 
CPT_LL12_214 131034 131798 - DNA cytosine methyltransferase 
CPT_LL12_215 131850 132332 - Hypothetical conserved protein 
CPT_LL12_216 132345 132740 - Hypothetical conserved protein 
CPT_LL12_217 132740 133042 - Hypothetical conserved protein 
CPT_LL12_218 133103 133444 - Hypothetical conserved protein 
CPT_LL12_219 133441 134811 - Helicase 
CPT_LL12_220 134811 136016 - rIIB-like protein 


















(gp35), tail sheath protein (gp53), and multiple predicted tail fiber proteins (gp27, gp29, 
gp32, gp33, gp36, gp41, gp42) were identified.  DNA replication proteins such as DNA 
polymerase (gp212), DNA replicative helicase/primase (gp213), and a helicase (gp219) 
were also identified.  The genes encoding the large terminase subunit (gp64) and DNA 
polymerase (gp212) are disrupted by predicted intron sequences.  These introns appear 
to be relatively short (~275-325 bp) and do not contain any significant protein-coding 
ORFs.  The boundaries of these introns were determined based on protein sequence 
similarity to homologous proteins found in other phages that were not disrupted by 
introns (AKU44155 in the case of gp64, and AKU44295 for gp212).   Like other large 
myophages, genes responsible for phage lysis are distributed across the LL12 genome 
rather than co-localized to a contiguous cassette; the phage endolysin (gp90), i-spanin 
(gp66) and o-spanin (gp65) were identifiable but the phage holin could not be positively 
identified.  Based on analysis of predicted protein sequences by BLASTp with a E value 
cutoff of 10-5, LL12 is most closely related to other V5-like myophages, including rV5 
(NC_011041) which shares 206 proteins with LL12, and ΦAPCEc02 (KR698074) which 
shares 204 proteins.  LL12 is also more distantly related to the E. coli phage phi92 
(NC_023693), with 48 common proteins detectable by BLASTp. 
  
Like the related phages rV5, phi92 and ΦAPCEc02, phage LL12 encodes an extensive 
set of predicted tail fibers: gp27, gp29, gp32, gp33, gp36, gp41 and gp42 (Fig. 4.2B, 
Table 4.2). All seven of these LL12 tail fibers are similar to the tail fibers in found in 
































rV5 NC_011041.1 YP_002003530.1 gp028 99.0 0 0.99  
APCEc02 KR698074.1 AKO61946.1  98.0 0 0.98  
phi92 NC_023693.1 YP_009012483.1 gp151 47.0 7E-23 0.08 
weak, 
partial 
phi92 NC_023693.1 YP_009012482.1 gp150 43.9 2E-22 0.07 
weak, 
partial 




APCEc02 KR698074.1 AKO61944.1  99.1 0 0.99  
rV5 NC_011041.1 YP_002003532.1 gp30 98.9 0 0.99  
rV5 NC_011041.1 YP_002003535.1 gp33 43.0 2E-90 0.44  
APCEc02 KR698074.1 AKO61941.1  43.0 2E-90 0.44  
phi92 NC_023693.1 YP_009012479.1 gp147 23.5 6E-18 0.25 full length 




APCEc02 KR698074.1 AKO61941.1  99.4 0 0.99  
rV5 NC_011041.1 YP_002003535.1 gp33 99.1 0 0.99  
APCEc02 KR698074.1 AKO61944.1  43.3 6E-91 0.44  
rV5 NC_011041.1 YP_002003532.1 gp30 42.7 1E-88 0.44  
phi92 NC_023693.1 YP_009012479.1 gp147 27.0 9E-29 0.30 
N- and C- 
terminus 
only 




rV5 NC_011041.1 YP_002003536.1 gp34 99.9 0 1.00  
APCEc02 KR698074.1 AKO61940.1  99.7 0 1.00  








APCEc02 KR698074.1 AKO61937.1  99.0 0 0.99  




















































APCEc02 KR698074.1 AKO61932.1  95.9 0 0.96  
rV5 NC_011041.1 YP_002003543.1 gp41 91.5 0 0.70  
rV5 NC_011041.1 YP_002003545.1 gp43 38.4 3E-15 0.04  
APCEc02 KR698074.1 AKO61930.1  38.4 3E-15 0.04  








rV5 NC_011041.1 YP_002003544.1 gp42 99.4 0 0.99  
APCEc02 KR698074.1 AKO61931.1  99.2 0 0.99  







these seven proteins are also detectable in the more distantly-related phage phi92, with 
three of these, gp29, gp33 and gp42 producing alignments to nearly the full-length phi92 
proteins 147, 142 and 141, respectively (Table 4.3). CryoEM reconstructions of phi92 
have indicated that this phage possesses multiple sets of tail fibers that are mounted to 
the baseplate in downward, sideward, and upward orientations (Schwarzer et al., 2012). 
These multiple tail fibers may contribute to a broadened host range in this phage and its 
relatives (Schwarzer et al., 2012).  The electron density of the downward-facing tail 
fiber was assigned to gp143, which is not conserved in LL12 (Schwarzer et al., 2012). 
LL12 gp27 shows weak similarity to the N-terminus of phi92 gp150, which is predicted 
to form downward-facing tail spikes in cryoEM reconstructions (Schwarzer et al., 2012). 
LL12 gp41 also possesses similarity to rV5 gp41 (Table 4.3), however LL12 gp41 is 
missing the C-terminal chaperone of endosialidase domain (pfam13884) of rV5 gp41 
spanning residues 1151-1200.   
 
Host range determination for phages LL5 and LL12 
Infection by STEC strains can result in watery or bloody diarrhea, hemolytic uremic 
syndrome, microangiopathic hemolytic anemia and thrombocytopenia (Gyles, 2007). E. 
coli strains belonging to several pathotypes tend to be clonal and are grouped as 
serotypes based on the O-antigens (lipopolysaccharide) and H-antigens (flagella) (Kaper 
et al., 2004). As phage LL12 bears similarity to phages rV5 and ΦAPCEc02, both of 




we sought to determine if phages LL5 and LL12 are also able to infect STEC 
representatives. 
 
Phages LL5 and LL12 were spotted on soft agar overlays of STEC strains and EOP 
compared to the Keio parental strain BW25113. Phage LL5 was unable to form plaques 
on any of the tested STEC strains, and phage LL12 exhibited EOPs of close to 1 on 
STEC strains with serotypes O157:H7, O145:NM, O121:H19, O111 and O121:H19, 
demonstrating a relatively broad host range among STEC serotypes for this phage (Table 
4.4). 
 
Development and optimization of screening assay 
Multiplicity of Infection (MOI) is the ratio of the number of the phages to host cells in a 
culture. The purpose of the phage Keio screen was to identify host genes required for the 
phage to successfully infect, replicate within, and lyse their host cells.  To determine 
this, it was imperative to optimize MOI for each phage as excessively high MOI’s could 
result in bacterial growth inhibition if the phage were able to infect the cells but still not 
produce progeny, while too low MOI’s could result in false positive results 
(Georgopoulos, 2006). Initially, the lowest input phage concentration required to control 
growth of parental BW25113 strain after 8 hr incubation at 37 °C was determined. A log 
higher phage concentration was applied in this screen so as to minimize false positives. 





Table 4.4. Host range of phages LL5 and LL12. Phage LL5 and LL12 were 
tested for their ability to infect Shiga toxin-producing Escherichia coli (STEC) by 
spotting serially diluted phages on the soft agar lawns of respective STEC isolates. 
The efficiency of plating (EOP) is relative to the number of plaques formed on the 
Keio collection parental E. coli strain BW25113. Cells marked with "-" indicate an 
EOP of less than 10-7 (insensitive to phage).  The data is the average of two 
biological replicates. 






Not STEC BW25113 1.0 1.0 K-12 
O157:H7a USDA-FSIS 380-94 - 0.8 R3 
O104:H21 ATCC BAA-178 - -  
O145:NMa 83-75 - 0.7 R1, K-12 
O26:H11a H30 - - R3 
O111:H-a JBI-95 - - R3 
O121:H19 ATCC BAA-2219 - 0.7  
O146 ATCC BAA-2217 - 1.0  
O103:H11 ATCC BAA-2215 - -  
O145:Nonmotile ATCC BAA-2192 - - R1, K-12 
O26:H11 ATCC BAA-2196 - - R3 
O45:H2 ATCC BAA-2193 - -  
O103:H2a CDC 90-3128 - - R3 
O121:H19a CDC 97-3068 - 0.6  
O45:H2a CDC 96-3285 - -  
     
aSources of these isolates are described in (Kirsch et al., 2014).                                        









viable counts. Based upon the cells inoculated and PFU of phages used, the initial MOI 
of LL5 and LL12 in this screen was calculated to be 1.0 and 0.001, respectively. 
 
Determination of genes required for phage propagation 
The Keio collection consists of a total of 3,985  individual gene knockout mutants in the 
E. coli K-12 strain BW25113.  Each gene knockout is represented twice in the collection 
(the results of two independent experiments) (Baba et al., 2006), thus the total collection 
contains 7,970 mutants, with each independent gene knockout mutants represented with 
even and odd numbers.  Phages LL5 and LL12 were screened against the entire odd-
numbered series of 3,985 Keio single-gene knockouts as described above.  E. coli 
mutants that were unable to support phage growth, as indicated by their growth to an 
OD550 of at least 0.2 or 0.11 at 8 h in the presence of phage LL5 or LL12, respectively, 
were considered positive hits in this initial screen. Using this selection criteria, 37 
knockout mutants (21 mutants for each phage) were selected for further investigation 
(Tables 4.5, 4.6, 4.7).  For each of these initial hits, the screening experiment was 
repeated using the same odd-numbered mutant and its even-numbered  counterpart from 
the collection.  From this second experiment, 11/21 mutants identified against LL5 and 
9/21 mutants identified against LL12 were found to produce the same phenotype in at 
least one of the paired knockouts, and these were retained for further study (Tables 4.5, 






Table 4.5. Summary of hits in Keio screening. Initial screening of the Keio collection 
against both phages LL5 and LL12 gave 21 hits. These initial hits were verified using 
both of the independently generated Keio mutants using the same screening procedure. 
For phages LL5 and LL12, 10 and 9 strains, respectively, were determined to be true 
positives, which were tested for plating efficiency of the respective phages. Phage LL5 
had a reduced efficiency of plating (EOP) of at least ~10-2 , as determined by spot titer 
assay, in 9 strains. Only 6 of these strains showed similar plating defect in full plate 
assay. Only 4 of these strains could be P1 transduced and phage LL5 had a similar 
plating defect, as compared to the original Keio mutants, in 3 of the P1 transductants. 
Phage LL12 had a reduced EOP of at least ~10-2 in 4 strains, as determined by spot titer. 
All 4 of these strains showed similar plating defect in full plate assay. Only 1 of these 
strains could be P1 transduced and phage LL12 had similar plating defect in the P1 
transductant, as compared to the original Keio strain. Whenever applicable, gene 
complementation to restore the plating defect was conducted on the P1 transduced 
strains. When the kanamycin resistance marker could not be transduced, gene 










P1 transduced strain 
with plating defect 
Spot titer Full plate titer 
LL5 21 10 8 4 4 3 
LL12 21 9 3 3 1 1 



























Table 4.6. Results of initial (untargeted) screening and targeted re-screening of phage LL5 against the Keio E. coli knockout collection.  In 
the initial screen, all mutants yielding a positive result were screened a second time against both independently-generated gene knockouts present in 
the Keio collection, denoted as the representatives from the even- and odd-numbered plate sets. Mutants with a positive result from either set were 
then tested for their efficiency of plating (EOP) by both spot titer and full-plate titration methods.  Mutants exhibiting a significant EOP defect (less 
than ~0.05) were used for further study. The presence of the appropriate gene deletion was confirmed by PCR and sequencing.  One knockout from 
each even/odd pair was selected for P1 transduction of the kan-marked deletion into the parental E. coli strain BW25113 background, re-tested for 
EOP defects and complemented in trans.  Selected gene knockouts from the collection that were not identified in the initial screen were targeted for 
re-screening (bottom panel).  Mutants were cultured from the Keio collection, the presence of the appropriate gene deletion confirmed by PCR, and 
the EOP determined in the knockout and its complemented counterpart.  Blank cells denote that data was not collected, usually because the desired 
EOP defects were not observed. 


























nted strain Odd Even Odd Even Odd Even 
nuoM + + + 0.06 0.04 0.3 0.3      
yehQ + - -          
ycdB + + - 0.4 0.2        
ydcR + + - 1 1        
ygcN + - -          










































nted strain Odd Even Odd Even Odd Even 
rof + - -          
crcB + - -          
ydjO + - -          
holD + - -          
aroC + - -          
ydgL + - -          
idi + - -          
rfaP + + + < 8 x 10-8 1.0 < 7.5 x 10-8 1.1 Odd Confirmed Yes < 7.5 x 10-8 2.2 
rfaG + + - 1.1 0.3    Confirmed    
rfaF + + + 0.3 0.03 1.3 0.3      
rfaQ + + + 0.01 0.4 0.04 0.04 Odd Confirmed Yes 0.3  
rfaH + - + 0.003 0.01 0.6 0.2      
rfaY + - -          
secB + + + 0.01 0.03 0.05 0.02 Odd Confirmed Yes 0.06 0.2 
ppiB + + - 0.003 0.3 0.04 0.4 Odd Confirmed Yes 0.09 1.5 
ylaC + + - 0.07 0.03 0.4 0.8      







Table 4.6 Continued.      













EOP (plate titer) in 
complemented strain 
lpcA Confirmed Even < 8 x 10-8 < 7.5 x 10-8 0.8 
rfaE Confirmed Even < 8 x 10-8 < 7.5 x 10-8 1.0 




































Table 4.7. Results of initial (untargeted) screening and targeted re-screening of phage LL12 against the Keio E. coli knockout collection.  In 
the initial screen, all mutants yielding a positive result were screened a second time against both independently-generated gene knockouts present in 
the Keio collection, denoted as the representatives from the even- and odd-numbered plate sets. Mutants with a positive result from either set were 
then tested for their efficiency of plating (EOP) by both spot titer and full-plate titration methods.  Mutants exhibiting a significant EOP defect (less 
than ~0.05) were used for further study. The presence of the appropriate gene deletion was confirmed by PCR and sequencing.  One knockout from 
each even/odd pair was selected for P1 transduction of the kan-marked deletion into the parental E. coli strain BW25113 background, re-tested for 
EOP defects and complemented in trans.  Selected gene knockouts from the collection that were not identified in the initial screen were targeted for 
re-screening (bottom panel).  Mutants were cultured from the Keio collection, the presence of the appropriate gene deletion confirmed by PCR, and 
the EOP determined in the knockout and its complemented counterpart.  Blank cells denote that data was not collected, usually because the desired 
EOP defects were not observed. 



























Odd Even Odd Even Odd Even 
pflC + - -          
cusB + - -          
ompR + + - 0.5 0.5        
envZ + - -          
ompC + + + 0.3 0.3        
yncJ + - -          













































ted strain Odd Even Odd Even Odd Even 
ycbL + - -          
yqjB + nt nt 1.9 1.1        
yaaW + - -          
yggT + + + 0.1 0.1        
rfaP + + + 0.06 1.1 0.04 1.2 Odd Confirmed Yes 0.02 1.0 
rfaD + - -          
rfaG + + - 7.1 x 
10-6 
1.0 5.1 x 
10-6 
1.3 Odd Confirmed No  1.1 
rfaF + - -          
rfaH + + - 0.4 0.8        
rfaY + + + 0.3 0.2        
rffE + + - 0.2 0.1        
lpcA + - + 0.8 < 4 x 
10-9 
1.5 < 4.4 x 
10-9 
Even Confirmed No  1.1 
trmC + - -          
ygbF + - -          





Table 4.7 Continued      













EOP (plate titer) in 
complemented strain 
rfaE Confirmed Even < 4 x 10-9 < 4.4 x 10-9 1.1 
rfaI Confirmed Odd 0.6  
 
rfaB Confirmed Even 0.4  
rfaC Loci intact    
rfaF Loci intact    



















The efficiency of plating (EOP) of phage LL5 on the retained mutant strains was 
determined by spot titer.  The observed plating efficiency of phage LL5 was reduced by 
at least ~20-fold in eight mutants. This plating defect was confirmed by titration of LL5 
in full plate assays, in which only four mutants showed an EOP reduction of ~20-fold or 
greater. In order to confirm the plating phenotype in a clean genetic background, the 
kanamycin resistance cassettes from these Keio mutants were transduced by P1 into the 
parental E. coli strain BW25113. Markers could be transduced from all four Keio 
mutants into the parental strain, and three showed a similar plating defect as the 
corresponding Keio mutant, indicating the phenotype was linked to the disrupted locus 
(Table 4.5).  One mutant, rfaQ, showed a ~25-fold reduction in EOP in the Keio mutant 
but its P1 transductant exhibited only a very mild EOP defect of 0.3 (Table 4.6), despite 
having the rfaQ deletion confirmed in the transductant by PCR and sequencing. This 
suggests an abnormality or additional defect in the original rfaQ Keio mutant; this 
mutant was not examined further.   
 
The same approach was applied to confirm the phenotypes of the Keio mutants 
identified from the screens against phage LL12. Spot titer assays showed that the EOP of 
phage LL12 was reduced in only three of the nine initially identified Keio mutants. This 
plating defect could be replicated via full plate plaque assay in all three mutants. Only 
one of these mutants could be P1 transduced into the parental strain BW25113 and same 
plating phenotype was observed in the P1 transductant as in the Keio mutant (Table 4.5).  





Based on the genes identified in these initial screens, additional mutants from the odd- 
and even-numbered Keio sets were subjected to targeted re-screening by directly 
determining the phage EOP by the spot method.  For both phages, genes involved in LPS 
biosynthesis (rfaP for LL5, and rfaP, rfaG and lpcA for LL12, Tables 4.6, 4.7, 4.8) were 
identified and confirmed, but these genes represented only parts of the known 
biosynthetic pathway.  Additional Keio mutants in lpcA, rfaE, rfaC, rfaF, rfaI and rfaB 
were confirmed by PCR and sequencing of the mutant locus; lpcA, rfaE, rfaI and rfaB 
were found to contain the appropriate deletions.  Strong EOP defects (< 10-8) were 
identified in the lpcA and rfaE mutants against LL5, and in rfaE in LL12 (an EOP defect 
in lpcA against LL12 was already identified in the initial screen) (Table 4.8).  These 
mutants could not be transduced due to P1 resistance. 
 
Five genes were determined to be required for efficient propagation of phage LL5, as 
evident by the reduced plating efficiency (Table 4.8). The Keio mutant strains deleted 
for genes rfaP, lpcA and rfaE showed severe plating defects with EOP of phage LL5 less 
than 8 x 10-8. This plating defect was also observed on the P1 transduced rfaP mutant. 
The plating efficiency of phage LL5 could be restored when the respective genes were 
provided in trans (Table 4.8). All plating phenotypes were complemented in the P1 
transduced strains when applicable, and in the original Keio strains when the mutations 
could not be transduced by P1 due to host resistance. Two additional Keio mutants, secB 






    
Table 4.8. E. coli genes required for phages LL5 and 
LL12 propagation. The genes required for phage infection 
cycle can be determined by testing the efficiency of plating. 
Five genes were found to be required for phage LL5 infection 
cycle, whereas 4 genes were required for phage LL12 
infection cycle. The kanamycin resistance cassette in the 
Keio strain was P1 transduced into parental BW25113, 
whenever possible. The P1 transductants are denoted by "#" 
and the original Keio mutants are denoted by "*". The plating 
phenotype was complemented in P1 transductants, when 
applicable. The data represents average and standard 
deviation of three biological repeats.  
Phages Gene EOP Complemented 
EOP 
LL5 
lpcA* < 8 x 10-8 0.8 ± 0.2 
rfaE* < 8 x 10-8 1.0 ± 0.5 
rfaP# < 8 x 10-8 2.2 ± 2.0 
secB# 0.06 ± 0.02 0.2 ± 0.04 
ppiB# 0.09 ± 0.05 1.5 ± 0.3 
LL12 
lpcA* < 4.4 x 10-9 1.1 ± 0.4 
rfaE* < 4.4 x 10-9 1.1 ± 0.5 
rfaP# 0.02 ± 0.01 1.0 ± 0.4 
rfaG* 5.1 x 10-6 ± 1.0 x 10-6 1.1 ± 0.2 








reductions of ~10- to 100-fold relative to the parental E. coli strain BW25113; these 
mutants could be transduced by P1 into the parental background and could also be 
complemented in trans (Table 4.8). 
 
The three genes lpcA, rfaE and rfaP are parts of the LPS biosynthesis pathway. The 
severe plating defects associated with multiple genes in this pathway strongly indicate 
that phage LL5 uses LPS as its receptor, and LPS defects result in major blocks to phage 
infection. Of these three genes, only rfaP appeared as a “hit” in the initial screen of the 
3,985 Keio mutants against phage LL5 (Table 4.6).  RfaP adds phosphate or 2-
aminoethyl diphosphate (PPEtN) to heptose (Hep) I of the inner core LPS, and the LPS 
of rfaP mutants does not have any phosphoryl substituents on Hep I or Hep II, and also 
lacks Hep III (Fig. 4.3) (Yethon et al., 1998). Hep I is transferred to LPS from the 
nucleotide precursor molecule ADP-L-glycero-D-manno-heptose, which is synthesized 
in a separate pathway involving lpcA, rfaE and rfaD (Fig. 4.3) (Gronow & Brade, 2001). 
In the absence of either LpcA or RfaE, heptoseless LPS core is formed (Valvano et al., 
2000), whereas rfaD mutants can still incorporate the stereoisomer D-glycero-D-manno-
heptose into the LPS (Coleman & Leive, 1979). Keio lpcA and rfaE mutants with 
heptoseless LPS core cannot be infected by bacteriophage P1, rendering P1 transduction 
of the genetic marker ineffective (Valvano et al., 2000).  
 
As the rfaP mutant is the last step in the LPS pathway with a strong observed plating 

























Fig. 4.3. Genes and biosynthetic pathway of the E. coli lipopolysaccharide (LPS) 
required for replication of phages LL5 and LL12. Proteins in the pathway are 
denoted in bold and label each step in biosynthesis. Black triangles indicate proteins 
that are required by LL5 for growth, and black circles indicate proteins required by 
LL12.  Panel A: The nucleotide sugar precursor ADP L-glycero-β-D-manno-heptose is 
used as a substrate for the transfer of heptose (green in panel B) to the E. coli core LPS. 
ADP L-glycero-β-D-manno-heptose is synthesized from sedoheptulose-7-P via a 
pathway comprised of LpcA, RfaE and RfaD.  Both LpcA and RfaE are required for 
growth of phages LL5 and LL12.  Panel B: LPS is composed of four distinct domains: 
Lipid A, inner core, outer core and O-antigen. The enzymes responsible for the addition 
of sugar residues and phosphoryl constituents relevant to this study are denoted. RfaC, 
RfaF, RfaQ, RfaG, RfaI and RfaB add hexo or hepto sugar residues to LPS, and RfaP 
and RfaY add phosphoryl substituents to the heptose residues I and II, respectively.  
RfaP is required for infection by phage LL5 and the open circle by RfaP indicates a 
milder plating defect (~50-fold reduction in plating efficiency) for phage LL12 in the 
absence of this protein.  RfaG is required for LL12 infection.  Panel A is adapted from 




addition of Hep III in the LL5 host recognition mechanism. RfaY adds the phosphoryl 
group to Hep II and RfaQ links Hep III to Hep II (Yethon et al., 1998). The Keio rfaY 
mutant was ruled out during the initial screen and the plating defect of phage LL5 on the 
rfaQ transductant was mild (Table 4.6). From this information, it can be inferred that the 
plating defect of phage LL5 on the rfaP mutant is solely due to the absence of 
phosphoryl substituents on Hep I. Moreover, no other molecule is linked to the 
phosphoryl group of Hep I, thus it can be concluded that inner core of LPS is used by 
phage LL5 as its receptor and the phosphoryl group of Hep I is required by phage LL5 to 
infect its E. coli host. The LPS receptor requirement of phage LL5 appears similar to 
those of phage TLS (German & Misra, 2001). Phage TLS utilizes outer membrane 
protein TolC and the sugar residues Hep I (and its phosphoryl group), and Hep II of the 
LPS inner core to recognize and infect its E. coli host (German & Misra, 2001). The 
putative tail fibers of LL5 bear similarity to those of TLS, so it was intriguing why tolC 
did not come up as in screen. The requirement of tolC for LL5 infection still needs to be 
tested. 
 
Apart from the three genes that were involved in LPS biosynthesis, the plating efficiency 
of phage LL5 was also reduced in Keio strains with deletion in two other genes, secB 
and ppiB.  The EOP of phage LL5 was 0.06 and 0.09 in secB and ppiB strains, 
respectively. The plating defect in both strains could be restored to normal levels when 




contribute to protein translocation and proline peptide bond isomerization, respectively 
(Bechtluft et al., 2010; Unal & Steinert, 2014).  
 
Proteins, once synthesized in cytoplasm, are sorted into compartments of the cell by 
different protein transport systems. SecB, a tetrameric cytoplasmic chaperone, is a 
component of the general secretory (Sec) system that transports proteins synthesized in 
the cytoplasm, post-translationally, to the extra-cytoplasmic compartments. Post-
translational transport is primarily preferred for periplasmic and outer membrane 
proteins (Denks et al., 2014; Findik & Randall, 2017). SecB binds to polypeptides and 
keeps them in an unfolded state until cytoplasmic ATPase SecA directs the bound 
polypeptide to the SecYEG transmembrane channel (Findik & Randall, 2017). The 
translocation of polypeptides across the SecYEG channel is powered by the cytoplasmic 
ATPase SecA (Denks et al., 2014). Eighteen E. coli proteins have been reported to be 
dependent on SecB-mediated translocation (Bechtluft et al., 2010) (Findik & Randall, 
2017). We do not know if any of these SecB-dependent proteins play a role in the 
infection cycle of phage LL5, or if the potential accumulation of cytoplasmic protein 
aggregates in secB mutants hampers phage replication. In the absence of SecB, other 
cytoplasmic chaperones have been reported to be upregulated to stabilize secretory 
proteins during their delayed translocation and/or to rescue protein aggregates (Baars et 
al., 2006). This compensatory mechanism by other chaperones may be the reason why 





Another chaperone affecting the plating efficiency of phage LL5 is PpiB, which belongs 
to peptidyl-prolyl cis/trans isomerase (PPIase) superfamily of proteins, catalyzing 
protein folding at the peptide bonds preceding proline residues (Unal & Steinert, 2014). 
Although PPIases play a role in several biological processes, there is no evidence of any 
biological process depending solely on any PPIases (Unal & Steinert, 2014). The 
genome of E. coli K-12 encodes eight PPIases, belonging to three families: FKPBs, 
cyclophilins and parvulins (Unal & Steinert, 2014). The cyclophilins family consist of 
PpiA and PpiB, which are periplasmic and cytoplasmic proteins, respectively (Unal & 
Steinert, 2014). To our knowledge, there is only one reported instance of the requirement 
of a PPIase for a phage infection cycle: SlyD, belonging to FKBP family of PPIases, has 
been shown to be required for plaque formation by the ssDNA phage ΦX174 (Roof et 
al., 1994). SlyD is required to stabilize ΦX174 lysis protein E, so that it can accumulate 
to optimum levels to lyse the host cell (Bernhardt et al., 2002). Since the infection cycle 
of phage LL5 has not been characterized, it is difficult to explain which aspect of phage 
replication is affected by the absence of PpiB. 
 
Four genes were determined to be required for efficient propagation of phage LL12, as 
evident by the plating defect (Table 4.8). All Keio strains in which phage LL12 showed 
plating defects were deleted for genes in the LPS biosynthesis pathway. Phage LL12 
showed severe plating defects (EOP < 10-8) in lpcA and rfaE deletions, and an EOP of 
~10-6 in the rfaG deletion. The plating defect of phage LL12 was milder (EOP ~0.02) in 




the respective genes were supplied in trans. All complementation assays were conducted 
in the P1 transduced strains when applicable, and in the original Keio strains when the 
mutations could not be transduced by P1 (Table 3). 
 
The functions of genes lpcA, rfaE and rfaP in LPS biosynthesis have been explained in 
context of phage LL5 above. RfaG links glucose (Glc) I to Hep II of the LPS inner core 
(Fig. 4.3) (Parker et al., 1992; Yethon et al., 2000), and marks the start of the outer core 
domain of the E. coli LPS. Sugar residues Glc II and galactose (Gal) are linked to Glc I 
by RfaI and RfaB respectively (Schnaitman & Klena, 1993). The plating efficiency of 
phage LL12 in the respective rfaI and rfaB mutants were close to wild type (~0.5) 
suggesting that Glc II and the Gal sidechain do not play significant roles in phage LL12 
infection (Table 4.7). The strongly reduced EOP of phage LL12 on rfaG deletions 
suggests a crucial role of the outer core Glc I in the host recognition mechanism of 
phage LL12.  This Hep II - Glc I linkage is conserved in K-12, and R1 - R4 LPS core 
types in E. coli (Amor et al., 2000). As shown in Table 4.4, phage LL12 is able to infect 
E. coli strains with K-12, R1 and R3 LPS core types, which is consistent with the finding 
that the Gal sidechain residue linked to Glc I in the K-12 core and the residues 
downstream of Glc I are not involved in phage receptor binding. To our knowledge, 
LL12 is the first candidate from the group of V5-like phages for which the host receptor 
has been characterized. Based upon the sequence similarities of their tail fibers, other 
closely related V5-like phages such as rV5, ΦAPCEc02, and the O157:H7 typing phages 





From genetic analysis, we have established that phage LL12 recognizes the E. coli LPS 
core as its host receptor in a K-12 background. However, LL12 is also able to infect 
multiple different serotypes of E. coli with varying O-antigen (Table 4.4). In the case of 
phage P1, the extensive O-antigen expressed by hosts such as E. coli O157:H7 and 
Salmonella Typhimurium is able to obscure the LPS core and loss of the O-antigen 
results in bacterial sensitivity to this phage (Ornellas & Stocker, 1974; Ho & Waldor, 
2007).  This observation suggests that phage LL12 has developed a mechanism to deal 
with the presence of O-antigen that may obscure its receptor in the LPS core.  Several 
phages are known to have evolved mechanisms to reach the cell surface to recognize 
these polysaccharide coats to facilitate infection. The tail spike protein (TSP) of 
Salmonella phage P22 recognizes O-antigen as its receptor and also has 
endorhamnosidase activity and cleaves its glycosidic linkages resulting in the shortening 
of the O-antigen (Andres et al., 2010a; Andres et al., 2010b). Coliphage G7C also 
expresses tail spikes with enzymatic activity against O-antigen that is involved in phage 
adsorption (Prokhorov et al., 2017).  
 
Conclusions 
The Keio collection is a library of single-gene deletion of non-essential genes in E. coli 
K-12 strain BW25113. The library consists of 7970 mutants, with each mutant generated 
independently and distributed in odd- and even-numbered plates (Baba et al., 2006). 




candidates for therapeutic use, and phage LL12 was shown to infect representatives of 
several prominent STEC serovars. Both phages LL5 and LL12 were screened against the 
Keio library to investigate the host factors required for successful phage propagation. 
Initial screens suggested that twenty-one E. coli genes were necessary for phage LL5 
and LL12 propagation (Table 4.5), but on further analysis a total of 5 and 3 E. coli genes 
were found to affect the propagation of phages LL5 and LL12, respectively (Tables 4.5, 
4.8).  Based on these figures, the screening process resulted in a false positive rate of 
86%; the false negative rate of this screen cannot be calculated but target re-testing of 
genes of interest identified two additional genes not identified in the initial screens. 
These observations highlight the generally noisy nature of high-throughput screens and 
the requirement for additional confirmatory experiments following screening. 
 
Through successive verification screen, spot and full plate plaque assays, it was 
established that three E. coli genes were needed for each of phage LL5 and LL12 
propagation (Table 4.8), which gives a false positive rate of ~86% for both phages. Of 
the genes required for propagation of either phage LL5 or LL12, ~60% of the genes 
constitute the LPS biosynthesis pathway. It was noteworthy that all the genes pertaining 
to the LPS pathway did not come in the initial screen “hits”, so targeted screen by spot-
titer method was done for phage LL5 against Keio mutants lpcA and rfaE, and for phage 
LL12 against Keio mutant rfaE (Table 4.8); the gene disruption in Keio mutants lpcA 
and rfaE was verified beforehand. Both phages LL5 and LL12 exhibited plating defects 





The genes presented in this study may not be exhaustive list of genes necessary for 
phage LL5 or LL12 propagation because of limitations of these high throughput screens. 
If any biological pathway is comprised of multiple genes, it is likely that some genes 
will appear as “hits” in the initial screen and the role of other genes of that particular 
pathway can be tested by using verified gene mutants. The Keio collection, nevertheless, 
is a great library for initial screen, but data should be interpreted only after exhaustive 





CHAPTER V  
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Co-evolution of phages and their bacterial hosts have resulted in development of several 
defense and counter-defense strategies (Chapter I). This dissertation focuses on the study 
of antirestriction system of coliphage P1, employed to overcome bacterial type I 
restriction and modification (R-M) systems (Chapters II and III). Two components of P1 
antirestriction system, DarA and DarB, were described previously (Iida et al., 1987). 
From genetic analysis, it was demonstrated that DarA protects P1 DNA from type I 
EcoA, whereas DarB protects P1 DNA from type I EcoB and EcoK systems (Iida et al., 
1987). Chapter II of this dissertation provides evidence suggesting P1 antirestriction is 
comprised of other components besides DarA and DarB. It has been shown that DarB 
and Ulx are required for protection against EcoB and EcoK systems, whereas Hdf, 
DarA, and DdrA are required for protection against EcoA, EcoB and EcoK systems. 
Interestingly, disruption of ddrB provided increased protection against EcoB and EcoK 
systems. Biochemical evidence supported by genetic analysis, suggests that components 
of P1 antirestriction system are incorporated into P1 virions in a definite order. Hdf and 
DarA are incorporated first, followed by DdrA. DarB, Ulx and DdrB are incorporated 
next. Specific order of incorporation of DarB, Ulx and DdrB is not known, but it seems 
that Ulx can be incorporated only in the presence of DarB (Chapter II). The role of Hdf 
and DarA in capsid morphogenesis has also been demonstrated in Chapter II. When 




The roles played by Hdf and DarA in head-size determination and incorporation of 
antirestriction proteins suggest that P1 antirestriction system is linked to capsid 
morphogenesis. 
 
Chapter III further explores P1 antirestriction system following upon information 
provided in Chapter II. Since the P1 antirestriction components were encoded in two 
operons separated by genes of unrelated functions, it was hypothesized that other regions 
of P1 could encode for other unknown components of the P1 antirestriction system. To 
determine if there are any other components of P1 antirestriction system, isogenic 
knockouts of P1 genes of unknown functions, were constructed. Out of 29 genes deleted, 
24 were found not to be required for P1 propagation at tested laboratory conditions. 
Isogenic P1 mutants disrupted for these 24 genes were tested for restriction phenotype 
by plating assays. None of these 24 genes were found to be required for antirestriction 
function. However, five genes pmgA, pmgB, pmgC, pmgG and pmgR were found to be 
required for P1 propagation. The essentiality of these genes still need to be confirmed by 
in trans complementation. After the phenotype of these genes have been confirmed, 
lysates of these mutants can be observed under transmission electron microscopy to see 
if these mutants have any morphogenesis defect. Specific roles of these genes in virion 
morphogenesis, if any, can then be further studied. 
 
To understand the mechanism of antirestriction, incorporation of DarB into P1 capsids 




antirestriction components are packaged before DNA. It has been demonstrated in 
Chapter II that proteins of P1 antirestriction system contribute to a significant mass in P1 
capsids. Since P1ΔdarA cannot package any antirestriction components, it could have 
greater internal volume compared to that of P1. As DNA is packaged into P1 procapsids 
by headful mechanism (Bachi & Arber, 1977; Lobocka et al., 2004), it can be 
hypothesized that P1ΔdarA can package more DNA because of the availability of more 
internal capsid volume. This can be tested by pulsed-field gel electrophoresis of phage 
DNA (Lingohr et al., 2009). 
 
SDS-PAGE analysis of procapsid/tail fractions of P1ΔpacA and P1ΔdarA_pacA lysates 
indicate presence of novel proteins in lanes of both P1ΔpacA and P1ΔdarA_pacA, which 
are missing in the lane of CsCl purified P1 (Chapter III). Proteins present in procapsids, 
but not in mature virions, are indicative of scaffolding core (Dokland, 1999). These 
novel proteins can be identified by mass spectrometry and if determined to be virion-
associated, their role in capsid morphogenesis can be further explored. 
 
Moreover, evidence suggests that incorporation of DarB into procapsid is guided a signal 
provided by N-terminal residues of DarB (Chapter III). By testing incorporation of 
recombinant foreign proteins fused at their N-terminus with N-terminal DarB residues 
into P1 virions, it can be determined if these residues are sufficient for incorporation. 
Moreover, it can also be determined if these residues are sufficient for ejection of 




residues of DarB have been fused to TetR-mCherry fusion protein. By testing the 
incorporation of these fusion proteins into P1ΔdarB, the necessity and sufficiency of 
these selected N-terminal DarB residues for capsid targeting can be determined.  
 
Even though genetic evidence has established the role of DarB in protecting P1 DNA 
from host restriction, biochemical activity of protection still needs to be determined in 
vitro. As protein purification protocol for DarB has been optimized, further biochemical 
assay can be conducted with purified DarB to elucidate biochemical mechanisms for its 
antirestriction activity. Since DarB can be incorporated into P1 capsids only in the 
presence of other P1 proteins Hdf, DarA, DdrA, it is possible that DarB is interacting 
directly with some of these proteins. Also, DarB might be interacting with host 
components such as type I R-M subunits and host chaperones for its activity. Since the 
affinity tag for DarB purification has been optimized, same tag can be exploited to 
determine interacting partners of DarB by conducting pull-down assays.  
 
High throughput genetic screens were conducted for novel T1-like coliphage LL5 and 
rV5-like coliphage LL12 against the E. coli Keio collection to understand components of 
phage-host interactions. Receptors for both phages LL5 and LL12 were characterized 
and two chaperones, PpiB and SecB were demonstrated to be required for efficient 
propagation of phage LL5. Bioinformatic analysis suggests that both phages encode 




have not been characterized. Further experiments can be designed to characterize the 
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